Sharkwater Trading

🦈 WOLF: The Loss Did Not Get Four Times Worse. The Share Count Got Three Times Smaller.

noreply@blogger.com (Unknown) — Fri, 21 Aug 2026 21:05:34 +0000

SharkWater Trading • Semiconductors • Post-Bankruptcy Equity • Earnings

WOLF: The Loss Did Not Get Four Times Worse. The Share Count Got Three Times Smaller.

August 21, 2026

Bottom Line Up Front

Wolfspeed (NYSE: WOLF) reported fiscal Q4 2026 on Wednesday, August 19, after the close. Revenue was $149.6 million, dead on the midpoint of the company's own guidance. The adjusted loss was $2.26 per share against $0.77 a year ago, and the wires called it a four times miss. In dollars, the adjusted net loss was $116.9 million versus $119.8 million a year earlier. It got smaller.

The per share number blew out because the share count fell from 155.6 million to 51.8 million in the Chapter 11 exchange. Run last year's loss through this year's count and you get $2.31 a share, worse than what just printed. The real damage sits one line down: materials revenue fell 45 percent year over year and adjusted EBITDA deteriorated to negative $62.4 million from negative $40.7 million. The stock fell for the wrong reason and landed in roughly the right place.

What Actually Printed

Everything in this table comes out of the Q4 FY26 earnings release filed as Exhibit 99.1 on August 19, 2026, for the quarter ended June 28, 2026. Prior year figures are the predecessor entity, before fresh start accounting.

Q4 FY26 (quarter ended 6/28/26)	Actual	Q4 FY25
Revenue	$149.6M	$197.0M
Power products	$106.3M	$118.6M
Materials products	$43.3M	$78.4M
GAAP gross margin	-25%	-13%
Non-GAAP gross margin	-20%	-1%
GAAP net loss	-$145.4M	-$669.3M
GAAP loss per share	-$2.81	-$4.30
Non-GAAP net loss	-$116.9M	-$119.8M
Non-GAAP loss per share	-$2.26	-$0.77
Diluted weighted shares	51,799K	155,631K
Adjusted EBITDA	-$62.4M	-$40.7M
Operating cash flow	-$54.1M	-$242.5M
Free cash flow	-$60.9M	-$454.0M
Cash and short-term investments	$1,088.6M	$955.4M

Source: Wolfspeed Q4 FY26 earnings release, Exhibit 99.1, August 19, 2026. Non-GAAP reconciliation tables, pages 10 through 12. Predecessor and successor periods are not directly comparable under fresh start accounting.

Guidance for Q1 FY27 is revenue of $140 million to $160 million, non-GAAP operating expenses of $62 million to $66 million, and non-GAAP gross margin that remains negative. No date attached to when it stops being negative.

The Four Times Miss Is A Denominator

Wolfspeed filed a prepackaged Chapter 11 on June 30, 2025 and emerged on September 29, 2025. The old equity was largely exchanged. Diluted weighted shares went from 155.6 million to 51.8 million, a factor of three.

Now do the arithmetic the wire services did not. Last year's adjusted net loss of $119.8 million, divided by this year's 51.8 million share count, is $2.31 per share. This quarter printed $2.26. On a constant denominator, the adjusted loss per share was slightly better than the year ago quarter.

The boat landed about the same catch it landed last August. What changed is that the crew went from a hundred and fifty-six hands to fifty-two. Everybody's share got three times bigger, and what they are splitting here is a loss.

None of this makes the quarter good. It makes the headline meaningless. And the headline is what moved 4.3 million shares.

There Is No Consensus To Miss

Here is the part that should stop you cold. Depending on which vendor you pulled the number from, Wolfspeed missed by four hundred percent, missed by fifty percent, or beat.

Source	Q4 EPS estimate	Q4 revenue estimate	Implied verdict
Investing.com / Motley Fool	-$0.52	$223.55M	Miss by 4x, revenue -33%
TipRanks (via CNN), one estimate	-$1.47	n/a	Miss
TradingView / FactSet feed	-$2.45	$150.00M	Beat by 7.8%
Company guidance midpoint	n/a	~$150M	In line

Source: secondary financial outlets and quote vendors, retrieved August 20 to 21, 2026. These figures are irreconcilable and I am not going to pretend otherwise. TipRanks explicitly labels its number "one estimate."

A $223.55 million revenue estimate against a company that guided to $140 million to $160 million and printed $150.2 million the prior quarter is not an estimate. It is a stale row in a database. The most plausible explanation is a model that never got rebuilt after the restructuring split fiscal 2026 into a successor period and a predecessor period.

Analyst coverage collapsed alongside the equity. TradingView's forecast page shows a target range of $25 to $30. One vendor shows a single covering analyst. Another still carried a $9.22 average target from pre-emergence work. TD Cowen weighed in after the print with a Hold and a $25 target, which is at least fresh.

Rule of the boat: a company that has been through fresh start accounting inside the trailing twelve months has no usable consensus, no usable trailing multiple, and no usable chart. Go to the filing. Everything else is a vendor guessing at which period to add to which.

What The Quote Page Will Tell You, And Why It Is Wrong

Pull WOLF up on the majors right now and you will find a trailing P/E of 1.33 next to a trailing EPS of positive $23.57. You will also find a trailing P/E of negative 2.39 on a different site. Both are artifacts of the same thing.

Fiscal 2026 splits into a successor period that lost $415.8 million and a ninety-one day predecessor stub that booked net income of $420.2 million. Sum them and you get positive $4.4 million of "full year net income," which several aggregators now display. That $420.2 million is not earnings. It is a $563.4 million reorganization gain from discharging debt in bankruptcy court. Nobody made $4.4 million.

The 52 week range is equally useless. Vendors variously show a low of $1.16, $8.05, or $0.39, because the low was set by a different security under the same ticker. Reported beta ranges from 3.9 to 5.4 for the same reason. Trailing anything on this name is measuring a tide gauge that got moved.

The Line That Should Have Moved The Stock

Strip out the denominator noise and there is still a genuinely bad quarter underneath, and it is not the one anybody wrote about.

Materials revenue fell from $78.4 million to $43.3 million. That is down 45 percent year over year. Power products fell 10 percent. So the collapse is concentrated almost entirely in the wafer and substrate business, which is the part of Wolfspeed that was supposed to be the moat. Wolfspeed does not have a scale advantage in devices. It has one in silicon carbide crystal growth. That is the segment that just halved.

Second, margins moved the wrong way in a period when management is selling a margin recovery story. Non-GAAP gross margin went from negative 1 percent to negative 20 percent. Adjusted EBITDA went from negative $40.7 million to negative $62.4 million, a 53 percent deterioration, in a quarter where revenue only fell 24 percent. Fixed cost absorption on two large fabs running well below capacity is doing exactly what fixed cost absorption does.

Third, and this is the one I would want explained on the next call: gross capital expenditure was $5 million in the quarter, down from $38 million the prior quarter and $210 million in the year ago quarter. Free cash flow of negative $60.9 million looks contained precisely because the company stopped building. You cannot ramp 200 millimeter capacity and spend five million dollars a quarter at the same time. One of those two facts has to give.

The Balance Sheet Is The Thing That Actually Got Fixed

As of June 28, 2026	Amount
Cash, equivalents and short-term investments	$1,088.6M
Long-term debt	$931.0M
Convertible notes, net	$756.5M
Total debt	$1,687.5M
Net debt	~$599M
Total stockholders' equity	$930.2M
Q4 free cash flow burn	-$60.9M

Source: Q4 FY26 condensed consolidated balance sheet, unaudited, and free cash flow reconciliation. Net debt is my calculation from the filed line items, not a company-reported metric.

A year ago this balance sheet carried $6.5 billion of current maturities and negative $447 million of equity. Today it carries $1.7 billion of debt against $1.1 billion of cash and $930 million of positive book equity, with management stating on the call that there are no maturities before 2030. Holders of $46 million of convertible notes voluntarily converted during the quarter.

At the fourth quarter burn rate that is roughly seventeen quarters of runway. Treat that number as a ceiling, not a plan: it assumes capex stays at five million dollars a quarter, which it will not if the business is actually going to grow.

What You Are Paying

At roughly $26 a share against 52.0 million shares outstanding, the market cap is about $1.37 billion. Add the $599 million of net debt and enterprise value is close to $1.97 billion. Against fiscal 2026 revenue of $665.1 million, that is roughly three times sales. Against the annualized fourth quarter run rate of about $598 million, closer to 3.3 times.

Three times sales for a business with negative gross margins is not obviously cheap and not obviously expensive. It is a bet on what the fabs are worth to somebody, and the honest answer is that nobody has marked them recently.

The Tape

Date	Price	Note
May 22, 2026	$80.82	52 week high, post-emergence
Aug 17, 2026	~$31.46	Down 10% on the session, no company news
Aug 19, 2026 close	~$29.10	Down 7.5% into the print
Aug 19, 4:10pm ET	~$29.80	Initially up 2% on the release
Aug 20 intraday low	~$24.70	Down about 15% mid-morning
Aug 20 close	~$26.00 to $26.40	Sources disagree, see below

Source: multiple secondary quote vendors, retrieved August 20 to 21, 2026. All prices approximate and unsettled. Thursday's official closing print does not reconcile across sources: reported one day declines range from 9.4% to 15.8%. Do not size anything off this table.

Two details in there are worth more than the rest of the table. First, the stock traded up two percent in the minutes after the release, then reversed hard once the numbers ran through the estimate engines. The selling was not a reaction to the filing. It was a reaction to a comparison.

Second, the options market had priced a 13.7 percent post-earnings move going in. The realized one day move came in under ten percent by most readings. Whoever sold that event premium got paid, which is the usual outcome and worth remembering the next time a binary looks expensive.

Bull Case

The dollar loss did not deteriorate. Adjusted net loss of $116.9 million against $119.8 million a year ago. The entire per share blowout is the exchange ratio.
Solvency is no longer the question. $1.09 billion of cash, $599 million of net debt, positive book equity, and no maturities before 2030 per management. A year ago this company had $6.5 billion of debt coming current.
The data center line is compounding. AI data center revenue more than doubled across fiscal 2026 and grew about 20 percent sequentially in Q4, with the Gen 5 SiC MOSFET launched, a LITEON collaboration announced, and a memorandum of understanding with GE Aerospace. Small base, right direction.
Management forecast its own business correctly. Revenue landed at the midpoint of guidance. For a company twelve months out of bankruptcy court with a new CEO and CFO, forecasting accuracy is a real signal.
You are paying roughly three times sales for the largest western silicon carbide substrate producer, with two 200 millimeter fabs already built, capitalized, and described by management as production ready.

Bear Case

The moat business halved. Materials revenue down 45 percent year over year. Devices are a competitive scrum. Crystal growth was supposed to be the defensible piece, and it is the piece that fell apart.
Margins moved the wrong way. Non-GAAP gross margin from negative 1 percent to negative 20 percent, adjusted EBITDA 53 percent worse year over year. Guidance says gross margin stays negative next quarter, with no date attached to when it does not.
The cash flow is flattered by a capex stop. Five million dollars of gross capital expenditure in a quarter, down from $210 million a year ago. That is not discipline at a company whose entire thesis is a 200 millimeter ramp. It is a pause.
Dilution is structural. $756.5 million of convertible notes net, sitting above a 52 million share count with a float of roughly 34 million. $46 million already converted voluntarily in Q4. Every good outcome for the equity accelerates the conversion.
Automotive visibility is poor by management's own account. The CEO flagged that automotive and industrial demand remains difficult to predict, including customer product mix changes. That is the volume that fills the fabs and fixes the absorption problem.

The SharkWater Take

I am not buying this and I am not shorting it, and I want to be precise about why, because the reasoning is not "it is risky."

The market sold Wolfspeed on a comparison to a number that three different vendors could not agree on, one of which scored the same print as a beat. That is a bad reason to sell a stock. But it arrived at a defensible price anyway, because underneath the noise the materials segment lost 45 percent of its revenue and the company is burning $62 million of adjusted EBITDA a quarter while spending five million dollars on capital equipment. Being right for the wrong reason is still being right. I am not going to fade a selloff just because the crowd got there sloppily.

What I would need to see is not complicated and it is not a lease or a contract or a partnership announcement. It is two consecutive quarters where materials revenue stops falling and gross capex goes back above thirty million dollars without the cash balance cratering. That combination would mean demand returned and management believed it enough to spend. Until then this is a well financed company with a shrinking moat business, and the balance sheet buys it time rather than momentum.

The tradeable observation here is not directional. It is that this ticker is a data quality trap. Anyone running a screen on trailing P/E, 52 week range, EPS surprise, or beta is screening a security that did not exist eleven months ago. If you find yourself looking at a positive 1.33 P/E on a company with negative gross margins, the screen is broken, not the market. That is worth more than a view on silicon carbide.

One more thing, on the vol. The event premium was 13.7 percent implied against a realized move under ten. Post-event implied volatility on a name like this usually stays elevated for a week or two after the catalyst has already passed, which is the single most reliably mispriced thing in the whole setup. I have not pulled the chain, so I am not putting strikes in print.

What I Could Not Reconcile

Thursday's closing price. Reported one day declines for August 20 span 9.4 percent to 15.8 percent across vendors, implying closes anywhere from $24.50 to $26.40. Every price in this post is approximate.

Consensus estimates. Four different figures, no way to adjudicate. I have shown all of them rather than picking the one that supports a narrative.

Debt maturity schedule. Management's "no maturities before 2030" comes from earnings call coverage, which is secondary. Bond listings for the outstanding paper show 2031 maturities on three issues. Consistent, but I have not read the indentures.

Gross versus net capex. The filed cash flow statement shows property and equipment spending net of incentive reimbursements. The $5 million gross figure comes from the earnings deck as reported by a secondary outlet, not from the release itself.

No options chain. I did not pull live quotes. No strikes, no premiums, no ladder in this post. The implied move figure of 13.7 percent is pre-earnings reporting, not a live read.

Triggers

The 10-K. Due within weeks of the release. That is where the segment detail, customer concentration, the full convertible note terms, and the going concern language actually live. The press release is a summary of a summary.

Materials revenue, Q1 FY27. Reports October 28, 2026. If $43.3 million goes to $35 million, the moat argument is finished and the three times sales multiple has to come down.

Gross capex. A return above thirty million dollars a quarter says management sees demand. A second quarter at five million says they do not.

Convertible note conversions. Each 8-K disclosing voluntary conversion tells you the notes are in the money and the share count is climbing. Track the count, not the price.

What invalidates the cautious read: a quarter with positive non-GAAP gross margin and stabilizing materials revenue. At that point the balance sheet stops being a life raft and starts being dry powder, and the multiple is arguably too low.

Fair winds and following seas.

Disclaimer: This post is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Financial figures are drawn from Wolfspeed's fiscal fourth quarter 2026 earnings release dated August 19, 2026 and are unaudited and subject to revision in the Form 10-K. Predecessor and successor period figures are not comparable under fresh start accounting. Share prices, market capitalization, enterprise value, net debt, and per-share restatements are approximate, are the author's calculations from filed line items rather than reported company metrics, and were retrieved from secondary vendors between August 20 and August 21, 2026. Analyst estimates cited are irreconcilable across sources and are reproduced as found. The implied move figure is pre-earnings secondary reporting, not a live options quote, and no executable option prices appear in this post. Forward-looking guidance regarding revenue, operating expenses, gross margin, and debt maturities is management's, not the author's. Wolfspeed is a recently reorganized issuer with negative gross margins, negative operating cash flow, and substantial convertible obligations, and its shares are highly volatile. Verify all figures against primary filings before acting. Past performance does not guarantee future results. Consult a licensed financial professional regarding your specific situation.

🦈 USA: Eleven Years, $7.01 Paid Out, And The Exact Same $6.84 NAV

noreply@blogger.com (Unknown) — Thu, 20 Aug 2026 01:33:17 +0000

SHARKWATER TRADING • CLOSED-END FUNDS • INCOME • DISCOUNT MECHANICS

USA: Eleven Years, $7.01 Paid Out, And The Exact Same $6.84 NAV

August 19, 2026

BOTTOM LINE UP FRONT

Liberty All-Star Equity Fund (NYSE: USA) pays approximately 10 percent of net asset value a year, in four quarterly installments of 2.5 percent. Unlike most double digit payers, the money is real: every 2025 distribution was characterized as ordinary dividends and long term capital gains, with zero return of capital in the final tax accounting and $163.4 million designated as long term capital gain dividends.

Here is the number that actually describes the vehicle. NAV per share was $6.84 at the end of 2014 and $6.84 at the end of 2025. Over that stretch the fund distributed roughly $7.01 per share. This thing is not built to compound your share price. It is built to convert a diversified large cap portfolio into quarterly cash and hand the base back to you unchanged in nominal terms.

The only live variable is the discount, and it has moved against holders all year. Shares closed July at $5.81 against a $6.60 NAV, a 12.0 percent discount, the widest reading in at least two years. NAV is up 4.96 percent year to date. The share price is up 0.63 percent. That gap is the whole trade, and the yield has nothing to do with it.

What You Are Actually Buying

USA is a closed end fund that launched in 1986 and, per the fund's own materials, was the first closed end fund to bring multi-management to individual investors. Assets are split roughly equally among five independent institutional managers: three value shops and two growth shops. ALPS Advisors sits above them and has the authority to hire and fire.

The Board used that authority this year. Effective June 15, 2026, Loomis, Sayles & Company, with Aziz Hamzaogullari's team, replaced Sustainable Growth Advisers as one of the five managers. The current lineup is Aristotle, Fiduciary Management and Pzena on value, Loomis Sayles and TCW on growth.

The portfolio itself is the least exotic thing on my watchlist. As of the December 31, 2025 audited annual report: 137 holdings, top ten at 26 percent of the fund against 41 percent for the S&P 500, a price to earnings ratio of 26 times versus 29 times for the index, and a weighted average market cap of $795 billion versus $1.435 trillion. It is a real diversified portfolio in a market that has not paid for diversification in four years.

Where It Stands Right Now

Metric	Reading
NAV per share	$6.60
Market price	$5.81
Premium / (Discount)	-12.0%
Net assets	$2,033.2M
2026 YTD return, NAV	+4.96%
2026 YTD return, market price	+0.63%
Top 20 holdings	39.1% of equity portfolio
Largest position	NVIDIA, 5.7%
Most recent declared distribution	$0.17, ex July 16, payable Aug 31, 2026

Source: Liberty All-Star Equity Fund July 2026 Monthly Update, issuer release dated August 14, 2026, all data as of July 31, 2026. Distribution per the issuer release dated July 6, 2026. No live quote is used anywhere in this post.

The History: Four Different Payout Rates In Four Decades

The distribution policy has been in place since 1988 and the marketing describes it as a rate "that approximates historical equity market returns." Read that carefully, because it is an admission. The payout is not funded by income. It is a decision to distribute the expected long run return of the portfolio whether or not the portfolio delivered it that year.

The rate itself has moved four times, and the moves tell you more than the current number does.

Period	Annual rate	What triggered the change
1988 to Q1 2009	10% of NAV	Original policy
Q2 2009 to Q1 2015	6%	Cut in the wreckage of the financial crisis
Q2 2015 to Q3 2017	8%	Raised to realign with historical equity returns
Q4 2017 to present	10%	Board cited narrowing the discount as a goal

Source: Table of Distributions, Tax Credits and Rights Offerings, Form N-CSR for the year ended December 31, 2025, footnotes 3, 4 and 5. Q4 2017 rationale from the Fund's third quarter 2017 shareholder report.

Note what happened in 2009. The Board cut the rate by 40 percent at exactly the moment shareholders wanted the cash most. That is the correct decision for a fund that does not want to liquidate itself into a crash, and it is also the precise reason nobody should treat the 10 percent as a contract. It is a policy, and policies get changed by the same eleven people who wrote them.

The dollars follow the same story:

Year	Distributions per share	Context
2000	$1.42	Peak year of the original 10% era
2008	$0.65	Last full year before the cut
2009	$0.31	Rate cut to 6% effective Q2
2017	$0.56	Rate restored to 10% effective Q4
2021	$0.81	Recent peak
2023	$0.61	Post-2022 drawdown low
2024	$0.71
2025	$0.67
Total since 1987	$31.67	More than $4.0 billion paid out

Source: Form N-CSR for the year ended December 31, 2025, Table of Distributions, Tax Credits and Rights Offerings.

A shareholder collecting $1.42 a share in 2000 collected $0.67 in 2025. The advertised rate never changed by a basis point across most of that span. The rate is a percentage of a number that moves, so it can look permanent while the cash quietly halves. Same mechanic I wrote about in the THTA post, different plumbing.

The Eleven Year Round Trip

Here is the cleanest way to understand what this fund does.

NAV per share entering 2015 was $6.84. NAV per share on December 31, 2025 was $6.84. Over the ten years ending December 2025 the fund distributed $6.50 per share, and 2015 added another $0.51. Call it $7.01 of cash out the door against a base that finished exactly where it started.

That is the machine working as designed, and it deserves to be said plainly before the criticism starts. The fund did not eat its principal. It earned enough to pay out more than 100 percent of its starting NAV over eleven years and still hand back the same nominal base. Plenty of double digit payers cannot say that. THTA gave back $4.33 of a $20 NAV over less than three years to fund a comparable headline rate.

But a flat nominal base over eleven years is a shrinking real one. Every dollar of that $6.84 buys measurably less in 2026 than it did in 2014. For a shareholder taking the distribution in cash, there is no per share compounding at all, by construction. The entire return arrives as a check and then leaves. That is a feature if you need income and a serious problem if you were expecting a growth fund with a nice dividend attached.

The fund's own long run illustration makes the point better than I can. A hypothetical $10,000 buying shares at the December 31, 1987 closing price of $6.00, with all distributions taken in cash, grew to $61,433 by December 31, 2021. The same $10,000 with everything reinvested grew to $410,893. Roughly 5.5 percent annualized against roughly 11.6 percent, over the same thirty four years, in the same fund.

Source: Form N-CSR for the year ended December 31, 2021, Growth of a Hypothetical $10,000 Investment. Annualized rates are my calculation from those endpoints, not fund-reported figures. The reinvestment scenario also assumes the shareholder exercised all primary rights in the Fund's rights offerings, which required additional capital beyond the original $10,000.

Six percentage points a year of difference, driven entirely by whether the cash goes back in. If you own this fund and spend the distribution, you are earning something close to a bond-like number from an all equity portfolio. Know which of those two lines you are on before you buy.

Distribution Quality: The Part That Actually Checks Out

My default assumption with any double digit payer is that a large slice of the money is your own capital coming back with a bow on it. That is not what the filings say here.

The 2025 annual report states that all 2025 distributions consist of ordinary dividends and long term capital gains, and the fund designated $163,414,020 as long term capital gain dividends under Section 852(b)(3) for the year. Zero return of capital in the final tax characterization. On $0.67 per share across roughly 300 million shares, the realized gains genuinely covered the payout.

That is what a 10 percent distribution looks like when the underlying portfolio actually produced 10 percent. It is also why USA is a fundamentally different animal from a fund that manufactures its yield out of an options overlay and a NAV drip.

One flag for 2026. The fund's monthly updates through July 2026 carry standing language that, based on current estimates, a portion of this year's distributions consists of return of capital. Those are Section 19(a) estimates, not final tax character, and 2025's estimates also carried that boilerplate before the year closed clean. Do not read it as a scandal, and do not read it as nothing either. The final answer lands on the 2026 Form 1099-DIV, and the number to watch is whether realized gains cover the payout in a year where NAV total return is running under 5 percent.

Performance: The Benchmark You Pick Does All The Work

Annualized, periods ended 12/31/2025	3 Years	5 Years	10 Years
USA, shares valued at NAV	16.10%	9.16%	11.84%
USA, shares valued at market price	14.15%	8.73%	12.50%
S&P 500 Index	23.01%	14.42%	14.82%
Lipper Large-Cap Core Average	20.76%	12.71%	13.46%
S&P 500 Equal Weight Index	12.76%	10.48%	11.71%
Distributions paid per share	$1.99	$3.49	$6.50

Source: Form N-CSR for the year ended December 31, 2025, Long-Term Performance Summary. Fund returns are net of expenses and assume reinvestment at actual reinvestment prices and exercise of all primary rights.

Against the cap weighted S&P 500 this fund has been beaten badly and consistently. Three years, five years, ten years, no argument. Against the equal weight version of the same index it beat on three years, lost on five, and edged it on ten. That is the honest comparison for a portfolio whose top ten is 26 percent of assets against an index whose top ten is 41 percent.

Management makes exactly this argument in the annual report, and it is a fair one rather than an excuse. It is also cold comfort. Shareholders do not get to spend a relative return against the benchmark they wish they owned.

The line I keep returning to is the five year: 9.16 percent annualized at NAV, against a policy that distributes 10 percent of NAV every year. A fund that pays out more than it earns is shrinking its own per share base. Reinvesting shareholders partially offset that, because they buy new shares at a discount. Cash-taking shareholders do not. In a decade of average or below average equity returns, that math grinds in one direction only.

It works like a well with a pump set to draw a fixed amount every quarter regardless of rainfall. In wet years the level holds and nobody thinks about it. In dry years the level drops, the pump keeps its setting, and the change only becomes visible when somebody finally lowers a rope and measures.

The Discount Is The Only Variable You Can Actually Trade

The portfolio is a diversified large cap book. You are not going to out-analyze five institutional managers on Capital One and Broadcom. The one thing in this security that is genuinely mispriceable is the spread between what the assets are worth and what the shares cost.

Period	Premium / (Discount) range	Endpoint
Calendar 2024	+0.8% to -5.8%
Calendar 2025	+1.2% to -10.4%	-8.2% at year end
July 31, 2026		-12.0%

Source: Form N-CSR for the year ended December 31, 2025, President's Letter, and the July 2026 Monthly Update dated August 14, 2026.

Shares traded at a premium to NAV as recently as calendar 2025. They now sit 12 percent below it. That move is the entire reason NAV is up 4.96 percent this year while the shares are up 0.63 percent. Roughly four points of shareholder return were consumed by sentiment, not by anything in the portfolio.

At a 12.0 percent discount, the arithmetic of the payout changes too. Four quarters at the most recently declared $0.17 is $0.68 a share. Against the $6.60 NAV that is 10.3 percent, right on policy. Against the $5.81 share price it is 11.7 percent. You are buying the payout stream at a discount to the assets generating it.

The $0.68 figure is a run rate, calculated by annualizing the single most recently declared quarterly payment. It is not a forward yield, not a guaranteed figure, and not a fund-published number. The actual next payment will be 2.5 percent of NAV on the Friday before the next declaration.

The Reinvestment Mechanic Nobody Reads

Every distribution release contains the same sentence, and it matters more at a 12 percent discount than it did at a premium. Shares under the reinvestment plan are issued at the lower of NAV or market price on a set date, but not less than 95 percent of market value. For the August 31 payment, that reference date is August 14, 2026.

Work through what that means when the shares trade below NAV. The fund issues new shares at roughly the market price while each share represents a larger amount of NAV. Reinvesting shareholders get more than a dollar of assets for every dollar they forgo, which is a genuine benefit to them. The offset is that issuing shares below NAV dilutes NAV per share for everybody, including the shareholder who elected cash.

Share count grew from 294,774,236 at the June 2025 record date to 301,551,615 at year end 2025, roughly 2.3 percent in six months, with no rights offering since 2021. The wider the discount, the more that machinery works against the cash-taker and for the reinvestor. If you own this fund at a double digit discount and you are taking the cash, you are on the wrong side of your own dividend reinvestment plan.

Reinvestment plan terms per the issuer distribution release dated July 6, 2026. Share counts per the Form N-CSR for the year ended December 31, 2025. The dilution conclusion is my derivation from those stated terms, not a fund-reported metric.

Bull Case

The distribution is earned, not manufactured. Zero return of capital in the final 2025 tax character, with $163.4 million designated as long term capital gain dividends. That is rare at this payout level.
The discount is at the wide end of its own recent history. Twelve percent below NAV, in a security that traded at a premium during 2025. You are paying $0.88 for a dollar of NVIDIA, Alphabet, Wells Fargo and Visa.
The effective payout on market price is 11.7 percent. The discount does not just offer capital upside, it mechanically lifts the cash return on every dollar you commit.
The portfolio is cheaper and broader than the index. 26 times earnings against 29 times, top ten at 26 percent against 41 percent, 137 names. If breadth improves, relative performance improves without management doing anything clever.
The advisor fires managers. Loomis Sayles replaced Sustainable Growth Advisers in June 2026 after a stretch of weak relative returns. The oversight layer is not decorative.
Forty years of operating history and $4.0 billion distributed. The structure has survived 2000, 2008, 2020 and 2022. Very little on my watchlist can say that.

Bear Case

The payout exceeds the five year return. Ten percent distributed against 9.16 percent annualized at NAV over five years. The fund needs an above average decade just to stand still per share.
It trails its own primary benchmark. NAV returned 8.80 percent in 2025 against 15.31 percent for the Lipper Large-Cap Core Average. Three, five and ten year figures all trail Lipper and the S&P 500.
The reinvestment plan dilutes NAV per share at a discount. Shares issued near market price while NAV sits 12 percent higher. Cash-takers absorb that.
The rate is a policy, not a promise.The Board cut it from 10 percent to 6 percent in 2009 and the annual dollars fell from $0.65 to $0.31. That precedent exists and the same mechanism is still in place.
The discount is widening, not narrowing. The 2017 rate increase was partly justified as a way to compress the discount. Nine years later the discount is wider than it was then, which is a reasonably direct verdict on that theory.
Diversification is the position, and it has been the wrong one. If AI leadership stays narrow, a 137 stock portfolio with a $795 billion weighted average market cap keeps losing to the index by construction.

The SharkWater Take

I like USA more than I like most things paying double digits, and I would buy it for a reason that has nothing to do with the yield.

The distribution here is honest. I went looking for the return of capital story and it is not there, at least not in 2025. That closes off my usual line of attack and forces a different question: what do you actually own? You own a diversified large cap portfolio with a rule attached that converts its entire long run return into quarterly cash. Per share, in nominal terms, it has gone nowhere in eleven years and it is not supposed to. The compounding lives entirely in the reinvestment decision, which the fund's own 1987 illustration prices at roughly six percentage points a year.

So the yield is not an edge. Ten percent of NAV distributed from a portfolio earning 9.16 percent over five years is not income, it is a schedule. The edge, if there is one today, is that the market has marked this basket down 12 percent below the value of its contents, in a fund that was trading at a premium last year. That is a spread I can measure, and it is the only thing in this security that is plausibly mispriced.

My read: this is a buy on the discount, held for the discount, with the payout treated as carry while you wait. If the spread closes back toward the 5 to 8 percent range that prevailed through 2024 and early 2025, you collect a mid single digit capital gain on top of a market return, in a name where the downside is a diversified equity portfolio rather than a story. If the spread never closes, you have bought a slightly cheap index proxy that mails you 11.7 percent a year and compounds only if you send it back. That is a fine outcome and a poor one at the same time, depending entirely on what you thought you were buying.

What I would not do is own this instead of bonds, or size it as though the 10 percent were a coupon. It is equity. The NAV fell more than 20 percent in 2022 and the distribution fell with it, because that is exactly what the formula does.

Two things I am watching. First, the fourth quarter Section 19(a) notices and the eventual 2026 Form 1099-DIV, to see whether the return of capital estimates in this year's monthly updates survive into the final tax character. A year with sub-5 percent NAV total return and a 10 percent payout is precisely when that changes. Second, whether the discount stabilizes. It has gone from a premium to negative 12 percent in about eighteen months, and I want to see it stop widening before I believe the mean reversion story.

Execution Notes

Anchor on the discount, not the price. The relevant number is the spread to NAV, which the fund publishes monthly and daily on its own site. A share price that looks cheap at a 3 percent discount is expensive relative to one that looks dear at 12 percent.
You can calculate the next distribution before it is announced.The payment is 2.5 percent of NAV at the close on the Friday prior to the declaration date. The 2026 declarations landed January 12, April 6 and July 6, which points to an early October window for the fourth quarter. That cadence is my inference from this year's pattern, not a date the fund has confirmed.
Make the reinvestment election deliberately. At a wide discount the plan issues shares at roughly market price against a higher NAV. Taking cash while the discount is double digit means paying for someone else's accretion.
Tax location matters more than usual. The 2025 distributions were ordinary dividends and long term capital gains, so the character is reasonably friendly, but a 10 percent annual distribution generates a taxable event every quarter whether or not you wanted one.
What invalidates the thesis: the discount widening through the negative 15 percent area without a market-wide closed end fund selloff to explain it, a 2026 tax character that comes back materially return of capital, or a Board move to cut the rate, which would be the 2009 playbook running again.

What I Could Not Verify

Three things, stated plainly rather than papered over. I did not pull the fund's total expense ratio from the December 31, 2025 financial highlights, so no fee figure appears anywhere above. I did not use a live quote: the most recent issuer-published price and NAV in this post are as of July 31, 2026, and the shares have traded for two and a half weeks since. And the Section 19(a) source-of-distribution detail for individual 2026 payments is referenced only through the standing language in the monthly updates, not through the individual notices themselves.

Fair winds and following seas.

Disclaimer: This post is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Fund data, distribution history, performance figures and tax characterizations are drawn from Liberty All-Star Equity Fund's Form N-CSR for the year ended December 31, 2025, its Form N-CSR for the year ended December 31, 2021, and issuer press releases dated July 6, 2026 and August 14, 2026. NAV, market price and discount figures are as of July 31, 2026 and are stale by the time you read this. Annualized return calculations on the hypothetical $10,000 illustration, the $0.68 distribution run rate, the payout-on-market-price figure and the reinvestment dilution conclusion are the author's derivations from fund disclosures, not fund-reported metrics. Distribution rates are not yields, are not guaranteed, and the Fund has reduced its distribution rate before. Estimated sources of distribution are not final tax character, which is determined on Form 1099-DIV after year end. Closed-end funds frequently trade at discounts to net asset value and those discounts can widen indefinitely. Past performance does not guarantee future results. Verify all figures against primary filings before acting and consult a licensed financial professional regarding your specific situation.

🦈 5.33 Percent On The Long Bond, And Three Setups With No Paper Behind Them

noreply@blogger.com (Unknown) — Wed, 19 Aug 2026 15:42:28 +0000

SharkWater Trading • Desk Notes • Rates • AI Infrastructure • Data Gaps

5.33 Percent On The Long Bond, And Three Setups With No Paper Behind Them

August 19, 2026

Bottom Line Up Front

The thirty year Treasury yield touched 5.33 percent on August 18, the highest since June 2007, after clearing 5.311 percent on the 17th. The space, nuclear, and data center complex sold off five to sixteen percent across the board. Almost none of those companies reported anything. They were repriced, not re-rated.

Three names had their own news. Nebius (Nasdaq: NBIS) launched a $4.50 billion convertible offering this morning and fell hard. Fundrise Innovation Fund (NYSE: VCX) ran about 19 percent on August 17 against a NAV last struck on March 31. Cerebras (Nasdaq: CBRS) shipped its CS-4 and lost 12.7 percent. I am not writing a trade on any of them today, because in all three cases the document that decides the trade has not been published. That is the post.

The Only Thing That Actually Happened This Week

Strip out the single stock headlines and the tape has one driver.

Instrument	Level	Note
30 year Treasury, Aug 17	5.311%	Highest since June 2007
30 year Treasury, Aug 18	~5.285% settle	Touched a fresh 19 year high intraday
10 year Treasury, Aug 18	~4.706%	Down about 1bp on the session
2 year Treasury, Aug 18	~4.175%	Essentially unchanged
$25B 30 year auction, prior week	5.216%	Highest auction stop since 2001

Source: CNBC and Bloomberg reporting on Treasury market levels, August 17 and 18, 2026. Intraday levels, not official close prints. The 5.33 percent figure is a secondary-source intraday high and has not been checked against the H.15 release.

Read the shape of that table, not the levels. The two year did not move. The ten year did not move. The long bond did. This is not the market repricing Fed policy. It is the market repricing the willingness to fund thirty year paper, against a June TIC report showing the United Kingdom, China, and Japan all trimming Treasury holdings, and against a calendar of long dated issuance that is not getting smaller.

Think of the discount rate as depth of water under the keel. Nothing about any of these boats changed on Tuesday. The tide dropped roughly sixty basis points at the long end over a month, and the hulls sitting deepest, the ones whose cash flow does not arrive until 2030, are the ones that touched bottom first.

Every name on this list is a duration asset wearing an equity ticker. A nuclear developer with first power in the early 2030s. A data center landlord commissioning in 2027. An inference company with a backlog that converts over eight years. When the long end moves, the present value of 2032 moves more than the present value of next quarter. That is arithmetic, not sentiment, and it explains a five to sixteen percent bucket move better than any single company story does.

NBIS: The Selling Is In The Press Release, Three Paragraphs Down

Nebius announced its intention this morning to offer $4.50 billion of convertible senior notes in two series: $2.75 billion due February 15, 2030 and $1.75 billion due February 15, 2034. Initial purchasers get an option on up to another $375 million of 2030 notes and $300 million of 2034 notes, so the deal can reach $5.175 billion. Proceeds are earmarked for data center construction, buildout, GPU procurement, and general corporate purposes.

The stock was quoted down between roughly 7.6 and 9.9 percent intraday depending on when you looked, on top of the prior session. Two day drawdown in the neighborhood of sixteen percent. Every wire story I read attributed that to dilution from the convert. That is the lazy read.

Read the exchange paragraph. Concurrently with pricing, Nebius expects to enter privately negotiated agreements with holders of its existing 2.00 percent notes due 2029 and 3.00 percent notes due 2031, exchanging a portion of that paper for Class A ordinary shares. The company then states, in its own release, that participating holders may sell those shares in the open market and enter into or unwind derivative hedge positions, and that this could decrease the market price of the Class A shares and may also affect the initial conversion price of the new notes.

That is the issuer telling you, in advance, that mechanical share supply and hedge unwinds are coming. Some material portion of today's move is that, not a verdict on the business. It is the same species of thing as a leveraged ETF rebalance. The print is not information.

What Is Known And What Is Not

Term	Status as of Aug 19
Size	$4.50B, up to $5.175B with the option. Known.
Maturities	Feb 15, 2030 and Feb 15, 2034. Known.
Coupon	Set at pricing. Not known.
Initial conversion rate and price	Set at pricing. Not known.
Accretion schedule	Set at pricing. Not known.
Call protection	No optional redemption before Feb 21, 2028 (2030s) or Aug 21, 2028 (2034s), then subject to a 130% price trigger, or 150% for 2034s redeemed between Aug 21 2028 and Aug 21 2029. Known.
Size of the note-for-share exchange	Individually negotiated. Not disclosed, may not happen at all.

Source: Nebius Group N.V. press release, August 19, 2026, issued via Business Wire. Terms are as proposed and the offering is not guaranteed to complete.

Note the accretion structure, because it is unusual enough to matter. Principal accretes to a premium over the original amount by maturity, and the redemption price is the accreted amount. But conversion is computed off the original principal, not the accreted principal. That splits the economics: bondholders get a compounding floor, equity holders get a conversion threshold pinned to the smaller number. Whether that is cheap or expensive capital depends entirely on the coupon and conversion premium, and neither exists yet.

One more thing worth putting in front of you. In March 2026 Nebius announced $3.75 billion of converts and priced upsized at $4.0 billion. Add today's deal and this company has brought up to roughly $9.2 billion of convertible paper to market in five months, and is simultaneously retiring some of the earlier tranches into stock. That is not a capital raise. That is a capital structure being rebuilt in public, at speed, while the long end sells off.

VCX: Two Corrections, And A NAV That Is Four And A Half Months Old

Fundrise Innovation Fund did run about 19 percent on August 17. The framing in my notes was wrong twice, so let me fix it before anything else.

Correction one: this was not an insider lockup. The post listing lockup covered restricted shares held by roughly 100,000 pre-listing retail investors, with an average cost basis reported around $10 to $11 a share. Fundrise accelerated the expiration on July 24 from September 14 to August 13, which made those shares tradable on August 14. Calling it an insider unlock gets the supply profile backwards. This is a hundred thousand retail accounts sitting on three to four times money, not a handful of affiliates.

Correction two: the August 17 move was almost certainly not the unlock. The unlock already traded, on the 13th and 14th. Here is the actual tape.

Session	Close	Move	What happened
Aug 12	$31.89	n/a	Day before expiration
Aug 13	$38.50	+20.73%	Lockup expires. Supply still locked. 1,402,447 shares.
Aug 14	$34.40	-10.6%	First tradable session. ~3.8M shares, roughly 17x median. All-time low $28.71 intraday.
Aug 17	$41.00	~+19%	Anthropic valuation headlines circulate
Aug 18	$40.10	-2.2%	Range $37.26 to $42.95

Source: session data compiled from Investing.com quote pages and third-party unlock analysis, August 2026. Not exchange-official. The August 17 attribution is inference from the timing of press coverage, not a company disclosure.

Anthropic is the fund's largest position at roughly 20.7 percent of the portfolio. On August 17 a wave of coverage put Anthropic's 2026 revenue somewhere between $100 billion and $120 billion, with public market speculation attaching a valuation well north of a trillion. A fund with a fifth of its book in one private company moved 19 percent on a headline about that company's hypothetical listing price. That is coherent. It has nothing to do with the lockup.

The Number Everything Hangs On, And Why I Will Not Publish It Yet

The last NAV I can find attached to a filing is $18.97 per share, for the period ended March 31, 2026. At the August 18 close of $40.10 that is a premium of roughly 111 percent. Which would be the entire story, except for three problems.

One. That NAV is four and a half months old, and it predates a materially higher Anthropic mark. If Anthropic's carrying value rose between March 31 and June 30, the premium the market is paying is smaller than 111 percent, possibly much smaller.

Two. The $18.97 figure has already been the subject of a public correction elsewhere. At least one widely read analysis originally published a NAV of $18.43, could not substantiate it against a primary source, and replaced it. When two versions of the anchor number are circulating, the anchor is not verified until you have the filing open in front of you.

Three, and this one is mine. A reported market cap of about $1.16 billion against a $40.10 price implies roughly 29 million shares. The August 14 volume, reported at about 3.8 million shares and described as 10.8 percent of shares outstanding, implies roughly 35 million. Those do not reconcile. Share count is an input to every premium calculation on this page, and I do not currently have a version of it I would defend.

The June 30 NAV print is the trade. Everything else is noise around a stale photograph. On the sister vehicle at Robinhood the quarterly update landed about sixty days after quarter end, which would put a Fundrise June 30 disclosure somewhere in the back half of August. That is now. Set the alert, pull the filing, then do the arithmetic. Not before.

CBRS: The Benzinga Miss Is The Warrant Footnote Again

Short answer to the question in my notes: the revenue miss is almost certainly not a business miss. It is the customer warrant amortization, and we wrote the mechanic up on August 17.

Line	Q2 2026	Comment
Core revenue	$209.9M	Up 103% year over year
Reported sales, as cited by Benzinga	$180.11M	Against $194.20M consensus
Gap between the two	~$29.8M	Author's arithmetic, not a company-disclosed line
Full year 2026 core revenue guide	$880M to $890M	Raised from $855M to $865M
Q3 revenue guide	~$215M	Consensus ~$216M
Adjusted gross margin	40.6%	Down from 46.5% sequentially

Source: Benzinga, Stocktwits, and Investing.com coverage of the August 12, 2026 Q2 report. The reconciliation below has not been checked line by line against the Form 10-Q. EDGAR was reachable only indirectly during this session.

Cerebras carried roughly $1.128 billion of customer warrant assets as of June 30, arising from warrants issued to OpenAI as part of the commercial agreement, amortizing against revenue through October 2031. Under ASC 606 that amortization is a reduction of reported revenue, not an expense line. A roughly $29.8 million wedge between core revenue and reported sales in a single quarter is the right order of magnitude for that schedule.

Order of magnitude is not confirmation. Pull the 10-Q and tie the number to the disclosed amortization line before quoting me on it. What I will state without hedging is the structural point: as long as your data feed compares management's core revenue guidance to a GAAP consensus, this company will manufacture a phantom miss every quarter for another five years.

The Wire Services Cannot Agree On The EPS Either

One outlet reported adjusted earnings per share of negative $2.98 against an estimate of negative $0.18, framed as a large miss. Another reported an adjusted loss of $0.05 against the same negative $0.18 estimate, framed as a beat. Both were published within a week of each other about the same quarter.

Those cannot both be adjusted figures. The likeliest explanation is that one is GAAP, carrying post-IPO stock compensation, and got mislabeled somewhere in the chain. I have not resolved it. If you are trading this name off a screener, understand that the screener is being fed one of those two numbers and you do not know which.

What Actually Deserved The Selloff

Adjusted gross margin fell roughly five points sequentially, to 40.6 percent from 46.5 percent. The CFO attributed it to higher costs to rent compute capacity the company had previously deployed with other customers. That is a real margin story on a company scaling into a very large contract, and it is a better reason to sell the stock than a revenue line that was never going to print where consensus expected.

The CS-4 itself, launched at Supernova on August 18, is three WSE-3 Turbo engines per system on TSMC five nanometer, claimed at six times CS-3 system performance, ten times throughput per watt, up to thirty times tokens per second versus GPU alternatives, and fifty percent fewer components. Shipping this quarter, CS-5 targeted for 2027, 600 megawatts of capacity by end of 2027. The stock fell 12.69 percent on the day, then extended lower, roughly sixteen percent on the week. Needham and Rosenblatt reiterated Buy at $300, UBS at $330, Mizuho trimmed to $300 from $310. ARK bought about 35,000 shares.

XE: Right Correction, Wrong Timing, And Read The Qualifiers

The ticker correction holds. XE is X-Energy (Nasdaq: XE), the small modular reactor developer that listed in late April 2026 with about $1.1 billion of net IPO proceeds. It is not Expand Energy. Any aggregator still serving natural gas fundamentals under that symbol is wrong.

The award timing in my notes was off. The Department of Energy funding was not fresh news on August 18. CEO Clay Sell disclosed it on the Q2 earnings call on August 13, describing a formal notification received the prior day. By the 18th it was a week old and already in the price.

More to the point, read what the award actually is.

Headline	What the transcript says
"$1 billion DOE award"	Up to an additional $1 billion on the ARDP cooperative agreement
Free federal money	Subject to the same 50:50 cost share as the original award. X-Energy matches it.
Booked	"Expected to be obligated" through the normal contractual process. Not obligated yet.
Total program	Would take DOE cost share contribution up to $2.115 billion

Source: X-Energy Q2 2026 earnings call transcript, August 13, 2026, as published by Benzinga and others, with DOE confirmation reported by Reuters the same day. Transcript text, not a filed document.

The rest of the quarter: total revenues and grant income of $54.6 million, up 154 percent, driven by ARDP engineering work. Liquidity around $1.9 billion. TX-1 fuel fabrication about 80 percent vertically complete, holding the first new NRC Part 70 fuel fabrication license in over fifty years. Management points to 414 million fully diluted shares as the right denominator, comprising 280 million Class A, 119 million Class B, and 15 million from options and restricted stock.

So a 7.82 percent decline on August 18 is not the market ignoring a billion dollars. It is a company whose first revenue-generating reactor is targeted for the early 2030s, marked down alongside everything else with that maturity date, one week after a conditional cost-shared grant that its own CEO called its largest current revenue source.

Watchlist Ticker Map, With Verification Status

Ticker	Maps to	Stale mapping to kill	Verified this session
XE	X-Energy Inc (Nasdaq)	Expand Energy	Yes, via Q2 call and Reuters
RVI	Robinhood Ventures Fund I (NYSE)	Retail Value Inc, the shopping center REIT	Yes, prior desk work
VCX	Fundrise Innovation Fund (NYSE)	None known	Yes, via 8-K coverage and issuer release
FLY	Firefly Aerospace	Fly Leasing, delisted aircraft lessor	No. Not checked this session.
CBRS	Cerebras Systems (Nasdaq)	None known	Yes

One note on VCX that is worth carrying forward. Yahoo currently labels the entity "Fundrise Growth Tech Fund, LLC" on the quote page while the fund markets itself as the Fundrise Innovation Fund. That is a naming inconsistency, not necessarily a stale-ticker problem, but it is exactly the sort of thing that turns into a wrong holdings table three months from now.

Tonight: Wolfspeed

Wolfspeed (NYSE: WOLF) reports fiscal Q4 and full year 2026 today at 5:00 pm Eastern. The stock fell about ten percent into the print and sits near $31.46.

Item	Figure
Consensus revenue, June quarter	~$223.6M
Consensus EPS	-$0.52
Prior quarter actual revenue	$150.2M, a 28% miss versus forecast
Company Q4 guidance given in May	$140M to $160M
Prior quarter stock reaction	Rose 7.26% on a 28% revenue miss
Consensus rating and mean target	Neutral, ~$30

Source: Investing.com earnings preview and quote data, August 18, 2026, and Wolfspeed's Q3 FY2026 guidance. Note the conflict: consensus revenue of $223.6M sits above the company's own $140M to $160M guidance range. I have not reconciled whether guidance was revised in the interim. Do not trade this spread without checking.

That last row is the whole setup. A stock that rallied seven percent on a twenty-eight percent revenue miss last quarter is not trading on the print. It is trading on the balance sheet repair, and the balance sheet is where I would look tonight: cash, debt retired, and whether the AI data center revenue line is still compounding after the March convertible and equity placement.

Bull Case On The Bucket

The move was rates, not fundamentals. Two year and ten year yields barely budged. Nothing in the demand picture for compute, power, or interconnect changed between Monday and Tuesday.

The operating news was mostly good. Cerebras raised full year guidance and margin guidance and shipped a product claiming six times the prior generation. X-Energy grew revenue 154 percent and got a federal cost share increase. Nebius is raising capital because it has somewhere to deploy it.

Forced selling creates dislocations. Convertible hedge unwinds, lockup supply, and leveraged ETF rebalancing all produce prints that are mechanical rather than informational. Those are the prints worth buying into if you know which is which.

Bear Case On The Bucket

A higher long end is a permanent haircut on 2030 cash flow. If the thirty year settles above five percent rather than visiting it, every discounted cash flow underwriting this complex needs rebuilding, and the answer comes out lower.

This complex funds itself with paper that gets more expensive as rates rise. Nebius, Wolfspeed, and Keel have all come to the convertible market in the last six months. Rising rates and falling equity prices raise the cost of that instrument from both directions at once.

The information quality is degrading, not improving. A ticker that still resolves to a natural gas producer. Two incompatible EPS figures for the same quarter. A NAV number that has already been publicly corrected once. Share counts that will not reconcile. When the data layer is this noisy, position sizing has to absorb the error, and most people are not sizing for it.

The SharkWater Take

I am not putting on any of these three trades today, and I want to be specific about why, because "wait for more information" is usually a cop-out and here it is not.

On NBIS, the coupon and conversion premium are the trade. A 4.5 billion dollar convert priced at one and a quarter percent with a forty percent conversion premium is a triumph. The same size priced at four percent with a fifteen percent premium is a distress signal. Those two outcomes lead to opposite positions in the equity, and the release explicitly says both numbers get set at pricing. Anyone with a view on Nebius this afternoon has a view on a document they have not read.

On VCX, the June 30 NAV is the anchor and it does not exist publicly yet. Trading an eleven-percent-or-a-hundred-and-eleven-percent premium is not a trade, it is a coin flip with a spread attached. And I cannot even fix the denominator right now.

On CBRS, I am confident enough in the warrant explanation to say the revenue miss is an artifact. I am not confident enough to publish the reconciliation, because I could not get EDGAR to answer cleanly today and I am not going to source a 10-Q claim to a wire story. The margin compression is the real issue anyway, and that number I do trust.

Here is what I actually think about the bucket. The rate move is the event and the single stock headlines are decoration. The long end going to a nineteen year high is a structural repricing of everything whose payoff sits past 2030, and this group is nothing but assets whose payoff sits past 2030. If you want to be long this complex, you are making a rates call whether you know it or not, and you should say so out loud before you size it.

The names I would look at first when I do act are the ones where the cash flow is nearer and the counterparty is diversified. That is the same conclusion I reached on Marvell two days ago and it survived contact with a bond selloff, which is more than the backlog stories can say.

Execution Notes

Structure: No position recommended and no option ladder published in this post. I did not pull a live chain on any of these five names. Any premium I printed here would be a Black-Scholes guess and this is not a post where a guess is good enough.

NBIS trigger: the pricing release and the corresponding 8-K or 6-K carrying coupon, initial conversion rate, conversion premium, and accretion schedule. Expected within days of the August 19 launch.

VCX trigger: the June 30, 2026 NAV and the corresponding portfolio schedule. On the comparable vehicle the lag ran about sixty days from quarter end, which puts this in the back half of August.

CBRS trigger: the Q2 Form 10-Q, specifically the customer warrant asset amortization line, tied against the $209.9 million core to $180.11 million reported gap.

XE trigger: formal obligation of the incremental DOE funds to the ARDP agreement, and the announcement of the utility agreement for the next gigawatt project that management said was being finalized.

Invalidation on the rates thesis: the long bond retracing back under roughly five percent with the two year unchanged would say this was a positioning event, not a repricing, and most of this post ages badly within a month.

Data Gaps In This Post

Publishing these rather than burying them, because a reader who does not know what I could not verify cannot weight what I wrote.

SEC EDGAR was reachable only indirectly for this entire session. Every filing referenced here came through a secondary carrier. Spot-check the primary documents before acting on any figure in this post.
The CBRS core-to-reported revenue reconciliation is arithmetic plus a disclosed mechanic. It is not tied to a line item in the 10-Q.
The VCX NAV of $18.97 is secondhand and has a competing figure of $18.43 in circulation. The share count does not reconcile across sources.
The two conflicting CBRS adjusted EPS figures, negative $2.98 and negative $0.05, are unresolved.
Wolfspeed consensus revenue of $223.6 million sits above the company's own May guidance range of $140 to $160 million. Unreconciled.
The 5.33 percent thirty year print is a secondary-source intraday high, not an H.15 close.
FLY mapping to Firefly Aerospace is carried forward from prior notes and was not re-verified.
All intraday percentage moves cited for August 18 and 19 are as-quoted and unsettled.

Fair winds and following seas.

Disclaimer: This post is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Prices, yields, and percentage moves cited are approximate, drawn from secondary market data providers and press reporting dated August 13 through August 19, 2026, and in several cases reflect unsettled intraday quotes. SEC EDGAR was accessible only indirectly during the preparation of this post, and figures attributed to filings arrived through secondary carriers rather than primary retrieval. Specific unverified items are enumerated in the Data Gaps section above and should be treated as unconfirmed. Reconciliations described as the author's arithmetic are estimates derived from public disclosures, not company-reported metrics. The Nebius convertible offering described here is proposed, its economic terms are undetermined as of publication, and it may not be completed. Forward-looking guidance and program funding expectations are management's or the relevant agency's, not the author's. All securities discussed are volatile and several are recent public listings with limited trading history. Verify every figure against primary filings before acting. Past performance does not guarantee future results. Consult a licensed financial professional regarding your specific situation.

🦈 KEEL: A Two Billion Dollar Bet That Somebody Signs A Lease

noreply@blogger.com (Unknown) — Tue, 18 Aug 2026 18:50:52 +0000

SharkWater Trading • Digital Infrastructure • Power • Speculative

KEEL: A Two Billion Dollar Bet That Somebody Signs A Lease

August 18, 2026

Bottom Line Up Front

Keel Infrastructure is the company formerly known as Bitfarms. It redomiciled to the US, rebranded on April 1, and is converting itself from a Bitcoin miner into a landlord for AI and high performance computing. Market cap is roughly $2.1 billion at about $3.54 a share.

Revenue from the HPC business is zero. The legacy mining revenue that remains carried a gross margin of negative 285 percent last quarter. What you are actually buying is 2.2 gigawatts of pipeline, three permitted sites, $819 million of liquidity, and the proposition that a creditworthy tenant signs a long term lease. Everything else in the financials is noise on the way to that one event.

What You Are Actually Buying

Strip away the transformation story and Keel is three things.

One: interconnection queue position. A 2.2 gigawatt development pipeline with established grid interconnections already in place, spanning PJM in Pennsylvania, Grant County PUD in Washington State, and Hydro-Québec territory in Canada. In a market where the binding constraint on AI buildout is power delivery rather than chips, an existing interconnect is the scarce asset. CEO Ben Gagnon put it plainly on the Q2 call: power is the constraint, and everything else is downstream of it.

Two: a cash pile. $819 million of liquidity as of August 7, made up of roughly $698 million in unrestricted cash and $121 million in unencumbered Bitcoin, funded in part by a $458 million convertible note offering during the quarter.

Three: a melting ice cube that used to be the business. All US Bitcoin mining has been decommissioned. The remaining legacy operation produced $30.4 million of revenue in Q2 against $117.2 million of cost of revenues.

The Sites

Site	Location	Status
Moses Lake	Washington	First Vertiv modules delivered. Likely first to commission.
Panther Creek	Pennsylvania (PJM)	Conditional land development approval secured.
Sharon	Pennsylvania (PJM)	Zoning secured, long-lead items arriving.
Scrubgrass	Pennsylvania	Potential gigawatt. 750 MW load study with FirstEnergy, visibility expected Q3 to Q4.
Sherbrooke	Québec	Agreement with Hydro-Sherbrooke for conditional transfer of 96 MW plus land purchase.

Management describes active negotiations with multiple prospective tenants at each of the three priority sites, targets lease execution in 2026, and commissioning in 2027. Environmental permitting is progressing across all three. Fiber contracts are in final execution.

Note what is absent from that list: a signed lease.

The Q2 Numbers, And The One Line Everybody Skipped

Q2 2026 (continuing operations)	Amount	vs Q2 2025
Revenue	$30.4M	-50%
Cost of revenues	$117.2M	+81%
Gross margin	-285%	from -6%
G&A	$31.3M	+62%
Operating loss	-$140.8M	from +$10.8M
Depreciation & amortization	$84.1M	+218%
Gain on derivatives	+$77.0M	from +$3.8M
Loss from continuing ops	-$64.0M, or -$0.11/sh	from +$13.2M
Adjusted EBITDA	-$23.7M	from +$6.6M

Look at the derivative line. Keel lost $140.8 million at the operating level. It reported a loss from continuing operations of $64.0 million. The bridge between those two numbers is largely a $77.0 million non-cash gain on derivative assets and liabilities, tied to the marks on its convertible notes and the associated capped call transactions.

That gain is an accounting revaluation, not cash, and it reverses when the marks move the other way. Anyone reading the headline loss per share of eleven cents and concluding the burn is modest has read the wrong line. The operating burn is roughly twice that, and the adjusted EBITDA figure of negative $23.7 million is the honest read on cash profitability.

This is the same species of thing as the return of capital footnote in an income ETF or the customer warrant amortization at a newly public chip company. The interesting number is never the one in the headline. It is the one three lines below it that explains why the headline looks the way it does.

The Bitcoin Stack Is Bridge Financing, And It Is Nearly Spent

Between April 1 and August 7, Keel sold 1,085 Bitcoin for $75 million in proceeds, an average of roughly $69,100 per coin. The remaining balance stands at 1,861 BTC, carried at about $121 million.

Do the arithmetic on what that means. The Bitcoin treasury is now about 15 percent of total liquidity. The company started this transition with just under 2,500 coins and has been selling them down deliberately to fund the pivot. That funding source has maybe one more meaningful draw left in it.

From here, the capital comes from the convertible notes already raised, from future equity or debt, or from project level construction financing. And project financing is precisely what requires a signed lease with a creditworthy tenant.

Here is the structural point that makes this company legible. Management has said it intends to finance construction through investment grade tenants and credit wrapped leases rather than by tapping capital markets. That means the lease is not merely the revenue event. The lease is the key that unlocks the construction financing. The $819 million on the balance sheet is designed to carry the company to signature, not to build the data centers. Understand that and the entire investment case collapses into a single question with a binary answer.

What The Market Is Paying Per Megawatt

Conventional multiples are meaningless here. Price to sales on a business being deliberately shut down tells you nothing. So price the asset instead.

Basis	Capacity	Market cap per MW
Full stated pipeline	2,200 MW	~$0.95M
Active plus secured only	~771 MW	~$2.7M

The gap between those two rows is the entire debate. The 2.2 gigawatt figure includes roughly 1.5 gigawatts described as expansion and evaluation, which is a different category of asset than energized capacity with a live interconnect. If the Scrubgrass 750 megawatt load study with FirstEnergy comes back favorably in the Q3 to Q4 window, a large chunk of that speculative bucket moves toward the secured column, and the per megawatt math changes materially.

Also remember that roughly $819 million of the $2.1 billion market cap is liquidity sitting on the balance sheet. Back that out and the market is assigning something on the order of $1.3 billion to the pipeline, the permits, and the team, against convertible obligations that will eventually either convert into shares or come due.

Bull Case

Power is genuinely the bottleneck in AI infrastructure right now, and Keel holds interconnection positions in PJM and the Pacific Northwest that would take years and considerable litigation to replicate from scratch. The balance sheet is the strongest in company history by management's own account, funded partly with 1.25 percent convertible paper, which is remarkably cheap capital for a business at this stage. Three sites are near full permitting with multiple prospective tenants negotiating for each. The company brought in a President specifically to run commercial and expansion activity, which is what you do when you expect to be signing contracts. The legacy mining drag is now largely decommissioned rather than lingering. Analyst consensus sits at Strong Buy with an average target near $6.67, roughly 88 percent above the current price. And a single anchor lease at any one of these sites would re-rate the equity in a way no amount of quarterly progress reporting can.

Bear Case

There is no lease. "Active negotiations" and "deepening commercial engagement" are the language of companies that have not yet closed. Hyperscalers and neoclouds have many suitors, and Keel is a first-time HPC developer competing against operators with track records.

The burn is real and the runway has a shape. Negative $23.7 million adjusted EBITDA per quarter is the baseline before development capital. Miss the 2026 lease target and 2027 commissioning slips, which pushes the financing question into a market that may be less friendly to speculative data center credit than it is today.

Dilution is structural, not hypothetical. The company's own risk factors name potential dilution from future stock issuances, conversion of the convertible notes, and exercise of options and warrants, plus counterparty risk on the capped call transactions.

Execution risk is stacked. Environmental permitting across three jurisdictions, supply chain and tariff exposure on long-lead equipment, community opposition to data centers, and regulated power rates in Québec, Pennsylvania, and Washington. Any one of those can add quarters.

And the residual Bitcoin exposure cuts both ways. $121 million of the liquidity is a volatile asset the company is trying to sell into strength while also depending on it.

A Word About The 2x ETF

There is a Defiance Daily Target 2X Long KEEL ETF trading under KEEX, with about $4.7 million in net assets and a 1.31 percent expense ratio. Its 52 week range runs from $15.35 to $181.67.

That range is not a typo and it is not an opportunity. It is what daily-reset leverage does to a volatile underlying over time. The fund resets its 200 percent exposure every day, so a stock that chops sideways with big swings grinds the leveraged product down regardless of where the underlying finishes. The prospectus language is explicit that investors could lose their entire principal in a single trading day.

Worth knowing for a second reason: flows into and out of leveraged products like this can create mechanical buying and selling pressure in a $2 billion stock. Some of the daily moves in KEEL are not information. They are rebalancing.

The SharkWater Take

I like this setup more than I expected to, and I would size it like the venture position it is.

The thesis is unusually clean. Most speculative names ask you to believe five things at once. Keel asks you to believe one: that a creditworthy tenant signs a long term lease at Moses Lake, Panther Creek, or Sharon, on terms that make the construction financing work. If that happens, the pipeline reprices from optionality to contracted cash flow and the current $2.7 million per secured megawatt looks cheap. If it does not happen in 2026, you are holding a cash-burning developer with convertible obligations and a shrinking Bitcoin stack, waiting on a 2027 that costs more to reach.

What I would actually watch, in order: the Scrubgrass load study result in the Q3 to Q4 window, because it either validates or deflates two thirds of the stated pipeline. Then any 8-K announcing a lease, because that is the entire thesis in a single filing. Then the cash balance each quarter against the $23.7 million adjusted EBITDA baseline plus development spend, because runway is what buys negotiating leverage, and management explicitly framed the $819 million as the source of that leverage.

One thing I would not do here is sell puts the way I would on an asset-backed closed end fund. When you sell a put on a fund holding Treasuries, assignment hands you T-bills at a discount. When you sell a put on Keel, assignment hands you a pre-revenue developer with negative gross margins and a binary catalyst. The premium may look attractive because the implied volatility is enormous, and that volatility is telling you something true. Respect it.

This is a position you size in basis points, enter with a thesis you wrote down, and exit on the catalyst rather than the narrative. It is not a core holding and the company's own filings say trading in its securities should be considered highly speculative. I take management at its word on that.

Fair winds and following seas.

Disclaimer: This post is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Financial figures are drawn from Keel Infrastructure's Q2 2026 results release and related SEC filings as of August 2026 and are subject to revision. Market capitalization, per-megawatt calculations, and capacity splits are the author's estimates derived from company disclosures, not reported company metrics, and depend on assumptions about share count and pipeline classification. Forward-looking statements regarding lease execution, permitting, and commissioning timelines are management's and are not assured. The company is loss-making, has negative gross margins in its legacy segment, and its own filings state that trading in its securities should be considered highly speculative. Leveraged ETFs referenced are not recommendations and carry risk of total loss. Verify all figures against primary filings before acting. Past performance does not guarantee future results. Consult a licensed financial professional regarding your specific situation.

🦈ORCL, MRVL, CBRS: Three Floors Of The Same Building, And Two Of Them Have The Same Landlord

noreply@blogger.com (Unknown) — Tue, 18 Aug 2026 15:21:05 +0000

SharkWater Trading • AI Infrastructure • Semis • Counterparty Risk

ORCL, MRVL, CBRS: Three Floors Of The Same Building, And Two Of Them Have The Same Landlord

August 17, 2026

Bottom Line Up Front

Oracle rents the building. Marvell sells the wiring. Cerebras builds a specialized engine that goes inside. All three are levered to the AI capacity buildout, but they are not three separate bets.

Roughly half of Oracle's $638 billion backlog traces to OpenAI. Roughly eighty percent of Cerebras' $25.4 billion backlog traces to OpenAI. Owning both is not diversification. It is the same counterparty bet placed twice, at two very different valuations. Marvell is the odd one out, and that is the most interesting thing about it.

The Stack At A Glance

	ORCL	MRVL	CBRS
Role	Capacity landlord	Interconnect and custom silicon	Wafer-scale inference
Price (Aug 17)	~$147.57	~$234.20	~$251.98
Market cap	~$420B	~$199B	~$60B
Revenue base	$67.4B FY26	~$10.8B run rate	$880 to $890M FY26 guide
Roughly, price to sales	~6x	~18x	~68x
Backlog (RPO)	$638B	Not reported this way	$25.4B
Backlog vs revenue	~9.5x	n/a	~29x
From 52-week high	Down ~57%	Down ~29% from $329	Down ~35% from $386
Next catalyst	FQ1 2027, ~Sept 8 to 14	FQ2 2027, Aug 27	SUPERNOVA event

Read the price to sales row from left to right and you are reading an escalator of expectations. Same theme, three wildly different prices for exposure to it.

Oracle: A Great Business Attached To A Terrifying Cash Flow Statement

Fiscal Q4 2026 was, on the surface, one of the better quarters any megacap has printed. Total revenue $19.2 billion, up 21 percent. Cloud revenue $9.9 billion, up 47 percent. Infrastructure alone $5.8 billion, up 93 percent. Full year revenue $67.4 billion, up 17.4 percent, with net income up 36.5 percent.

And RPO, the contracted backlog, hit $638 billion, up 363 percent year over year and up roughly $85 billion in that quarter alone.

The stock is down about 57 percent from its high.

Why The Market Stopped Caring About The Backlog

Because backlog is a promise, and promises have to be financed before they become cash.

Metric	FY2026
Capital expenditure	~$55.6B (above the $50B target)
Free cash flow	-$23.7B
FY2027 capex guidance	Up to ~$95B, roughly $70B net Oracle spend
Corporate debt	Above $110B

For context, Oracle averaged about $1.7 billion in annual capex between fiscal 2018 and 2021. It is now spending that much roughly every eight days.

The catalyst chain that broke the stock was specific. December's Q2 print disclosed $12 billion of capex in a single quarter and a $15 billion raise to the full year forecast, and shares fell 15 percent on the day. Blue Owl Capital then walked away from a $10 billion data center financing deal, reportedly over Oracle's spending pace and debt load. S&P downgraded. Securities class actions followed. And reports surfaced that OpenAI, the counterparty behind an estimated $300 billion of that backlog, had missed internal revenue targets.

Management has an answer, and it is a decent one: much of the recent RPO growth came from contracts where the customer either prepaid for the GPUs or supplied the GPUs directly, which reduces what Oracle itself has to finance. That is a real mitigant and it deserves weight.

The right analogy is a contractor who has just signed the largest order book in the history of the trade, from a client whose own financing is not fully secured, and who must now borrow heavily to buy the materials. The order book is real. The question is who runs out of money first.

Bull: 44 analysts carry an average target near $246, roughly 68 percent above the current price. The underlying database and applications business still throws off cash. If even half of that backlog converts on schedule, the revenue math is transformative, and the stock is priced at roughly six times sales for it.

Bear: Every dollar of that backlog assumes the customer can pay and Oracle can build. Gross margin has already compressed from 81 percent to around 69 percent as revenue mix shifts toward infrastructure. Negative free cash flow of $23.7 billion in a single fiscal year, funded by debt, in a business where the largest customer is a company that is itself not yet reliably profitable, is the definition of a leveraged bet on somebody else's business plan.

Marvell: The Only One Here Selling To Everybody

Marvell is up roughly 161 percent in 2026, joined the S&P 500 in June, took a $2 billion investment from NVIDIA, and got publicly called a future trillion dollar company by Jensen Huang. Q1 FY2027 revenue was $2.42 billion, up 27.6 percent, with Q2 guided to about $2.7 billion. Roughly 75 percent of revenue is tied to data center and AI demand.

It also trades around 81 times trailing earnings and about 18 times sales, and it peaked at $329 in June before falling 35 percent and clawing back to the mid $230s. This is not a cheap stock and it is not a calm one.

The Narrative Gap Worth Watching

Most of the retail conversation treats Marvell as a custom AI silicon story, a Broadcom competitor. On that axis the position is honestly mediocre. Marvell holds an estimated 20 to 25 percent design share against Broadcom's roughly 70 percent, and Broadcom serves three of the five major hyperscaler programs including Google's TPU, Meta's Iris, and OpenAI's Jalapeño. Marvell has Amazon Trainium and Microsoft Maia 200.

But management has guided optical interconnect revenue to grow above 70 percent in fiscal 2027, versus 20 percent plus for custom silicon. In optical DSPs, Marvell holds an estimated 60 to 65 percent share, built on a position that predates the AI boom entirely. The Celestial AI acquisition added plasmonics-based silicon photonics and XConn added PCIe and CXL switching.

The company's own guidance says the growth engine is the interconnect business, not the ASIC business the market argues about. If you are underwriting this name, that is where the work should go.

Bull: Every AI cluster needs optics regardless of whose accelerator wins. Revenue is recognized on shipment, not promised over eight years. Marvell has no OpenAI counterparty concentration, and its custom silicon customers are Amazon and Microsoft, two of the best-capitalized buyers on earth. Analyst consensus is Strong Buy with an average target near $257.

Bear: 81 times trailing earnings after a 161 percent run leaves no margin for a soft quarter, and one downgrade to Hold already flagged exactly that. Operating margin sat at 14 percent in Q1, in line with a year prior, meaning the revenue growth has not yet produced the operating leverage the story promises. Marvell is materially smaller than Broadcom and NVIDIA and has to outspend its weight class to stay relevant. Earnings land August 27, one day after NVIDIA, in the middle of the most concentrated AI sentiment window of the year.

Cerebras: Read The Warrant Footnote

Cerebras went public in May 2026, raising $6.4 billion in the largest semiconductor IPO on record, oversubscribed roughly twenty times. It ran to $386.34 intraday, collapsed to $160.81 by late June, and now sits around $252. Reported beta is above 5. Treat every number in this section as attached to a stock that moves 15 percent on a Monday.

The Q2 print on August 12 was, operationally, excellent. Core revenue $210 million, up 103 percent, against consensus of $193.6 million. Cloud revenue nearly quadrupled. Full year core revenue guidance was raised to $880 to $890 million from $855 to $865 million, and full year gross margin guidance was raised to 41 to 43 percent from 38 to 41 percent.

The stock fell 13 to 20 percent.

Here Is Why, And Almost Nobody Explained It Properly

In December 2025 Cerebras signed a master relationship agreement with OpenAI covering 750 megawatts of inference capacity through 2028, valued above $20 billion, with an option for an additional 1.25 gigawatts by 2030. OpenAI also provided a roughly $1 billion working capital loan in January 2026 and received warrants for approximately 10 percent of the company.

Under ASC 606, warrants issued to a customer as part of a commercial arrangement are treated as consideration paid to that customer. The fair value sits on the balance sheet as a customer warrant asset and gets amortized against revenue as the customer buys compute.

As of June 30, Cerebras carried roughly $1.128 billion of customer warrant assets, split $167.8 million current and $960.6 million non-current, and the 10-Q states this amortizes through October 2031.

Translation: there is a permanent, structural wedge between the "core revenue" management guides to and the GAAP revenue that hits the income statement, and it runs for another five years. If your data feed compares management's core guidance to a GAAP consensus, you will get a phantom miss every single quarter. That is roughly what happened on August 12, and it produced a $13 million GAAP shortfall that knocked a fifth off the market cap on a quarter where the business beat and raised.

Then on August 17 the stock ran 15 percent on renewed attention to the OpenAI relationship. Same company, same footnote, opposite direction, five days apart.

Bull: Independently benchmarked as the fastest inference hardware available, with an anchor contract above $20 billion, AWS distribution through Bedrock, and over $10 billion of capital to deploy. RPO of $25.4 billion against an $885 million revenue year, with roughly 22 percent, about $5.59 billion, expected to convert within 24 months. Margin guidance was raised, not cut.

Bear: Roughly eighty percent of that backlog is one customer, and the rest is concentrated in AWS and G42. The company is not profitable. It trades near 68 times current year revenue. Any slippage in OpenAI's deployment schedule does not dent the story, it removes it. And OpenAI holds warrants on ten percent of the company, which is an alignment mechanism and a dilution overhang in the same instrument.

The SharkWater Take

The concentration point is the one I would tape to the monitor. If OpenAI is more than half of Oracle's backlog and roughly four fifths of Cerebras' backlog, then a position in both is one position in OpenAI's ability to fund what it has signed, expressed through two balance sheets you do not control. Anyone holding both and feeling diversified should size accordingly.

On the individual names:

Oracle is the only one of the three where the pessimism is already in the price. Down 57 percent, roughly six times sales, with a real underlying enterprise business underneath the AI wager. It is also the one with $110 billion of debt and negative $23.7 billion of free cash flow, so "cheap" is doing a lot of work. The September print is the tell, and the numbers that matter are cloud growth against the guided 57 to 63 percent range, capacity actually delivered, and any commentary on the credit outlook. Not the RPO headline.

Marvell is the cleanest business model of the three and the one I understand best. It ships product, books revenue, and gets paid, with no eight-year backlog requiring an act of faith. It is also priced for perfection at 81 times earnings after a 161 percent year, reporting the day after NVIDIA. If you want exposure to this theme without underwriting a single counterparty, this is the vehicle. If you want it at a sane entry, you probably want it after August 27, not before.

Cerebras is a venture position that happens to have a ticker. Beta above five, no profits, 68 times sales, one customer, and an accounting quirk that will manufacture optical misses through 2031. There is a genuine technology edge here and the AWS channel is real. But a stock that travels from $386 to $161 to $252 in ninety days is not an investment, it is a position you size in basis points and defend with rules you wrote before you entered.

The broader test arrives in the next three weeks. NVIDIA on August 26, Marvell on August 27, Broadcom shortly after, Oracle in the second week of September, and Marvell's investor day on October 6. That sequence will tell you more about whether the buildout is being financed or merely announced than any backlog figure will.

Fair winds and following seas.

Disclaimer: This post is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Prices, market capitalizations, valuation multiples, and analyst targets are approximate and as of mid-August 2026, and will change. Price-to-sales figures are derived estimates, not reported metrics. Backlog attribution to specific customers reflects analyst estimates and press reporting rather than company disclosure in every case, and should be treated as an estimate. Forward-looking guidance is management's, not the author's. All three securities discussed are volatile, and one is a recent IPO with limited trading history and a reported beta above five. Verify all figures against primary filings before acting. Past performance does not guarantee future results. Consult a licensed financial professional regarding your specific situation.

🦈 RVI: The Fund Where Nobody Knows What It Is Worth, And That Is Exactly Why You Sell Puts

noreply@blogger.com (Unknown) — Mon, 17 Aug 2026 15:55:14 +0000

SharkWater Trading • Income Strategies • Options • Private Markets

RVI: The Fund Where Nobody Knows What It Is Worth, And That Is Exactly Why You Sell Puts

August 17, 2026

Bottom Line Up Front

Robinhood Ventures Fund I (NYSE: RVI) went public at $25 in March, ran to $77.39 in May, fell all the way back to $24.10 in late July, and now trades near $28. The last audited net asset value the fund published was $24.05 per share, dated March 31. That number is four and a half months old.

Implied volatility sits near 87 percent against 30 day realized volatility of roughly 61 percent. When a market is charging you 87 percent vol on a fund whose true value updates once a quarter and holds a large slug of money market funds, the cleanest way to play it is not to buy the shares. It is to sell out of the money cash secured puts at or below the last known NAV and get paid to wait for a price that actually makes sense.

First, Almost Everything You Have Read About RVI's Holdings Is Wrong

Search "RVI holdings" and you will find confident pages telling you the fund owns Anthropic, xAI, Perplexity, Anduril, Scale AI, Figma, Notion, Discord, Chime, Brex, Plaid, and Mercury, with a $725 million NAV. Other pages will tell you the NAV is $300 million. One popular page insists RVI does not own SpaceX. Another insists SpaceX is the largest position at 22 percent of the fund.

None of that survives contact with the audited annual report. RVI's fiscal year ends March 31, and the Form N-CSR filed with the SEC lays out the entire schedule of investments, line by line, with cost basis and fair value. Nine private companies. Not twenty. Not one of the exotic names above.

It gets worse. Pull up RVI on some of the major quote sites and the fundamentals block still shows a market cap of $63 million, a 734 percent dividend yield, an industry classification of "Real Estate Operations," and a next earnings date in 2022. That is leftover data from Retail Value Inc., the shopping center REIT that used to trade under this ticker. The vendor never fully flushed it.

Rule of the boat: on a fund this new, with a recycled ticker and a quarterly valuation cycle, you go to EDGAR or the fund's own newsroom. Nowhere else. If your data source cannot tell you whether RVI is a venture fund or a strip mall landlord, it cannot tell you what it is worth.

What RVI Actually Owns

Here is the audited portfolio as of March 31, 2026, straight out of the schedule of investments, plus everything the fund has announced since.

Position	Type	Fair Value / Cost	Status
Databricks (Series K + L)	Preferred	$81.7M	Marked up 26.7% from entry
OpenAI	Class A Common	$75.0M	Added April 17
Revolut	Ordinary	$50.2M	At cost
Mercor	Series C Preferred	$50.0M	At cost
Whatnot	Preferred	$30.0M	Added Aug 5, $20B round
Airwallex	Series G Preferred	$25.0M	At cost
Boom Supersonic	Series B-1 Preferred	$25.0M	At cost
Oura	Series E Preferred	$25.0M	At cost
Ramp (common + preferred)	Both	$25.0M	At cost
Canva	Class A Common	$25.0M	Added June 24
ElevenLabs	Series D-1 Preferred	$20.0M	At cost
Stripe (+ June follow-on)	Class B Common	$14.6M plus	Follow-on June 29
SpaceX	Public common	$6.8M	IPO allocation, June
Money market funds	Level 1	$347.1M at 3/31	53% of net assets

Net assets were $655.3 million across 27,247,215 shares, which is where the $24.05 NAV comes from. The single most important line in that table is the last one. On March 31, more than half of this "venture fund" was sitting in a government money market fund yielding about 3.6 percent.

Since then the fund has deployed roughly $137 million into OpenAI, SpaceX, Canva, and Whatnot, plus an undisclosed Stripe follow-on. Back of the envelope, that still leaves somewhere in the neighborhood of $180 million to $210 million in cash equivalents, or roughly $6.50 to $7.75 per share. Call it a quarter to a third of NAV in T-bill proxies.

That matters enormously for a put seller. It means a meaningful chunk of what you would be buying on assignment is not a Level 3 guess about a private company. It is cash.

The NAV Problem, Which Is Really The Whole Trade

Here is the structural quirk that drives everything. RVI marks its portfolio and calculates NAV once per business quarter. The private positions are Level 3 fair value, determined by the adviser using precedent transactions, funding rounds, and secondary prints. The share price, meanwhile, trades every second the NYSE is open.

Think of it like a boat sitting on a mooring in fog. The NAV is a photograph somebody takes of the boat once every three months. The stock price is a crowd on shore shouting guesses about where the boat is right now. Sometimes the crowd is right. In May, the crowd decided the boat was worth $77 when the last photograph said $24.

The crowd was wrong. It usually is at extremes, in both directions.

The premium round trip on this thing has been violent:

Date	Price	vs Last Published NAV
March 6, IPO	$25.00 issue, opened near $22	Discount on day one
March 31	$26.54	+10% to $24.05 NAV
May 13, peak	$77.39	Roughly +220%
July 29, trough	$24.10	Roughly flat to NAV
Mid August	~$28.20	About +17%

A 68 percent drawdown from peak to trough in eleven weeks, on a fund holding money market funds and a dozen private marks. Nothing in the portfolio moved 68 percent. Only the story did.

Why The Options Are Rich

Metric	Reading
Implied volatility (30 day)	~86.6%
Historical volatility (30 day)	~61.3%
IV rank / IV percentile	~33% / 26%
IV high / low, trailing year	120.6% (June 9) / 69.6% (Aug 6)
Expected move, 10 DTE	+/- 11.8%, range $24.88 to $31.56
Put / call open interest ratio	1.21
Total open interest	~11,400 contracts

Roughly 25 volatility points of spread between what the market is charging and what the stock has actually delivered over the last month. That gap is your edge, and it exists for a reason worth naming out loud: the market genuinely does not know what this fund is worth between quarterly marks, so it prices uncertainty into every contract.

Note also that IV rank is only 33 percent. Vol is elevated in absolute terms but it is not stretched relative to this fund's own short history. It has been much higher. That argues for selling premium in size you can defend, not backing up the truck.

The Trade: Selling Out Of The Money Puts Below NAV

The setup writes itself. You have a fund trading at a 17 percent premium to a stale NAV, with roughly a quarter of that NAV sitting in cash equivalents, an 87 percent implied vol, and a demonstrated willingness to trade all the way back down to the low twenties. You do not want to buy $28 shares. You want to get paid for agreeing to buy $20 to $22 shares.

That is the entire thesis. You are selling insurance against a price you would happily pay anyway.

Strike Selection Logic

Anchor your strikes to NAV, not to the current share price. Three reference points:

$24.05 is the last published NAV. Anything above that strike and you are agreeing to pay a premium to stated value.
$24.10 is the July low. The market has already tested and defended roughly this level once.
$21.00 is the 52 week low and represents about a 13 percent discount to the last NAV. At that level you are buying private venture marks at a real discount with cash backing part of it.

The ladder below uses model derived premiums at the observed volatility surface. These are theoretical values, not live quotes. Pull the actual chain before you place anything. On a name with 11,400 total open interest, the bid ask spread will take a real bite.

Expiry	Strike	Est. Premium	Breakeven	vs $24.05 NAV	Return on Cash
Sep 18 (32d)	$25.00	~$1.50	$23.50	-2.3%	6.1%
Sep 18 (32d)	$22.50	~$0.85	$21.65	-10.0%	3.8%
Sep 18 (32d)	$20.00	~$0.45	$19.55	-18.7%	2.3%

The sweet spot in my read is the October and November $22.50 strikes. They sit below the last published NAV, below the July low, collect a genuinely meaningful premium, and give you enough calendar to survive one full quarterly NAV print. The September $20 line is the sleep at night trade: small premium, but your breakeven is nearly 19 percent under stated NAV, and roughly a third of what you would own at that basis is money market funds.

The Catalyst Nobody Is Marking On Their Calendar

The March 31 shareholder update was published on May 29, about sixty days after quarter end. Which means the June 30 quarterly NAV update should land in the back half of August, along with the corresponding portfolio schedule filing. That is a defined, dateable event that will replace a four month old number with a fresh one.

This is the closest thing a closed end fund has to an earnings print, and unlike an earnings print, almost nobody is watching for it. If you are selling premium here, know that this date is inside your September and October contracts. That is a feature if you are short strikes well below NAV and a problem if you are short strikes near the money.

Bull Case

The fund is still roughly a quarter to a third in cash, which means the adviser has real dry powder to deploy into new rounds at current marks. The Databricks position is already marked 27 percent above entry, and Whatnot came in through a priced $545 million Series G at a $20 billion valuation, which is a hard valuation event rather than a model guess. There is no carried interest, which is a genuine structural advantage over a standard two and twenty venture fund. And if the OpenAI, Databricks, or Revolut positions get repriced upward at the June 30 mark, the NAV anchor moves up under the share price and the current 17 percent premium suddenly looks a lot more modest.

Bear Case

Three things worry me, in order.

One, the overhang. Robinhood Markets owned 52.18 percent of the fund as of March 31, and the fund has filed to register 14,217,271 of those shares for resale. That is more than half the share count sitting in a registered resale shelf above a thinly traded security. If that supply starts hitting the tape, the premium does not just compress, it inverts.

Two, the fee step up. The management fee is 2.00 percent of net assets, waived to 1.00 percent for the first six months after the IPO. That waiver runs out around early September. The all in expense ratio for the stub year already ran about 2.7 percent. On a fund holding a third in money market funds, you are paying venture fees on Treasury bills.

Three, Level 3 marks can gap. Every private position in this book is valued by the adviser using unobservable inputs. A down round at any one of Mercor, Boom, Oura, or ElevenLabs shows up as a step function in NAV, not a gradual drift. And RVII just listed on August 13 at $25 with roughly 80 Y Combinator names, which gives the same retail dollar somewhere else to go.

The SharkWater Take

I do not want to own RVI at $28. Paying a 17 percent premium to a NAV that is itself a quarterly estimate, in order to pay 2 percent a year on a portfolio that is one third cash, is not an edge. It is a subscription fee for a story.

But I very much want to own it at $20, and I am happy to be paid 5 to 11 percent on my collateral for saying so out loud. That is the entire trade. Sell the puts well below the last published NAV, size them so that assignment is a good day rather than a margin call, and let the 25 point vol spread work.

If you get assigned, you own a basket of Databricks, OpenAI, Stripe, Revolut, Canva, and a pile of T-bills at a real discount to stated value, and you flip straight into the wheel by selling calls into the next premium spike. If you do not get assigned, you keep the money and reload. Both outcomes are acceptable, which is the only kind of trade worth putting on.

Execution Notes

Use limit orders, always. Average daily option volume is under 700 contracts across the whole chain. Market orders here are donations.
Cash secured, not margin. A fund with a 68 percent peak to trough drawdown in eleven weeks is not where you want leverage on short puts.
Size for full assignment. One contract equals 100 shares. At the $22.50 strike, that is $2,250 of real obligation per contract. Only sell what you can take delivery of without flinching.
Close at 50 to 60 percent of max profit rather than riding to expiration. On a name with this much headline risk, the last 40 percent of the premium is the worst paid part of the trade.
There is no dividend to cushion assignment. The fund has stated it does not anticipate being a predictable distributor. Your entire return on an assigned position is price plus whatever calls you write against it.
Watch the quarterly update, not the ticker. Set an alert for the June 30 NAV publication and the corresponding portfolio filing. That number is the only thing that resets your anchor.

Fair winds and following seas.

Disclaimer: This post is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Option premiums shown are model derived estimates, not live market quotes, and will differ from actual executable prices. Selling puts carries the obligation to purchase shares at the strike price and can result in losses substantially greater than the premium collected. RVI is a non diversified closed end fund holding illiquid Level 3 private securities whose fair values are estimates and may differ materially from realizable value. NAV figures cited are as of March 31, 2026 and are stale. Portfolio and financial data sourced from the fund's SEC filings and company announcements. Verify all figures independently before trading. Past performance does not guarantee future results. Do your own diligence and consult a licensed financial professional regarding your specific situation.

🦈 Novel Trading Ideas for the AI Titans: OpenAI vs. Anthropic Exposure, Relative NAV, and Proxy Trading Strategies

noreply@blogger.com (Unknown) — Sat, 15 Aug 2026 13:49:23 +0000

A slightly different way to trade.

The foundation model landscape in 2026 has fundamentally reshaped the definition of mega-cap tech. With OpenAI commanding an $852 billion post-money valuation and Anthropic filing for an IPO that targets an astronomical $965 billion, these private entities are structurally larger than almost every publicly traded pure-play software company on earth. For traders and portfolio managers, the challenge isn't recognizing the macro trend—it's determining how to efficiently trade private-market behemoths using public-market instruments.

Here is a breakdown of the relative valuation landscape and the capital-preserving strategies required to trade the proxy spread.

The Tale of the Tape: Relative NAV and Growth Velocity

We are currently witnessing multiple expansions that completely defy traditional SaaS metrics.

OpenAI: Following its unprecedented $122 billion funding round in March 2026, OpenAI's implied NAV sits at $852 billion. With an officially confirmed annualized revenue run-rate crossing $24 billion, the market is pricing the company at roughly a 35x to 39x revenue multiple.

Anthropic: The growth velocity of Anthropic has been staggering. After exiting 2025 at a $9 billion run-rate, Anthropic hit a $47 billion annualized run-rate by mid-May 2026. Valued at $380 billion in February, secondary markets and their Fall 2026 IPO filings point to a valuation approaching $965 billion. Despite the higher gross valuation, Anthropic's explosive revenue acceleration brings its forward multiple into a comparable orbit relative to OpenAI.

The Public Proxy Ecosystem

Because pure-play access remains locked behind private secondary markets or impending IPO lockups, public equity exposure requires navigating the massive tech conglomerates. It is a tangled web of overlapping investments, compute agreements, and circular spending:

Amazon (AMZN): Originally Anthropic's primary backer with an $8 billion stake, Amazon dramatically expanded its foundation model footprint by committing $50 billion to OpenAI's March 2026 round.

Microsoft (MSFT): The legacy proxy for OpenAI is now actively hedging its bets. Microsoft recently committed up to $5 billion to Anthropic, coupled with a $30 billion Azure compute deal.

Alphabet (GOOGL): Committed roughly $3 billion to Anthropic alongside a massive TPU supply agreement.

Nvidia (NVDA): The ultimate picks-and-shovels hardware play, investing $30 billion into OpenAI and $10 billion into Anthropic to ensure its GPUs remain the industry standard.

SoftBank (SFTBY): A heavily leveraged proxy, holding over $71 billion in total OpenAI commitments.

Equity and Option Trading Strategies

Direct directional bets on AI via these public proxies can subject portfolios to heavy beta drawdowns if the broader market contracts. A sound, capital-preserving approach requires structuring trades that isolate the AI exposure or strategically monetize the inherent volatility.

1. Relative Value Pairs Trading

Rather than taking a naked long position in a tech giant, a market-neutral pairs trade can isolate the relative success of these foundation models while dampening broader market noise.

The Trade: Long AMZN / Short GOOGL.

The Rationale: Amazon has effectively cornered equity exposure to both OpenAI and Anthropic while driving massive AWS compute consumption across both ecosystems. Alphabet, while partnered with Anthropic, is simultaneously forced to defend its core search monopoly from both entities. This pairs trade capitalizes on Amazon's dominant compute-and-equity moat while neutralizing general tech beta.

2. Proxy Collars for Downside Protection

For those holding legacy long equity positions in Microsoft or Nvidia but wary of multiple compression or sudden AI capital expenditure fatigue, an options collar provides structured downside protection while maintaining exposure to the underlying growth.

The Trade: Sell an out-of-the-money (OTM) Covered Call, and use the collected premium to finance the purchase of an OTM Put.

The Rationale: This defines the exact risk/reward parameters. If the hardware or compute providers experience a rapid drawdown, the put rigidly caps the loss. The sold call caps extreme upside, efficiently financing the protection and maintaining a hedged posture.

3. Automated SPX Premium Collection

The S&P 500 has effectively become an AI proxy index. The companies providing compute, hardware, and capital to Anthropic and OpenAI command a massive weighting in the SPX. Instead of attempting to pick the winner between the foundation models, a highly robust strategy focuses on the systemic volatility their capital wars create.

The Trade: Deploying automated SPX option rulesets (e.g., selling systematic short strangles or iron condors on the SPX index) while maintaining heavy cash positions.

The Rationale: AI headlines—whether it is OpenAI's next funding round or Anthropic's IPO pricing—inject structural implied volatility into the broader index. By keeping capital secure in cash and deploying automated SPX premium collection strategies, traders can consistently harvest the inflated premiums generated by the AI hype cycle. You don't need to predict whether Anthropic or OpenAI wins the model war; you simply collect the premium generated by the market's uncertainty over the outcome.

🦈 The Trillion Dollar Waiting Room: Trading Anthropic and OpenAI Before the Bell Rings

noreply@blogger.com (Unknown) — Sat, 15 Aug 2026 02:50:29 +0000

SharkWater Trading | August 2026

In May, a private company you cannot buy raised $65 billion at a $965 billion valuation. Nine days later it confidentially filed for an IPO. Its chief rival, valued at $852 billion, filed its own confidential paperwork the same month and is reportedly holding out for a trillion dollar sticker before it lists.

Anthropic and OpenAI are the two largest IPOs in the pipeline, possibly the two largest in history. Neither trades. But the market has already built a shadow order book around both of them, and if you understand how NAV works, you can trade it today.

This post maps the exposure vehicles, explains the premium and discount math that actually drives returns in these wrappers, and lays out equity and options structures for playing the runway into the listings.

The Scoreboard

Quick state of play as of mid August:

Anthropic: $965B post-money after the Series H in May. Revenue run rate crossed $47B. Confidential S-1 filed June 1. The chatter points to a fall 2026 window, which would put it public before OpenAI.

OpenAI: $852B after the record $122B round in March. Confidential filing in June, but reporting suggests a 2027 listing because leadership will not accept a valuation below $1 trillion. Cash burn is the elephant here, reportedly on the order of $27B this year with a bigger number projected next year.

The race matters for trading purposes. Whichever lists first sets the comp for the second, and every vehicle holding either name gets re-marked off that print.

The Exposure Map

Think of this like a water table. The companies are the aquifer. Every vehicle below is a well drilled at a different depth, with different pipe losses along the way.

Tier 1: Listed closed-end funds (tradeable, premium risk)

DXYZ (Destiny Tech100) is the retail favorite. Per its SEC filings, in January it put $100 million into an SPV holding economic exposure to Anthropic Series B preferred shares. Read that sentence twice. Not common stock, not direct shares. Economic exposure, through a special purpose vehicle, to an early preferred series. That structure means layered fees, stale marks between funding rounds, and liquidation preference mechanics that most holders have never modeled.

DXYZ already ran this playbook once. It spiked hard on the SpaceX IPO filing in May, and now that SpaceX is public, the fund is rotating and the Anthropic stake becomes the marquee private asset. Sell-side estimates put projected NAV somewhere in the $33 to $47 range depending on how aggressively you re-mark Anthropic, and the stock has swung from a 52-week low near $20 to a high near $73. Short interest has run in the mid-teens. This is a NAV re-marking story with a squeeze chaser attached.

VCX (Fundrise Innovation Fund) is the more concentrated AI bet. Roughly 20.7% Anthropic, 9.9% OpenAI, about 5% SpaceX, with AI-related names near 44% of the book. It is the only listed wrapper with meaningful exposure to both horses. The catch: after listing it ripped several hundred percent above a stated NAV around $18. When you pay a large premium to NAV, you are not buying Anthropic. You are buying other people’s excitement about Anthropic, and excitement mean-reverts.

Tier 2: Interval funds (buy at NAV, no listing pop)

ARKVX (ARK Venture Fund) holds both names and prices at NAV with quarterly liquidity windows. No premium to pay, no premium to capture. This is the boring well. It is also the only one where your entry price equals the fund’s stated look-through value. For a long-horizon core position, boring is a feature.

Tier 3: Public equity proxies (liquid, options-rich, diluted)

MSFT is the single largest look-through position in either company. Microsoft owns roughly 27% of OpenAI on an as-converted basis, marked around $135B at the October 2025 recap and worth potentially $270B if the IPO prices at $1 trillion. Here is the interesting part: MSFT is down roughly 19% this year, the worst of the Magnificent Seven, while sitting on a stake worth as much as 9% of its own market cap that the market is arguably assigning little credit. That is a stub trade hiding inside a mega cap.

GOOGL and AMZN are the Anthropic side of the same coin. Amazon has $8B invested plus participation in later rounds, and Google has been a major holder since the early days. The stakes are smaller relative to their market caps than Microsoft’s OpenAI position, so the look-through torque is weaker, but the Anthropic S-1 will force a public mark on both.

The NAV Math That Actually Matters

Premium and discount to NAV is the whole game in the Tier 1 wrappers. Three mechanics to internalize:

1. Marks lag reality. A fund’s Anthropic position gets re-marked at funding rounds and audits, not continuously. Anthropic went from $380B in February to $965B in May. Any fund still carrying the position at the old mark has embedded NAV growth that shows up on the next report. That re-mark is a scheduled catalyst, and the market front-runs it.

2. The wrapper’s scarcity value dies at the IPO. This is the trade everyone gets wrong. The premium on DXYZ or VCX exists because they are the only liquid doors into a locked building. The day Anthropic lists, anyone can buy ANTH or whatever the ticker becomes, and the wrapper’s reason to trade above NAV evaporates. SpaceX just demonstrated the pattern: filing announcement pops the wrapper, the actual listing deflates it. The pre-IPO run is a rental, not a marriage.

3. Preferred is not common. SPV exposure to Series B preferred behaves differently from common stock in a down scenario and converts on specific terms in an IPO. In a strong listing this mostly washes out. In a weak one, the waterfall matters.

Equity Strategies

The premium rental (DXYZ, VCX). Long into re-mark and S-1 catalysts, with a hard rule to be flat or short-biased by the time the underlying actually prices its IPO. You are trading the anticipation, not the event. Position sizing should assume 30% drawdowns are normal here, because they are.

The NAV accumulator (ARKVX). Dollar-cost average at NAV through the quarterly windows. No premium risk, no timing genius required. This is the sleep-well allocation for the thesis that both companies are worth owning through the IPOs and beyond.

The stub trade (MSFT). Long MSFT on the argument that a beaten-down 2026 tape is giving you Azure at a discount and the OpenAI stake nearly free. If you want to isolate the stub, pair it: long MSFT against a partial short in QQQ or a basket of the other mega caps strips out the market beta and leaves you with mostly the OpenAI optionality plus the relative valuation gap.

Options Strategies

Liquidity check first. MSFT, GOOGL, and AMZN have deep, tight chains. DXYZ options exist but trade wide with fat spreads, so use limit orders and small size or skip them entirely. VCX has no practical options market. Structure accordingly.

MSFT long-dated call spreads. The cleanest expression of the OpenAI IPO catalyst. Jan 2027 or Jun 2027 call spreads financed partly by the elevated put skew a down 19% stock carries. The spread caps your cost against the real possibility that the IPO slips or prices soft. Buying the spread rather than naked calls matters because IV will inflate into the IPO date and collapse after pricing, and a spread is largely immunized against that vega crush.

The MSFT wheel. Regular readers know this is home turf. Selling cash-secured puts at technical support on a Mag Seven laggard with a $270B lottery ticket attached is about as good as wheel candidates get. If assigned, you own a quality name at a discount and roll into covered calls above cost basis. The IPO catalyst gives the covered call premium a persistent bid.

Calendar spreads into S-1 events. When the confidential filings go public, the amendment and roadshow dates become known events. Front-month IV inflates around those dates while back-month stays calmer. Selling the inflated front expiry against a longer-dated long leg harvests that event premium. Works on MSFT for OpenAI dates and, with wider tolerances, on DXYZ for Anthropic dates.

DXYZ put protection on core longs. If you are running the premium rental into the Anthropic listing, cheap out-of-the-money puts a few months out are the insurance against the wrapper deflation described above. Spreads are ugly, so buy them on green days when the market maker is happy to sell you downside.

What Kills This Trade

IPO slippage is the obvious one. A 2027 OpenAI listing means a full year of theta on anything short-dated. A broad AI multiple compression re-marks everything down at once and the wrappers fall faster than NAV because premiums compress into discounts. And the burn numbers in the actual S-1s could shock a retail base that has only seen the revenue headlines. $47B of run rate is real. So is $27B of cash burn.

The waiting room is crowded and the door has not opened yet. Trade the line, not the room.

Nothing here is financial advice. I trade some of these names and structures. Do your own homework, size like you can be wrong, and read the actual filings before you touch an SPV wrapper.

🦈 ASTS

noreply@blogger.com (Unknown) — Mon, 27 Jul 2026 18:41:27 +0000

SharkWater Trading • Income Strategies • Options • Space

Turning the Wheel on ASTS: How I'm Getting Paid While a $134 Rocket Drifts Sideways at $56

Six weeks ago, AST SpaceMobile was a $134 stock and every timeline on the internet was screaming to the moon. Today it's drifting in the mid-$50s, chopping between roughly $55 and $60 like a boat with no wind in its sails.

For the buy-and-hold crowd, that's purgatory. You bought the story, the story got cut in half, and now it just… floats.

For a premium seller, it's payday. Because a stock that can't decide which way to go is a stock whose options are stuffed with rich implied volatility — and rich IV is chum in the water. When the tape won't hand you a trend, you stop betting on direction and start charging rent on the chop.

Here's how I'm turning the wheel on ASTS.

Why the Rocket Is Drifting

To sell premium on a name, you first have to understand why it's stuck. ASTS is caught in a genuine tug-of-war:

Pulling up: The BlueBird Block 2 birds launched in June — the largest commercial comms arrays ever put in low Earth orbit. Piper Sandler named it their preferred space stock and slapped an Overweight on it. The bull case (direct-to-phone, from space, no tower) is still very much alive.

Pulling down: A billion-dollar convertible note raise dropped a dilution anvil on the chart. Revenue is real but still a rounding error against a ~$22B market cap. And there's a Q2 earnings date circled in early August that nobody wants to be offside on.

Bulls and bears pulling equally hard is the definition of lateral. And lateral, high-IV chop is the exact ocean the wheel was built to sail.

The Wheel, Plainly

The wheel is three moves that feed each other:

Sell cash-secured puts below the stock to get paid for agreeing to buy shares cheaper.
If assigned, take the shares at a net cost below today's price.
Sell weekly covered calls against those shares to get paid again while you hold.

Then it repeats. You are, quite literally, getting paid at every point on the compass.

Step 1 — Ladder the puts, don't stack them on one strike

I don't sell one fat put and pray. I spread a ladder across several strikes below the current price, so I'm not all-in at any single level. Something like (illustrative — pull the live chain for real numbers):

Sell-to-open put	Cushion below spot	Why
$52.5	~7%	Closest to the money — richest premium, highest assignment odds
$50.0	~11%	The psychological round number, strong support zone
$47.5	~15%	Deeper cushion, lighter premium, "I'd genuinely love it here"

Each rung throws off weekly or bi-weekly premium. If ASTS keeps drifting sideways above them, every one of those puts bleeds to zero and I keep 100% of the credit as income. The ladder means a dip might assign me the top rung while the lower rungs keep printing — I get paid and I get my shares at a discount.

Step 2 — Get assigned, and mean it

Here's the rule that separates wheel traders from wheel victims: only sell a put at a strike where you'd be genuinely happy to own the stock. Assignment isn't the accident — it's a designed outcome. When ASTS taps $52.5 and puts those shares in my account, I'm not panicking. I wanted them at $52.5 minus the premium I already pocketed. My real cost basis is lower than the strike.

Step 3 — Sell weekly covered calls on the assigned shares

Now I own shares, and idle shares are a lazy crew. So I put them to work selling weekly covered calls above my cost basis — say the $60 or $62.5 line. High IV means even a one-week, out-of-the-money call pays real money. Three outcomes, all of them fine:

Stock stays flat → call expires, I keep the premium, I sell another next Friday.
Stock drops → the call cushions the loss, and I keep wheeling.
Stock rips through my strike → my shares get called away for a gain plus all the premium, and I start the whole wheel over selling puts again.

That's the machine. Puts pay me to wait. Assignment hands me shares cheap. Calls pay me to hold. The wheel turns as long as the water stays choppy — and choppy is exactly what ASTS is serving.

The Sharks Circling This Particular Wheel

Now the part most "passive income" posts conveniently skip. ASTS is not a sleepy dividend stock you can wheel on autopilot. This is a high-voltage name, and the wheel has real teeth pointed back at you:

The earnings landmine. There's a Q2 report due in early August. Selling puts or calls across an earnings date on a stock this volatile is picking up coins in front of a freight train — one gap can blow through every rung of your ladder at once. I either close the wheel before the print or size it knowing the whole thing is a binary bet. No pretending otherwise.

It can be a falling knife. This stock has already put down 36% in nine days on the tape this year. The wheel is beautiful in a range and brutal in a sustained downtrend — you get assigned on the way down, then your covered calls are stranded underwater while the shares keep sinking. The strategy assumes the chop holds. If the bottom falls out, you're a long-term bag-holder collecting nickels against a boulder.

Your calls cap the moonshot. ASTS ran to $134 once. If the next catalyst reignites that move, my $60 covered calls hand the upside to someone else. Selling premium on a rocket means agreeing, in advance, to get off before orbit.

High IV is high for a reason. The fat premiums aren't free money — they're the market pricing in exactly the gap risk above. You're being paid well because the danger is real. Respect the quote.

Rules of the Deck

Only wheel a name you'd hold through a drawdown. If you don't believe in the ASTS story long-term, you have no business getting assigned its shares.
Size it small. This is a speculative, cash-burning story stock — wheel a slice, never the whole account.
Mind the calendar. Earnings and big launches change the whole risk picture. Trade around them deliberately, not by accident.
Take the premium and stay humble. The wheel is a rent-collection business, not a lottery ticket. Consistency beats hero trades.

The Takeaway

You don't need ASTS to go up to make money on ASTS. You need it to keep doing what it's doing right now — drifting, chopping, going nowhere in particular while its options stay fat with fear. Sell the puts, take the shares on the dips, sell the calls on the shares, and let the wheel turn.

Just keep one eye on the August print. That's the wave that can flip the whole boat.

Watch the water. 🐚

SharkWater Trading is educational content, not financial advice. Options carry substantial risk of loss and are not suitable for every investor. ASTS is a highly volatile, speculative security capable of large, sudden moves; the strategies described can result in assignment, capped gains, and losses exceeding the premium collected. Strike and premium figures are illustrative — always pull the live option chain. Do your own diligence and size for the storm, not the calm.

🦈 Trading Space

noreply@blogger.com (Unknown) — Tue, 14 Jul 2026 22:34:07 +0000

Trading the Space Lane: An Options Playbook for the Cosmos Watchlist

BLUF: Space stocks are volatility machines right now, and that is exactly what an options trader wants. The playbook splits in two. Around a hard, dated catalyst (a launch, a landing, an earnings print) you either buy cheap directional exposure before the event or sell the fat premium and let the volatility crush work for you after. In the quiet windows between catalysts, you harvest income by selling cash secured puts on the names you actually want to own.

The one rule that governs all of it

Implied volatility is the price of the option. It swells before a known event and collapses the moment that event passes. That collapse is the “IV crush,” and it is the most important thing to understand before you trade any of these names.

Think of it like flood insurance on the Gulf. The week a hurricane is forecast, premiums spike because everyone wants coverage. The day after the storm passes, hit or miss, that same policy is cheap again. Buying options into a catalyst is buying insurance at hurricane prices. Selling options into a catalyst is writing that policy and collecting the fear premium. So the question before every trade is simple: am I buying insurance or writing it?

The Core Traders: liquid options, real catalysts

RKLB — Rocket Lab (High IV)

Next earnings Aug 6, 2026, after close (confirmed). The bigger prize is the Neutron rocket’s first flight, targeted for Q4 2026. Over the past eight quarters the stock has averaged roughly an 8% move around earnings.

• Bull: record revenue, a backlog north of $2B, stacking defense awards, Neutron finally in sight.

• Bear: valuation prices in near flawless execution; any Neutron slip and it gives back 10% on a headline.

• SharkWater Take: two catalysts stacked into the back half of the year make this both a premium seller’s dream and a lottery buyer’s playground.

• Play it: into earnings, sell a cash secured put or put credit spread below support to harvest IV and let the crush do the work. For Neutron, a call debit spread dated past the launch window caps cost and defines risk on a binary event.

ASTS — AST SpaceMobile (Highest IV)

Next earnings around mid August 2026. The rolling catalyst is the launch cadence: BlueBird satellites launching every one to two months on average toward 45 to 60 in orbit by end of 2026. Beta near 2.7 with short interest close to 18%.

• Bull: FCC commercial authorization in hand, ~60 carrier agreements, a fresh catalyst almost every launch.

• Bear: serial earnings misses, heavy cash burn, a prior launch failure write off, and a valuation that lives on flawless deployment.

• SharkWater Take: highest octane name on the board, and the short interest means squeezes are real.

• Play it: IV is expensive, so naked long calls bleed. Prefer a call debit spread ahead of a scheduled launch, or sell weekly cash secured puts into the fear if you want the shares. Size small; this gaps 15% overnight.

LUNR — Intuitive Machines (Binary catalyst)

Next earnings early August 2026. The real event is the IM-3 lunar landing; the mission timeline currently runs through March 2027 after a launch delay. Backlog is roughly $1.1B.

• Bull: now a vertically integrated prime after the Lanteris deal, record backlog, positive adjusted EBITDA.

• Bear: success based missions mean one tipped over lander re-rates the story, as IM-1 and IM-2 taught traders.

• SharkWater Take: the truest binary on the list. A landing is a coin flip the market treats as a referendum.

• Play it: for the landing, a cheap call spread is pure speculation, not a position. For income, the weekly put premium is generous; sell cash secured puts on dips to get paid to wait for a lower entry.

FLY — Firefly Aerospace (Newer chain)

Next earnings around late September 2026. Firefly still expects three more Alpha launches in 2026, with Flight 8 targeted for late summer. Earnings prints have averaged roughly a 9% move. Note it has only traded publicly since August 2025, so the chain is young.

• Bull: record revenue growth, expanding NASA lunar opportunity, SciTec adding missile warning exposure.

• Bear: wider spreads, thinner open interest, and the market has punished record prints on margin slips.

• SharkWater Take: great story, thinner plumbing. Respect the bid ask and skip market orders.

• Play it: stick to defined risk spreads and work limit orders. A put credit spread into a launch you expect to succeed collects premium with a known max loss.

PL — Planet Labs (Quiet window)

Fell about 26% the day after its June 4 report; next earnings land around September 8 to 14, 2026. Record quarterly revenue of $94M, up 42%, with backlog over $906M.

• Bull: recurring revenue base is real, defense and intelligence revenue up more than 65%, three straight quarters clearing Rule of 40.

• Bear: the market just knocked it down 26% on a solid print, so positioning matters more than fundamentals short term.

• SharkWater Take: with earnings behind it, PL sits in a catalyst quiet window until September, the cleanest premium selling setup on the board.

• Play it: this is a wheel candidate. Sell cash secured puts where you would happily own it, collect through the quiet weeks, and if assigned, sell covered calls. No binary event risk until the September print.

The ETFs and thin names: different rules

ARKX (ARK Space & Defense) and NASA (Tema Space) are diversified baskets with lower IV and thin options interest. Treat them as directional core positions or covered call vehicles, not premium farms. The basket smooths out the fear premium you are trying to sell. YSS (York Space Systems) is newer and thinly covered; confirm the chain has real open interest and tight spreads before trading options at all. If the plumbing is not there, trade the shares.

Bottom line

Two clean ways to make money here. Sell rich premium in the quiet windows on names you would own anyway (PL now, LUNR and RKLB on dips), and buy cheap, defined risk directional exposure ahead of the hard catalysts (Neutron on RKLB, the launch cadence on ASTS and FLY, the IM-3 landing on LUNR). Let the IV crush be your tailwind. Size for double digit overnight gaps, keep event bets small enough to lose, and always know whether you are buying insurance or writing it.

Fair winds and full premium. Keep your risk tight and your powder dry. ⚓

Disclaimer: Educational content only, not financial advice or a recommendation. Options carry substantial risk and are not suitable for every investor. Earnings dates and launch windows shift; confirm with a live source before trading. Past performance does not guarantee future results.

🦈 What Just Happened: Robinhood Opened Its Doors to AI Agents

noreply@blogger.com (Unknown) — Sat, 27 Jun 2026 17:43:57 +0000

By Sharkwater Trading Analysis Team | June 27, 2026

Sharks, the rules of retail trading just changed — again.

For decades, algorithmic trading was the exclusive territory of hedge funds and proprietary trading desks. You needed Bloomberg terminals, co-located servers, quant PhDs on staff, and a minimum of $10 million in capital before anyone would even hand you the keys. The technology gap between Wall Street and Main Street wasn't just wide — it was designed to be wide.

Then Robinhood gave everyone commission-free trading. Then zero-commission options. Then fractional shares. Every time retail caught up, the pros found another edge. But nothing has closed the gap faster than what happened on May 27, 2026, when Robinhood launched something called Agentic Trading — and Robinhood stock jumped 28.1% the same day the market understood what it meant.

What it meant was this: any retail investor can now connect an AI agent — including Claude — directly to their Robinhood account and let it execute trades autonomously. Not hypothetically. Not in a sandbox. With real money, in real markets, executing real orders based on instructions you write in plain English.

Today, Sharkwater breaks down exactly how it works, why it matters, what strategies it can automate, and — critically — how even the most non-technical Shark in the tank can set this up without writing a single line of code.

Let's dive in.

🦈 What Just Happened: Robinhood Opened Its Doors to AI Agents

On May 27, 2026, Robinhood launched its official Model Context Protocol (MCP) server — a standardized interface that lets AI agents like Claude, ChatGPT, and others connect directly to your brokerage account and take action on your behalf. The official endpoint is:

https://agent.robinhood.com/mcp/trading

This is not a third-party hack or a workaround. This is Robinhood's own infrastructure, purpose-built for AI agents, with its own authentication system, its own safety architecture, and its own dedicated account type that keeps your AI trading money separate from your main portfolio. This is Robinhood officially inviting AI into the brokerage relationship — and the 28.1% single-day stock pop told you exactly how the market felt about that decision.

But to understand why this matters so much, you need to understand what MCP actually is — because it's the technology that makes all of this possible, and it was built by Anthropic, the company behind Claude.

🦈 Understanding MCP: The Protocol That Connects AI to Everything

Model Context Protocol (MCP) is an open standard created by Anthropic that gives AI models a structured, secure way to connect to external tools, data sources, and systems. Think of it as a universal translator between an AI brain and the real world.

Before MCP, AI models like Claude could read text and generate text — but they couldn't take action. They couldn't look up live stock prices, check your portfolio balance, or place an order. They could tell you what to do, but you had to go do it yourself.

MCP changes that. When a service publishes an MCP server — the way Robinhood just did — it's defining a set of "tools" that an AI model can call. Each tool is a specific action: get a quote, check my balance, place a limit order, cancel an order. The AI decides which tools to use, in what order, based on your instructions. The MCP server executes the action against the real system and sends the result back to the AI.

Here is a simplified example of what happens when you tell Claude "buy 10 shares of AGNC if it drops below $10.50 today":

Claude receives your instruction and holds it in its working context
On its monitoring cycle, Claude calls the get_quote tool → Robinhood returns: AGNC = $10.48
Claude compares $10.48 to your $10.50 threshold — condition is met
Claude calls the place_order tool with parameters: symbol=AGNC, quantity=10, order_type=market
Robinhood executes the order, returns confirmation
Claude logs the action and notifies you

This entire workflow happens without you clicking a single button. Claude is the reasoning layer. MCP is the communication bridge. Robinhood is the execution engine. Together, they form your personal AI trading desk — available 24 hours a day, never emotional, never distracted, and operating exactly according to the rules you set.

🦈 What the Robinhood MCP Can Actually Do

Here's what Robinhood's official Agentic Trading MCP exposes to AI agents as of launch — it's more capable than you might expect for a beta product:

Category	What the Agent Can Do	Status
Portfolio Intelligence	Read account balances, buying power, positions, portfolio value, order history, sector exposure, concentration risk	✅ Live
Market Data	Live equity quotes, symbol search, watchlist management	✅ Live
Trade Execution	Market orders, limit orders, stop orders, stop-limit orders — equities only in beta	✅ Live (Agentic Account)
Backtesting	Test strategies (momentum, mean reversion, etc.) against historical data	✅ Live
Rebalancing	Analyze target vs. actual allocations, suggest and execute rebalancing trades	✅ Live
Options Trading	Agent-executed options orders	🔜 Rolling out
Crypto Trading	Agent-executed crypto orders	🔜 Coming soon
Futures / Event Contracts	Agent execution	❌ Not yet available

The Safety Architecture: Robinhood built real guardrails into Agentic Trading — this wasn't just an API thrown open to the public. The key safety features:

Dedicated Agentic Account: Completely separate from your main Robinhood portfolio. You fund it with only what you're willing to expose to the agent. If the agent goes wrong, it can only affect what's in that account.
Push notifications for every trade: Every single order the agent places triggers a push notification to your phone in real time.
Real-time activity feed and P&L: Live dashboard in the Robinhood app showing every agent action.
One-tap kill switch: Disconnect the agent and halt all trading with a single button press.
OAuth authentication: The agent never sees your password — it authenticates through Robinhood's own login flow, the same way Google or Apple sign-in works.

🦈 Claude as Your Trading Agent: Why Claude Specifically?

Robinhood's MCP server works with multiple AI models — Claude, ChatGPT, and others. So why is Sharkwater specifically focused on Claude? Several reasons, and they're not just because Anthropic built MCP.

1. Claude was designed for agentic tasks. Anthropic built Claude with multi-step, tool-use workflows explicitly in mind. Claude's ability to reason through a sequence of tool calls — check a price, compare to a condition, decide whether to act, place an order, log the result — is more reliable than models optimized primarily for conversation.

2. Context window advantage. Claude Sonnet 4.6 and Opus 4.8 have context windows large enough to simultaneously hold your entire trading methodology, your current portfolio state, a watchlist of 50 tickers, today's market news, and the full conversation history. Claude doesn't lose track of your rules halfway through a trading session.

3. Claude Code's /loop command. Claude Code — Anthropic's CLI tool — has a native /loop command that turns any workflow into a recurring, scheduled agent. You can tell Claude to monitor your positions every 15 minutes and execute your rules, and it does that automatically without you manually starting each cycle. This is the foundation of an "always-on" trading agent.

4. Natural language rules that actually stick. Claude's ability to interpret nuanced, plain-English instructions — "don't buy anything on Fridays before a long weekend," "if the VIX is above 25 reduce all positions by half," "never put more than 8% of the account in any single name" — and apply them consistently across hundreds of decisions is genuinely superior to rigid if-then rule engines.

5. Persistent methodology files. You can write your entire trading philosophy as a plain text markdown file — entry criteria, exit criteria, position sizing rules, sector limits, risk parameters — and Claude reads it as its operating context at the start of every session. Your trading brain, written down once, applied every time.

🦈 How to Connect Claude to Robinhood: Step-by-Step

Here's exactly how to get Claude trading in your Robinhood Agentic Account. We'll give you both the technical path (Claude Code CLI) and the no-code path (Robinhood's consumer interface).

Path A: Consumer Setup (No Technical Knowledge Required)

Robinhood built the Agentic Trading feature with a consumer-friendly OAuth flow — the same kind of "Connect with Google" experience you've used a thousand times. Here's the flow:

Open your Robinhood app and navigate to Account → Agentic Trading
Create your Agentic Account — this takes about two minutes. Fund it with whatever amount you want to make available to the agent (start small — $500–$1,000 while you learn)
Select "Connect an AI Agent" — choose Claude from the supported agent list
Authorize via OAuth — you'll be redirected to Anthropic's authorization page, log in with your Claude account, and approve the connection. Claude never sees your Robinhood password.
Set your initial instructions — Robinhood provides a simple text box where you describe your trading rules in plain English (more on this below)
Enable push notifications — you want to know about every trade the agent makes
Enable the kill switch shortcut on your phone home screen — one tap to pause everything

That's it. No terminal. No code. No API keys. Claude is now authorized to trade in your Agentic Account based on your instructions.

Path B: Claude Code CLI Setup (For Technically Comfortable Users)

If you use Claude Code (Anthropic's CLI tool), connecting to the Robinhood MCP takes a single command:

claude mcp add robinhood-trading --transport http https://agent.robinhood.com/mcp/trading

After running that command, Claude Code will prompt you to authenticate via the OAuth flow. Once connected, you can interact with your Robinhood account directly from the Claude Code terminal using natural language — or set up scheduled /loop workflows for continuous monitoring.

Setting up an always-on loop:

/loop 15m Monitor my Agentic Account positions. If any position is down more than 4% from my purchase price, sell it. If AGNC drops below $10.50, buy 20 shares. Log every check and every action.

Claude Code will now check your portfolio every 15 minutes and execute those rules automatically — notifying you of every action it takes.

🦈 Writing Your Trading Rules in Plain English: The Non-Technical Shark's Superpower

Here's where this gets genuinely exciting for non-technical investors. You don't need to know Python. You don't need to understand APIs. You don't need to write a single line of code. You need to be able to describe what you want in plain English — and Claude will translate that into action.

Let's look at real examples of the kinds of trading rules any Shark can write:

Example 1: Dividend Capture Strategy (From Our mREIT Analysis)

"I run a dividend capture strategy on AGNC. AGNC always sets its ex-dividend date on the last business day of the month. The dividend is $0.12 per share. Seven days before the end of each month, buy 100 shares of AGNC. The day before the ex-dividend date, sell all AGNC shares. Never buy AGNC if the stock is below $10.00. Never invest more than 15% of the account in this strategy. Send me a notification when you buy and when you sell."

Claude reads this, tracks the calendar, monitors the price condition, executes the entry and exit, and reports every action. A strategy that previously required a custom Python script and brokerage API integration now runs on a paragraph of English.

Example 2: Moving Average Momentum Strategy

"Monitor the following tickers every morning at 9:45 AM Eastern after the open: IONQ, OKLO, BWXT, GEV, CEG. If any of them closes above their 20-day moving average for the third consecutive day, buy $500 worth at market price. If any position I hold drops below its 20-day moving average for two consecutive days, sell it. Never hold more than 5 positions at once. Never invest more than $2,500 total across all positions."

Example 3: RSI Mean Reversion Strategy

"Watch my watchlist every day. If any stock on my watchlist has an RSI below 30 (oversold), buy $300 worth at market open the next morning. If any position I own reaches an RSI above 70 (overbought), sell half my position. Never buy more than three new positions in one week. If the S&P 500 is down more than 2% on the day, don't make any new purchases — wait for stability."

Example 4: Portfolio Rebalancing on Autopilot

"I want to maintain the following target allocation in my Agentic Account: 30% in nuclear energy stocks (split equally between CEG, VST, and BWXT), 30% in quantum computing (split equally between IONQ and QBTS), 20% in dividend income stocks (AGNC and MFA), and 20% cash. Every Sunday evening, check my actual allocations versus these targets. If any position is more than 5 percentage points off target, execute the trades needed to rebalance. Use limit orders priced within 0.5% of the last closing price."

Example 5: Trend + News Combination Strategy

"Every morning at 8:00 AM, search for recent news on the following tickers: SMR, OKLO, IONQ, LEU, RGTI. If any ticker has a significant positive catalyst announced — an earnings beat, a major contract win, a government award, a regulatory approval — and the stock is trading within 5% of its 52-week high, buy $400 worth at market open. If I already hold that ticker, don't buy more. Sell any position that's up 15% from my purchase price. Hold any position for a maximum of 30 days regardless of performance."

Claude can execute all of these. The key insight is that the strategy lives in English — in your head, or in a text file — and Claude is the implementation layer. You don't need to translate your thinking into code. You explain it the same way you'd explain it to a smart trading assistant, and the assistant goes to work.

🦈 Beyond Robinhood: The Full Ecosystem of AI Trading Tools

Robinhood's official MCP is the biggest story, but it's not the only way to automate your trading with AI. Here's the full landscape, organized by how much technical comfort each option requires:

Level 1: Zero Setup — Robinhood Native Features

Before you connect any AI agent, Robinhood already has built-in automation that requires nothing beyond the app:

Recurring Investments: Automated dollar-cost averaging into any stock, ETF, or crypto on a daily, weekly, or monthly schedule — already available
Dividend Reinvestment (DRIP): Auto-reinvest dividends into more shares — already available
Limit and Stop Orders: Rules-based execution without an agent — if the stock hits X, buy/sell automatically
Agentic Trading (Consumer Interface): As described above — connect Claude or ChatGPT in minutes without any technical setup

If you're not yet using these basics, start here before adding an AI agent layer on top.

Level 2: No-Code AI Trading — Composer

For Sharks who want a fully automated strategy but aren't ready to connect an AI agent to a live brokerage account, Composer (now a SoFi product) is the most polished no-code algorithmic trading platform available to retail investors.

Here's how Composer works:

Describe your strategy in plain English — "Invest in the top 5 performing sector ETFs from the last month. Rebalance weekly. Switch entirely to cash if the S&P 500 drops more than 10% from its 12-month high."
Composer's AI converts it to executable logic and shows you exactly what rules it created
Backtest it instantly against up to 10 years of historical data — see the equity curve, drawdowns, Sharpe ratio, and performance in different market environments
Deploy it live — Composer executes your strategy at market close each day automatically

Pricing runs from $30/month for a single strategy up to $120/month for unlimited strategies. Composer uses Alpaca as its brokerage backbone — not Robinhood — so it requires opening a separate account, but the process is straightforward. The single biggest advantage over the Robinhood/Claude approach: the backtesting interface is excellent and visual, making it easy for non-technical investors to see how a strategy would have performed before risking real capital.

Level 3: Visual Workflow Automation — n8n

For Sharks who want more flexibility than Composer but aren't ready to write code, n8n is a visual drag-and-drop workflow builder with native AI agent support and over 264 community-built crypto and stock trading workflow templates.

In n8n, you build trading workflows visually by connecting blocks:

Schedule Trigger (every 15 min) → HTTP Request (get quote from Alpaca) → AI Agent Node (Claude analyzes condition) → IF Node (condition met?) → Alpaca Order Node (place trade) → Push Notification Node (alert you)

n8n has a pre-built Alpaca integration and an "AI Agent" node that supports Claude, GPT-4o, and Groq. Community templates exist for momentum trading, mean reversion, and portfolio monitoring. You can self-host n8n on your own computer (free) or use n8n's cloud version. No coding required — just drag, drop, and configure.

Level 4: Community MCP Servers (For the Adventurous)

Before Robinhood launched its official MCP, the developer community built their own. These community projects predate the official offering and provide capabilities the official MCP doesn't yet have — including options trading:

open-stocks-mcp (GitHub: Open-Agent-Tools/open-stocks-mcp) — 104 MCP tools covering both Robinhood (80 tools) and Schwab (24 tools), including full options trading support. The most feature-complete community solution.
trayd-mcp (GitHub: trayders/trayd-mcp) — Built specifically for Claude Code; the developer who created it wrote up the build story on DEV Community before the official MCP launched. Full trading, not just read-only.
verygoodplugins/robinhood-mcp — Read-only portfolio research MCP. Good for analysis without execution risk.
kvcpers/Robinhood-Portfolio-Tracker-MCP — Includes paper trading mode, essential for testing strategies before going live.

Important caveat: Community MCPs that use the reverse-engineered Robinhood API operate outside Robinhood's terms of service and may break without warning when Robinhood updates its platform. Use the official MCP for anything involving real money. The community servers are best for paper trading and research.

Level 5: Alternative Brokerages with AI Integration

Robinhood isn't alone. Two alternatives worth knowing about:

Public.com — Has its own official MCP server supporting stocks, ETFs, options, and crypto via Claude. Includes IRA account support, which Robinhood's agentic feature does not yet cover. If you want AI-automated trading inside a retirement account, Public.com is currently your best option.
Alpaca — The developer-focused brokerage most used in tutorials and community projects. Alpaca has an official MCP integration with Claude, excellent documentation, and is the backend behind Composer and many n8n templates. If you're comfortable with some technical setup, Alpaca offers more flexibility than Robinhood for custom strategy implementation.

🦈 Real-World Examples: What's Already Working

This isn't theoretical — retail traders are already doing this. Here are documented examples from the community:

The Quant Factor Miner (February 2026): A trader named Saulius used Claude Code to build an autonomous factor mining framework analyzing 53 commodity futures contracts over 10 years. The system went through five rounds of automated analysis, explored 20 different trading factors, and identified a standout strategy with a Sharpe ratio of 1.72 and 38.7% annualized return from January 2023 through February 2026. The entire research process — which would have required a team of quants and weeks of work at a hedge fund — ran autonomously through Claude Code.

The Trayd Developer (May 2026): A retail developer published "I Built an MCP Server to Trade Robinhood Through Claude Code" on DEV Community, documenting the complete build process of the trayd-mcp before the official Robinhood MCP launched. The post showed Claude executing natural language trading commands against a live Robinhood account, with the full order lifecycle visible — quote retrieval, order placement, confirmation, and position tracking — all within a Claude conversation.

The 24/7 Alpaca Agent (2026): MindStudio published a complete tutorial: "How to Build a 24/7 AI Trading Agent with Claude Code Routines" — a step-by-step guide showing Claude Code's /loop command executing momentum and mean-reversion strategies continuously through Alpaca's MCP. The tutorial is public and replicable by non-technical traders.

The AstraZeneca Signal (June 2025): At the institutional level, IonQ and AstraZeneca jointly published a quantum advantage claim in drug discovery — demonstrating how AI and quantum hybrid systems identified molecular simulation results classical computers couldn't match. While that's institutional research rather than trading, it's the same AI reasoning architecture that Claude uses for trading decisions, applied at pharmaceutical scale.

The YouTube Proof of Concept: A video titled "Finally FULL Portfolio Trade Automation with AI - Claude MCP Routines (IT WORKS)" went viral in the trading community, showing a live demonstration of the full agentic loop: Claude receiving a portfolio brief, analyzing positions, identifying a setup, executing a trade through the MCP, and logging the action — all without a single human click.

🦈 The Big Policy Shift That Makes This Even Better: PDT Is Dead

One more piece of context that changes the calculus for retail AI trading: on April 14, 2026, the SEC officially eliminated the Pattern Day Trader (PDT) rule — the regulation that required retail traders to maintain a $25,000 minimum account balance to make more than three day trades in a five-business-day period.

For retail AI agents, this is significant. The PDT rule was one of the primary friction points that limited how active an automated strategy could be in a sub-$25K account. An AI agent running a momentum strategy or a dividend capture workflow might naturally make four or more roundtrip trades in a week — under the old PDT rule, a $5,000 account would have been locked out. Under the new framework, the only limits are margin-based circuit breakers.

The elimination of PDT combined with Robinhood's Agentic Trading launch creates the most retail-friendly environment for automated trading in U.S. market history. The regulatory and technological gates that kept algorithmic trading as a Wall Street monopoly are both gone — at the same time.

🦈 Benefits at a Glance: Why Every Shark Should Know This Exists

Benefit	What It Means for You
Emotionless Execution	Claude doesn't panic-sell when markets drop 3% at open. It doesn't hold a loser because it's attached to a thesis. It executes the rules you wrote — every time, without hesitation or regret.
24/7 Monitoring	Claude doesn't sleep. It can monitor pre-market conditions, watch for price triggers while you're in a meeting, and react to your ex-dividend calendar events you'd otherwise miss.
Consistent Rule Application	You wrote the rules when you were calm and analytical. Claude applies them even when the market is volatile and your instinct is to override everything. That discipline is worth more than most strategies.
Plain English Strategy	Your strategy lives in English, not Python. You can update it with a sentence. You can explain it to anyone. You're not locked into code you wrote once and can't change without breaking something.
Multi-Strategy Management	Claude can simultaneously run a momentum strategy, a dividend capture strategy, and a rebalancing workflow — all within the same account, applying different rules to different positions.
Backtesting and Iteration	Robinhood's MCP includes backtesting support. Claude can test a strategy variation against historical data and report results before you deploy it live.
Natural Language Analysis	Ask Claude "why did my portfolio underperform last month?" and it will analyze your trade history, identify patterns, and suggest adjustments — in plain English, not a spreadsheet.
Institutional-Grade Discipline at Retail Scale	Hedge funds automate for discipline, not just speed. Removing human emotion and reaction from the trade execution loop is the single biggest edge automation provides — and it's now available to any retail investor with a Robinhood account.

🦈 The Risk Section Every Shark Needs to Read

We wouldn't be Sharkwater if we didn't name every current in the water that can pull this trade sideways. AI trading automation has real, specific risks that are different from manual trading risks — know them before you connect the agent.

You own every trade the agent makes. The SEC is unambiguous: you are legally responsible for every transaction in your account, regardless of whether a human or an AI placed it. "My AI did it" is not a defense with FINRA or the IRS. The agent is your instrument. Own it.

Hallucination risk is real in trading contexts. Claude is an AI. AI models occasionally confabulate — confidently stating something that isn't true. In a conversation, a hallucination is an inconvenience. In a trading context, it could mean Claude acting on a price it invented, a ticker it misread, or a rule it misremembered. This is why position size limits in your instructions are non-negotiable, and why the Agentic Account's separation from your main portfolio is so important.

Algorithmic herding amplifies volatility. When thousands of retail AI agents all receive the same news, run the same RSI calculation, and trigger the same "buy oversold" signal simultaneously, they can move stocks — especially small-caps — in ways that wouldn't happen with manual trading. The 2010 Flash Crash and the August 2024 Nikkei collapse (-12.4% in a single day) are warnings about what happens when correlated algorithms all move the same direction at the same time. Diversify your signals; don't be the 10,000th person running the same RSI bot.

Overfitting kills live performance. Backtesting looks great until you realize a strategy that worked perfectly from 2020–2024 was specifically optimized for a period that won't repeat. A strategy that backtests at 40% annual return should be greeted with deep skepticism, not excitement. Paper trade everything for at least 30–60 days before going live.

Tax complexity multiplies with automation. Automated strategies can generate dozens or hundreds of trades per year. More trades mean more tax events, potential wash sale violations, and a Schedule D that your tax software might struggle with. Short-term gains (positions held less than one year) are taxed as ordinary income — at rates up to 37%. A strategy that looks profitable before taxes might be mediocre after them. Model your after-tax returns before you deploy.

Security exposure. Your Robinhood MCP connection is authenticated through OAuth, which is solid. But your Claude account and any configuration files containing your trading rules are security-sensitive. If your Claude account is compromised, someone could modify your trading instructions. Use strong, unique passwords and two-factor authentication on every account in the chain.

🦈 The Guardrails You Must Build Into Every Strategy

Before you write a single trading rule for Claude, build these guardrails into your instructions. Copy them verbatim if you like:

"Never invest more than [X]% of the account in a single position. Never invest more than [Y]% of the account in a single sector. If the total account value drops more than [Z]% in a single day, stop trading and alert me. Never place a market order for more than $[amount] without first requesting my confirmation. Never trade in the 30 minutes immediately after market open or the 30 minutes before market close. Always use limit orders priced within 0.5% of the last trade price. If you are uncertain about any instruction, do not trade — alert me instead."

These aren't suggestions. They are the circuit breakers that prevent a misunderstood instruction from becoming a portfolio-level event. Build them in from day one.

🦈 The Sharkwater Quick-Start Checklist

Ready to get started? Here's your step-by-step launch sequence:

☐ Open a Robinhood Agentic Account — separate from your main account, fund it with only what you're willing to test with ($500–$2,000 to start)
☐ Connect Claude via the Robinhood consumer interface (no code needed — OAuth flow)
☐ Enable push notifications for every agent trade
☐ Write your trading rules in plain English — include guardrails, position limits, daily loss caps
☐ Backtest first — use Robinhood's built-in backtest tool or Composer to validate your strategy against historical data before going live
☐ Paper trade for 30 days — run your strategy in simulation mode and compare results to your backtest assumptions
☐ Go live with minimal capital — deploy with the minimum amount that lets you validate the strategy is working correctly
☐ Review agent activity weekly — audit the trade log, not just the P&L. Understand every decision the agent made.
☐ Iterate your rules — natural language makes this easy. When something isn't working, update your instructions and the agent adapts immediately.

🦈 Final Word: The Democratization of the Trading Desk

Here's the honest truth about what Robinhood's Agentic Trading launch means for retail investors. For thirty years, the most durable edge in the market belonged to institutions — not because they were smarter, not because they had better information (though they had that too), but because they had the technology and discipline to execute a strategy perfectly, every time, without emotional interference.

Automated execution. Rules-based position management. 24/7 monitoring. Consistent application of pre-defined strategy. These aren't proprietary secrets — they're table stakes for every algorithmic trading desk in the world. They work because markets are full of human traders who deviate from their own rules, panic at the wrong moment, hold too long, sell too early, and let last Tuesday's loss affect today's decision.

That institutional edge — the disciplined, emotionless, always-on execution layer — just got democratized. It's sitting at https://agent.robinhood.com/mcp/trading, waiting for you to connect to it with a plain-English description of your strategy.

We're not saying this turns every retail investor into a quant. The alpha still has to come from somewhere — from a real edge, a thoughtful strategy, a risk-adjusted approach to position sizing. Claude can't invent alpha that doesn't exist. But it can execute the alpha you identify — consistently, without emotion, without the behavioral errors that cost retail investors an estimated 1.5–2% of annual returns every year according to Dalbar's long-running behavioral finance research.

That's not nothing. For a $50,000 portfolio, 1.5–2% per year compounded over 20 years is the difference between a good outcome and a great one.

The tools are here, Sharks. The rules are yours to write. Get in the water.

— The Sharkwater Trading Analysis Team

🦈 Useful Resources and Links

Robinhood Agentic Trading: robinhood.com/us/en/agentic-trading/
Robinhood MCP Documentation: docs.robinhood.com
Composer (No-Code Algo Trading): composer.trade
Public.com MCP (Options + IRA support): public.com
n8n (Visual Workflow Automation): n8n.io
Alpaca MCP + Claude Tutorial: alpaca.markets
Community: open-stocks-mcp (multi-broker, options): GitHub
Community: trayd-mcp (Robinhood + Claude Code): GitHub
Video Demo: "Finally FULL Portfolio Trade Automation with AI - Claude MCP Routines" — search YouTube
Claude API (build your own): anthropic.com/api

Disclaimer: This blog post is for informational and educational purposes only and should not be considered financial advice. Automated trading carries significant risk, including the risk of total loss of invested capital. AI agents can malfunction, misinterpret instructions, or act on erroneous data, resulting in unintended trades or financial losses. You are legally responsible for every trade executed in your account, regardless of whether it was placed by a human or an AI agent. Past performance of any strategy or technology discussed is not indicative of future results. Tax consequences of automated trading strategies can be significant and complex — consult a tax professional before deploying any automated strategy. Always test strategies with paper trading before deploying real capital. The tools, platforms, and regulatory changes referenced in this article reflect conditions as of June 27, 2026, and are subject to change. Neither Sharkwater Trading nor the Sharkwater Trading Analysis Team is a registered investment advisor. This post does not constitute a solicitation to buy or sell any security or to use any specific product or service. Please consult a qualified financial and legal professional before making any investment decisions or deploying any automated trading system.

🦈 The Big Picture: Why Quantum Matters Right Now

noreply@blogger.com (Unknown) — Sat, 27 Jun 2026 17:13:11 +0000

By Sharkwater Trading Analysis Team | June 27, 2026

Sharks, some trades are cyclical. Some are structural. And then — maybe once a generation — a trade comes along that is civilizational.

Quantum computing is that trade.

We know what you've heard. Quantum computers are science fiction. They're always "ten years away." The companies are money-losing hype machines. The tech doesn't work. We've heard all of it — and frankly, two years ago, a lot of it was fair.

That's not where we are in June 2026.

In October 2025, Google's Willow chip performed a calculation in under five minutes that would take the fastest classical supercomputer on Earth 10 septillion years. That's 10 followed by 25 zeros — longer than the age of the universe by a factor of roughly 700 trillion. And unlike prior "quantum supremacy" claims, this one used an algorithm that can be independently verified on other quantum hardware. It counts.

In February 2025, Microsoft unveiled the world's first topological qubit processor. In March 2025, D-Wave demonstrated quantum supremacy on a real-world materials science problem. In June 2025, IonQ and AstraZeneca jointly claimed quantum advantage in drug discovery. In February 2026, D-Wave acquired Quantum Circuits Inc. for $550 million to become a dual-platform quantum powerhouse. In June 2026, Quantinuum IPO'd at a $15.7 billion valuation, raising $1.68 billion from institutional investors who don't write billion-dollar checks on science fiction.

Meanwhile, the U.S. government committed $2 billion in the May 2026 CHIPS Act quantum package — and for the first time in history, took equity stakes directly in quantum companies. The DOE has pledged another $2.5 billion through 2030. DARPA launched the Quantum Benchmarking Initiative to determine whether an industrially useful quantum computer is achievable by 2033.

The tide has shifted. The question is no longer if quantum computing becomes real. It's who gets paid when it does — and which stocks you own when the institutional money that's currently sizing positions grows into full allocation mode.

Today, Sharkwater maps the entire quantum food chain: pure-play developers, the big tech players with quantum divisions worth more than the stock market currently prices them, the encryption play that nobody's talking about, and the picks-and-shovels company that powers all of it. Let's get in the water.

🦈 The Big Picture: Why Quantum Matters Right Now

Before we pick stocks, let's get the thesis straight — because the quantum investment story runs on three separate tracks simultaneously, and each track has a different time horizon and risk profile.

Track 1 — Near-Term Commercial Applications (2025–2030): Quantum computers don't need to be perfect to be useful. Hybrid quantum-classical approaches — where quantum processors handle specific subroutines while classical computers handle the rest — are already producing measurable advantages in drug discovery, materials simulation, financial optimization, and GPS-denied navigation. This is happening now. Companies generating real revenue from real customers are in this lane.

Track 2 — Fault-Tolerant Quantum Computing (2028–2033): This is the true prize — a fully error-corrected quantum computer capable of running arbitrary algorithms at scale. IBM's roadmap targets 2029 for "Starling," the first fault-tolerant system with 200 logical qubits. Once achieved, every combinatorial optimization problem in logistics, finance, and chemistry becomes tractable at speeds classical computers can't touch. This is where trillion-dollar value creation happens.

Track 3 — Q-Day and Post-Quantum Cryptography (2029–2035+): Google's internal research suggests some encrypted systems could be vulnerable to quantum attack as early as 2029. Most experts say 2030–2035. The "harvest now, decrypt later" threat — where adversaries capture encrypted data today to decrypt it once quantum computers are capable — is already real. NIST finalized its first post-quantum encryption standards in August 2024, and Executive Order 14119 mandates all U.S. federal agencies complete migration by 2035. This creates an immediate, multi-billion-dollar cybersecurity spending wave independent of whether a single commercial quantum computer ever gets built.

Three tracks. Three time horizons. Multiple ways to win. Now let's look at every name worth owning.

🦈 TIER 1: THE PURE-PLAY QUANTUM LEADERS — Where the Real Action Is

These are the companies for which quantum computing is not a side project or a research budget line item. It is the entire business. Higher risk than the large caps — but dramatically higher leverage to the quantum upside when it comes.

IONQ — IonQ, Inc. | ~$49.65 | Market Cap: $20.8B | ⭐⭐⭐⭐⭐

Technology: Trapped-Ion Quantum Computing

IonQ is the undisputed commercial leader among pure-play quantum stocks, and it's not particularly close. In 2025, IonQ became the first publicly traded quantum company to exceed $100 million in GAAP revenue — a milestone that separated it from every competitor. In Q1 2026, it reported $64.7 million in revenue, a staggering 755% year-over-year increase. Full-year 2026 guidance: $260–$270 million. The backlog stands at $470 million — roughly 28 quarters of contracted revenue visibility. The company holds $3.3 billion in cash.

Those numbers don't come from vaporware. IonQ uses trapped-ion quantum computing — individual ytterbium atoms suspended in electromagnetic fields and manipulated with laser pulses. Each atom is identical by nature of its atomic species, giving trapped-ion systems exceptionally high qubit fidelity. In 2026, IonQ sold its first 6th-generation, chip-based 256-qubit system, deployed systems to the University of Cambridge, and expanded to more than 30 countries. About 60% of its revenue is now commercial (vs. government), and 52% of new revenue came from multi-product system sales — customers aren't just paying for cloud access anymore, they're buying hardware.

The government pipeline is equally compelling. IonQ holds DARPA HARQ contracts, Missile Defense Agency SHIELD IDIQ contracts, Space Development Agency partnerships, and was named in the May 2026 Commerce Department $2B CHIPS Act quantum allocation. The June 2025 announcement with AstraZeneca claiming quantum advantage in drug discovery put one of the world's largest pharmaceutical companies on record as a paying, believing customer.

Is the stock expensive? At $20.8 billion market cap against $260–270 million in 2026 guided revenue, yes — this is a growth stock priced for a future where quantum computing generates billions in annual revenue. That future is coming, and IonQ is the company that looks most likely to be there when it arrives.

The Trade: Core long position — the highest-quality risk/reward in the pure-play quantum space. Accumulate on pullbacks. The $470M backlog provides a revenue floor, the $3.3B cash balance provides protection, and the 755% revenue growth rate tells you this company is in an entirely different league from its peers. If you own one quantum pure-play, own IONQ.

QBTS — D-Wave Quantum | ~$21.80 | Market Cap: $8.1B | ⭐⭐⭐⭐☆

Technology: Quantum Annealing + Gate-Model (via Quantum Circuits acquisition)

D-Wave is the oldest quantum computing company and the most commercially battle-tested. While competitors are still running proof-of-concept trials, D-Wave has over 100 paying customers — including Ford, BASF, Shionogi, Pattison Food Group, Fortune 500 companies, and government agencies. Full-year 2025 revenue hit $24.6 million, a 178% increase from the prior year, with three distinct revenue streams: system sales, quantum-computing-as-a-service subscriptions, and professional services.

In March 2025, D-Wave made the boldest claim in quantum computing's commercial history: the first demonstration of quantum supremacy on a useful real-world problem — specifically, simulating magnetic materials with results that outperformed a leading supercomputer. Critics debate the methodology, but no one disputes that D-Wave's systems are producing results that paying customers find valuable.

The January 2026 acquisition of Quantum Circuits Inc. for $550 million is the move that changes D-Wave's story entirely. D-Wave built its reputation on quantum annealing — a specialized approach optimized for combinatorial optimization. Academics have long questioned whether annealing is "real" quantum computing. By acquiring Quantum Circuits and its dual-rail qubit gate-model technology, D-Wave is transforming itself into a dual-platform quantum company — the only one in the world offering both annealing and gate-model capabilities. The world's first gate-model system using Quantum Circuits' architecture is slated for general availability in 2026.

D-Wave also relocated its headquarters from Silicon Valley to Boca Raton, Florida — a move that positions it closer to the southeastern U.S. data center cluster and the defense/government corridors of the mid-Atlantic. The $10 million two-year QCaaS contract with a Fortune 100 company and the $20 million system purchase from Florida Atlantic University announced in 2026 show the commercial pipeline is real.

15 analysts cover QBTS with an average price target of $36.80 — approximately 69% upside from current levels near $21.80.

The Trade: Strong long. D-Wave's 100+ customer base makes it the most commercially mature pure-play by customer count. The Quantum Circuits acquisition is a genuine strategic bet that, if it pays off, dramatically expands its addressable market. The 69% analyst upside target and 178% revenue growth make this compelling at current prices.

QNT — Quantinuum | ~$75.57 | Market Cap: ~$15.7B | ⭐⭐⭐⭐☆

Technology: Trapped-Ion (H-Series) + Full Software Stack | IPO: June 4, 2026

Quantinuum is the newest pure-play in the public market and, in the opinion of many quantum researchers, the one with the highest-quality qubits in the industry. Formed from the 2021 merger of Honeywell Quantum Solutions and Cambridge Quantum Computing, Quantinuum priced its IPO at $60 per share on June 4, 2026, opened at $68, and currently trades above $75. It raised $1.68 billion — institutional investors don't write billion-dollar checks for hype.

What makes Quantinuum unique is the full-stack positioning. Other quantum companies sell hardware access or cloud time. Quantinuum sells hardware and a comprehensive software suite: TKET (circuit optimizer used across the entire industry), InQuanto (quantum chemistry), Lambeq (quantum natural language processing), and Quantum Origin (quantum random number generation for cybersecurity). This software revenue is stickier and higher-margin than pure hardware access fees.

Quantinuum's H-Series trapped-ion processors are widely regarded as having the highest two-qubit gate fidelity of any commercial system — a technical advantage that translates directly into better algorithm performance. The quality-over-quantity approach stands in contrast to competitors racing to maximize raw qubit counts while fidelity lags.

One caution: revenue is inherently lumpy. Large system sales can make one quarter look spectacular and the next look weak — Q1 2026's $5.24 million against a $136.5 million net loss reflects timing of system deliveries, not underlying demand weakness. Honeywell retains a majority ownership stake post-IPO, providing institutional backing and balance sheet support. As a brand-new public company, price discovery is still happening — early-stage volatility should be expected.

The Trade: Quality-focused long for investors who prioritize technical leadership. Quantinuum's fidelity advantage and full-stack positioning are genuine differentiators. Consider a staged entry over 4–8 weeks to smooth through post-IPO volatility. This is the kind of company that looks obvious in hindsight five years from now.

RGTI — Rigetti Computing | ~$18.46 | Market Cap: ~$6.1–7.1B | ⭐⭐⭐☆☆

Technology: Superconducting Qubits (Tunable Transmons) | In-house Fab

Rigetti is the scrappiest fighter in the pure-play ring. Unlike IBM and Google — which are largely cloud-access players — Rigetti builds its own quantum chips in its proprietary Fab-1 facility, manufactures tunable superconducting transmon qubits, and sells access through its Quantum Cloud Services (QCS) platform. In April 2026, Rigetti became the first company to deliver a generally available 108-qubit system (Cepheus-1-108Q) with 99.1% median two-qubit gate fidelity — accessible on Amazon Braket.

In Q1 2026, Rigetti reported $4.4 million in revenue — a 199% year-over-year increase, though still tiny in absolute terms ($7.1 million trailing twelve months). The headline catalyst that sent the stock flying was the strategic collaboration with Taiwan's Quanta Computer, with both parties committing over $100 million each over five years. Quanta Computer is the world's largest contract laptop manufacturer with enormous manufacturing scale — the partnership gives Rigetti a path to industrialized quantum chip production that it could not achieve alone. A $8.4 million purchase order from India's C-DAC for the 108-qubit system, with deployment scheduled H2 2026, was the first significant international government hardware sale.

The roadmap calls for a 150+ qubit system by end of 2026 targeting 99.7% median two-qubit gate fidelity — a performance level that would be competitive with anyone in the field.

The risks are real: TTM revenue of $7.1 million against a $6+ billion market cap is almost entirely valuation on future potential, not present earnings power. A CTO share sale in June 2026 rattled the stock. And Rigetti competes directly against IBM and Google in superconducting qubits — the most crowded technical lane in quantum computing.

The Trade: Speculative long for traders with risk tolerance. The Quanta Computer alliance is the most significant near-term catalyst — manufacturing scale is the bottleneck for superconducting systems, and Quanta may be the answer. Position sizing is key: treat this as a satellite position, not an anchor. The 57% implied upside to the $29.24 analyst consensus is real, but so is the binary risk.

QUBT — Quantum Computing Inc. | ~$10–$12 | Market Cap: ~$2.05B | ⭐⭐☆☆☆

Technology: Integrated Photonics / Thin-Film Lithium Niobate

Quantum Computing Inc. occupies the most contrarian corner of this space. While everyone else races to pack more superconducting or trapped-ion qubits into cryogenic refrigerators operating near absolute zero, QUBT is betting on photonic quantum computing — using photons (light particles) as quantum bits, with the potential to operate at room temperature and enable quantum networking that cryogenic systems simply cannot do.

The company has pivoted hard from software to hardware, developing thin-film lithium niobate (TFLN) chips and its Entropy Quantum Computer (EQC) architecture. In June 2026, it agreed to acquire NHanced Semiconductors, expanding its semiconductor chip manufacturing capabilities for photonic components — a push toward vertical integration.

The honest assessment: QUBT is the most speculative name on this list. Revenue is minimal, the -40.1% decline over the prior year reflects investor frustration with slow commercialization, and the $2.05 billion market cap is almost entirely a technology thesis bet. But the photonic approach is technically legitimate — if room-temperature quantum computing ever works at scale, the cryogenic cooling requirements that make every other quantum system enormously expensive and difficult to deploy simply disappear. The technology is real. The timeline is the question.

The Trade: Micro-position only for aggressive speculative traders. Think of this as a lottery ticket with a credible technology thesis behind it — size it accordingly (1–2% of portfolio maximum). The NHanced acquisition is the right strategic move; execution will determine whether the photonic bet pays off.

ARQQ — Arqit Quantum | ~$27.11 | Market Cap: ~$477M | ⭐⭐⭐☆☆

Technology: Post-Quantum Cryptography / Quantum-Secured Encryption

Arqit is the sleeper in the quantum portfolio — a play not on building quantum computers, but on the threat that quantum computers pose to existing encryption. Its QuantumCloud platform delivers quantum-secured symmetric encryption keys to enterprise and government clients. In January 2026 it launched "Encryption Intelligence" — a service helping enterprises audit their cryptographic infrastructure and plan their migration to post-quantum encryption standards.

Here's why this matters right now: the NIST finalized its first post-quantum cryptographic standards in August 2024. Executive Order 14119 mandates all U.S. federal agencies complete migration to PQC by 2035. The "harvest now, decrypt later" attack vector — where adversaries are capturing encrypted government and corporate communications today to decrypt them once fault-tolerant quantum computers exist — is real and documented. Every federal agency, every financial institution, every critical infrastructure operator has to spend money on post-quantum security whether or not a single commercial quantum computer ever gets built. That spending wave is already beginning.

With a market cap of only $477 million and a 52-week range of $11.52 to $62.00, Arqit is volatile and thinly followed. It faces competition from large incumbents including Thales, AWS, and Palo Alto Networks. But as a focused, pure-play post-quantum encryption company, it offers a unique angle on the quantum security theme that none of the hardware companies provide.

The Trade: Speculative small position as a portfolio diversifier within the quantum theme. The post-quantum cryptography spending wave is real and beginning now — Arqit is one of the few pure expressions of that theme in public markets. Size it small and monitor for enterprise contract wins as catalysts.

🦈 TIER 2: THE BIG TECH QUANTUM PLAYS — Where The Research Lives

These are the companies doing the most scientifically advanced quantum research in the world — but quantum is not their primary business, and owning them is not primarily a quantum bet. That said, each has quantum assets that may be worth more than the market currently prices them. Think of these as quantum exposure with large-cap ballast.

IBM — International Business Machines | ~$253 | ⭐⭐⭐⭐☆

Best Large-Cap Quantum Exposure | $10B committed | $1B CHIPS Act allocation

IBM has the most detailed, most credible, and most consistently executed quantum roadmap of any company in the world. IBM's Nighthawk processor — deployed now in 2026 — scales to 360 qubits across three interconnected 120-qubit modules, running circuits with up to 7,500 gates. The Kookaburra module launching in 2026 is the first quantum-error-correction-enabled logical qubit module — a critical step toward fault tolerance. The IBM quantum roadmap beyond that:

2028 — Nighthawk Scaled: 1,080 qubits, 15,000-gate circuits
2029 — Starling: 200 logical qubits, 100 million gates — IBM's first fault-tolerant quantum computer
2033+ — Blue Jay: 2,000 logical qubits, 1 billion gates — full commercial fault tolerance

The U.S. government selected IBM as the anchor company in the $2 billion CHIPS Act quantum package, awarding it $1 billion — the single largest allocation of the nine companies selected. That is not a political decision. That is the U.S. government saying, in the clearest possible terms, that IBM is the company it is betting on to win the quantum race for America. IBM's Quantum Network includes more than 210 research organizations and companies using its cloud-based quantum systems — the largest installed base in the industry.

Analysts estimate IBM's standalone quantum division will generate $600 million in revenue by 2028 and could be valued at approximately $35 billion on a standalone basis — a number that is larger than most companies' entire market capitalizations. IBM's total market cap is roughly $230 billion. If the quantum thesis plays out, the quantum division alone may justify a significant portion of that valuation.

The Trade: Strong long for investors who want quantum exposure with large-cap stability. IBM is not a pure quantum play — it has AI infrastructure, cloud, consulting, and mainframe businesses that provide revenue floor. But the quantum option embedded in the stock is the most credible in the large-cap universe. The $1B federal endorsement is the cleanest signal you'll find.

GOOGL — Alphabet / Google Quantum AI | ⭐⭐⭐☆☆ (as a quantum play)

Best Quantum Research in the World | Willow Chip Changed Everything

Google's Willow chip announcement in October 2025 was the most significant quantum computing milestone in the history of the field. Not because of the headline number — though "faster than the age of the universe" is admittedly a jaw-dropping line — but because of how it achieved the result. Willow solved a 30-year-old problem in quantum error correction: as the qubit grid scaled from 3×3 to 5×5 to 7×7, the error rate was cut in half at each step. Errors reducing exponentially as scale increases is the holy grail of quantum computing — if that property holds as systems scale further, fault tolerance becomes achievable without impractical numbers of physical qubits.

In 2026, Google used Willow to study molecular behavior in 15-atom and 28-atom molecules, matching results from traditional nuclear magnetic resonance techniques — the first step toward genuinely useful quantum chemistry. Google's internal research suggests some encrypted systems may be vulnerable to quantum attack as early as 2029, a timeline that — if accurate — would represent extraordinary acceleration and would trigger massive policy responses across governments and enterprises globally.

The honest caveat for investors: Alphabet is a $2+ trillion company. Google's quantum work, while the most scientifically advanced in the world, generates essentially zero revenue today. GOOGL stock moves on AI monetization, search advertising, and YouTube — not quantum milestones. You are not buying a quantum stock when you buy Alphabet. You are buying a diversified technology empire that happens to house the best quantum physics team on Earth.

The Trade: Own GOOGL for AI, cloud, and search. Treat the quantum division as a free option embedded in the stock — a potential value unlock that could become significant in the 2030s. Don't buy GOOGL as a quantum play; appreciate it as a bonus on a great business.

MSFT — Microsoft Azure Quantum | ⭐⭐☆☆☆ (as a quantum play — high upside/high uncertainty)

The Biggest Bet in Quantum | Topological Qubits | Majorana 2

Microsoft is making the most audacious bet in all of quantum computing, and the verdict from the physics community is genuinely split. In February 2025, Microsoft unveiled Majorana 1 — the world's first quantum processor built on topological qubits, using a new class of material called a "topoconductor." In June 2026 at Microsoft Build, it unveiled Majorana 2, built with lead superconductor instead of aluminum, achieving mean qubit lifetimes of 20 seconds (with instances up to 1 minute) — a 1,000× reliability improvement over the prior generation.

The promise of topological qubits is extraordinary: if they work, Microsoft believes it can achieve one million qubits on a single palm-sized chip. Every other quantum architecture is scaling toward thousands of physical qubits, requiring enormous dilution refrigerators the size of chandeliers. Microsoft is betting it can leapfrog everyone with a fundamentally different architecture that eliminates the scaling problem entirely. The timeline to a scalable quantum computer, Microsoft now says, has been compressed to 2029.

The risk: the physics community remains skeptical. Topological qubit claims from Microsoft have a history of high-profile retractions — a 2018 Nature paper claiming Majorana fermion detection was ultimately retracted. Scientists at Scientific American have publicly noted that Microsoft has not yet met the independent verification bar that physicists require to confirm true topological protection. Microsoft has not granted external researchers access to validate Majorana 2's claims.

Microsoft's Azure Quantum platform is real business today — it sells quantum development tools and cloud access to IonQ, Quantinuum, Rigetti, and others' hardware. Platform revenue is real regardless of whether the topological hardware bet works out. But as a quantum hardware play specifically, MSFT is the highest upside and highest uncertainty position in the entire sector.

The Trade: Own MSFT for AI (Copilot), cloud (Azure), and enterprise software. The topological qubit option is real but unverified — treat it as a speculative bonus in an already great large-cap holding. If Majorana 2 gets independent validation in 2026–2027, the re-rating of MSFT's quantum assets could be significant.

🦈 TIER 3: THE QUANTUM ENABLER — Classical Power Behind the Quantum Revolution

NVDA — NVIDIA Corporation | ⭐⭐⭐☆☆ (as a quantum play)

The GPU That Runs the Quantum World | CUDA-Q | Ising AI Models

NVIDIA is not building a quantum computer. It doesn't need to. It's positioning itself as the essential classical computing substrate that every quantum computer runs on top of — and if that sounds familiar, it should. It's the same play NVIDIA ran with AI: don't compete with the models, sell the GPUs that train them.

NVIDIA's CUDA-Q platform enables quantum circuit simulation on classical GPUs, letting researchers and developers write and test quantum algorithms without access to real quantum hardware — critical for the 99% of the quantum developer community that doesn't have a cryogenic quantum system in its server room. In 2026, NVIDIA unveiled "Ising" — a suite of open-source AI models for calibrating quantum processors that enable error-correction decoding 2.5× faster and 3× more accurate than conventional methods. When fault-tolerant quantum computers eventually arrive, they will require enormous classical processing power for real-time error correction. NVIDIA's GPUs are the obvious substrate.

As with GOOGL and MSFT, NVDA is not a quantum stock — it is an AI infrastructure stock with quantum optionality. The primary thesis is data center GPU dominance. But as hybrid quantum-classical computing scales, NVIDIA's installed base of GPU clusters becomes increasingly important to the quantum ecosystem. Own it for the AI; appreciate the quantum angle for free.

The Trade: Own NVDA for AI dominance. The quantum enabler thesis is a multi-year tailwind embedded in a stock you probably already want to own anyway.

🦈 The Government Is Going Venture Capital — And That's Your Signal

Sharks, when the U.S. federal government starts taking equity stakes in technology companies for the first time in modern history, pay attention. That's exactly what happened in May 2026.

The Department of Commerce announced $2.013 billion in quantum investments under the CHIPS Act — and rather than grants, it took minority equity stakes in nine quantum companies. IBM received $1 billion. That's not a research grant. That's the federal government becoming a co-investor in the quantum race, with the same upside (and downside) that private investors have.

The broader quantum investment landscape from Washington:

$2.013 billion — Department of Commerce CHIPS Act Quantum Package (May 2026) — equity stakes in 9 companies
$2.5 billion — DOE Quantum Leadership Act (FY2026–2030)
$625 million — DOE Quantum Research Centers (2025 awards)
$1.8 billion — National Quantum Initiative reauthorization (FY2025–2029)
$240 million — DARPA + New Mexico Quantum Frontier (jointly funded, through 2029)
Classified — DARPA Quantum Benchmarking Initiative: can we build an industrially useful quantum computer by 2033?

Total confirmed federal quantum investment in the current cycle: over $7 billion. Add DARPA's classified programs, NSA/DoD quantum spending, and the intelligence community's post-quantum cryptography transition, and the real number is likely north of $10 billion. This level of government commitment creates a floor under the entire sector — pure-play companies with government contracts don't go to zero when Uncle Sam is both a customer and a shareholder.

🦈 Q-Day and the Post-Quantum Cryptography Gold Rush

There's a sub-theme within the quantum story that most investors completely miss, and it's probably the most immediately actionable one: post-quantum cryptography.

Here's the problem in plain English. Every piece of sensitive data transmitted or stored today — banking transactions, military communications, medical records, corporate secrets — is encrypted using RSA or elliptic-curve cryptography. These encryption standards are mathematically secure against classical computers. A sufficiently powerful quantum computer running Shor's algorithm could break them in hours or days.

When will that quantum computer exist? Experts disagree, but the range is 2029 to the mid-2030s. The Global Risk Institute rates a "quite possible" probability within 10 years. Google's internal research warns some systems could be vulnerable by 2029. The U.S. government is planning on a 15–25 year worst case.

But here's what makes this an immediate investment theme: the threat doesn't need to materialize for the spending to begin. The "harvest now, decrypt later" attack vector — capturing encrypted communications today and decrypting them once quantum hardware matures — means foreign adversaries may already be doing this to U.S. government traffic. NIST finalized post-quantum cryptographic standards in August 2024. Executive Order 14119 mandates federal agency migration to PQC by 2035. Every financial institution, every healthcare provider, every critical infrastructure operator now has regulatory pressure to replace their encryption infrastructure before Q-Day arrives.

This is a multi-hundred-billion-dollar infrastructure replacement cycle driven by a threat that quantum computers only need to theoretically be capable of — not actually operational — to trigger. The spending is happening now. It will accelerate through the late 2020s.

The direct play: ARQQ (Arqit Quantum) — the only pure-play post-quantum encryption company in the public markets. The indirect plays: Thales (CIGI), Palo Alto Networks (PANW), NXP Semiconductor (NXPI), and any cybersecurity company with a PQC product line.

🦈 The Industries That Get Disrupted First

Knowing the timeline of quantum disruption determines which stocks you own and when. Here's the realistic sequence:

Timeline	Industry	Application	Who Benefits
Now (2025–2027)	Defense / Navigation	GPS-denied quantum inertial navigation (50–100× classical); Q-CTRL demonstrated this on World Quantum Day 2025	IONQ (govt contracts), BWXT (if quantum sensors adopted in defense)
Now (2025–2027)	Cybersecurity	Post-quantum cryptography migration; encryption audit and replacement cycle underway	ARQQ, Palo Alto, Thales, NXP
Near-term (2026–2029)	Drug Discovery / Pharma	Molecular simulation; IonQ + AstraZeneca claimed quantum advantage in June 2025	IONQ, QNT (Quantinuum), IBM
Near-term (2026–2029)	Materials Science	Battery chemistry, catalyst design, superconductor discovery; D-Wave's March 2025 supremacy claim	QBTS, IBM, GOOGL
Medium-term (2028–2032)	Finance	Portfolio optimization, Monte Carlo simulation, real-time risk; JPMorgan already running quantum streaming algorithms	IONQ, QNT, IBM
Medium-term (2028–2032)	Logistics / Supply Chain	Combinatorial optimization; D-Wave's commercial sweet spot today	QBTS
Long-term (2033+)	Energy	Fusion plasma simulation, battery chemistry, carbon capture catalyst design	All quantum hardware companies
Long-term (2033+)	Cryptography (offense)	Breaking RSA/ECC encryption at scale requires ~4,000 logical qubits — IBM's Blue Jay (2033+) territory	Whoever builds fault-tolerant systems first

🦈 Full Scorecard: Every Name, Every Tier, Ranked

Tier	Ticker	Company	Price	Mkt Cap	Revenue Status	Risk	Conviction
Pure-Play Leader	IONQ	IonQ	~$49.65	$20.8B	$260–270M guided 2026; 755% YoY growth	Medium	⭐⭐⭐⭐⭐
Pure-Play	QBTS	D-Wave Quantum	~$21.80	$8.1B	$24.6M FY2025; 100+ customers; growing	Medium-High	⭐⭐⭐⭐☆
Pure-Play (IPO)	QNT	Quantinuum	~$75.57	$15.7B	Lumpy; best qubit quality; full-stack	Medium-High	⭐⭐⭐⭐☆
Large Cap / Best Quantum Div.	IBM	IBM	~$253	~$230B	$60B+ total; quantum div. ~$150M+ est.	Low	⭐⭐⭐⭐☆
Pure-Play	RGTI	Rigetti Computing	~$18.46	$6.1–7.1B	$7.1M TTM; 199% YoY growth	High	⭐⭐⭐☆☆
Post-Quantum Crypto	ARQQ	Arqit Quantum	~$27.11	$477M	Small; encryption-as-a-service; PQC play	High	⭐⭐⭐☆☆
Large Cap Quantum Research	GOOGL	Alphabet / Google	N/A	~$2T+	Quantum not material; Willow is the science leader	Low (as stock)	⭐⭐⭐☆☆ (as quantum play)
Large Cap Quantum Bet	MSFT	Microsoft	N/A	~$3T+	Azure Quantum platform real; Majorana hardware unverified	Low (as stock)	⭐⭐☆☆☆ (as quantum play)
Quantum Enabler	NVDA	NVIDIA	N/A	~$3T+	GPU substrate for quantum simulation; AI primary thesis	Low (as stock)	⭐⭐⭐☆☆ (as quantum play)
Photonic Speculative	QUBT	Quantum Computing Inc.	~$10–$12	$2.05B	Pre-revenue; photonic pivot	Very High	⭐⭐☆☆☆

🦈 How to Build the Quantum Portfolio: The Sharkwater Framework

The quantum trade spans at least a decade. That changes how you build the portfolio — you're not trying to time a single catalyst, you're positioning for a multi-act story where different chapters reward different stocks. Here's how we think about it:

Conservative Sharks — Quantum Exposure Without Pure-Play Risk: Own IBM as your primary quantum position. The $10 billion investment commitment, $1 billion federal endorsement, and 210-company installed quantum network give you the most credible large-cap quantum exposure in the market. Add NVDA for the AI + quantum enabler thesis and MSFT for Azure Quantum platform revenue (whether or not topological qubits pan out). This portfolio wins if quantum matures over 10+ years and doesn't require any pure-play to survive.

Balanced Sharks — Core Pure-Play Plus Large-Cap Ballast: Lead with IONQ as your pure-play anchor — it's the only quantum company with real revenue, a growing backlog, and $3.3 billion in cash. Add QBTS for the most commercially diversified customer base and the Quantum Circuits strategic optionality. Layer in IBM as the large-cap foundation. This portfolio wins if quantum commercializes on the 2027–2030 timeline and the revenue leaders take disproportionate market share.

Aggressive Sharks — Full Food Chain with High-Beta Exposure: IONQ as the anchor, QBTS for commercial breadth, QNT for technical qubit quality, RGTI for the Quanta Computer manufacturing wildcard, and ARQQ for the post-quantum cryptography angle. This portfolio has maximum leverage to the quantum upside but requires position discipline — don't let the speculative names exceed 15–20% of total portfolio weighting in aggregate.

Apex Sharks Only — Maximum Torque: Add QUBT for the photonic room-temperature bet. Size it at 1–2% maximum. This is a venture bet in public market clothing — the technology is legitimate, the timeline is long, and the downside is near-total loss if the pivot doesn't execute. Know what you're doing before you enter.

🦈 Risks That Can Pull This Trade Underwater

Any Sharkwater analysis worth reading calls the risks clearly. Here they are:

The timeline slippage problem: Quantum computing has been "ten years away" for forty years. Every milestone above could slip. IBM's Starling (fault-tolerant, 2029) has never been built before. Microsoft's topological qubits have faced prior retraction embarrassments. Build your position sizes with the assumption that timelines are optimistic.
Valuation risk on pure-plays: IONQ at $20.8 billion market cap against $270 million in guided 2026 revenue is trading at roughly 77× revenue. RGTI at $7 billion with $7 million in TTM revenue is 1,000×. These are not value stocks. Any broader risk-off rotation out of speculative growth names will hurt the pure-plays severely, regardless of technical progress.
The Microsoft physics problem: If topological qubits face another major scientific retraction — given the prior 2018 Nature retraction — it would likely crater the entire quantum sector for a period. Microsoft's public credibility in this space is already on thin ice with the physics community.
Competition from non-public companies: Some of the most advanced quantum work is happening inside companies that are not publicly traded — Quantinuum only recently IPO'd, Kairos Power (nuclear) and PsiQuantum (photonic, backed by SoftBank) remain private. The competitive landscape is not fully observable from public markets.
Export controls and geopolitical risk: The U.S. government considers quantum computing a national security technology. Export controls could limit market access for U.S. companies outside allied nations, and Chinese quantum progress (Jiuzhang 4.0, etc.) represents an ongoing competitive and geopolitical risk.
Dilution risk: All pre-revenue or early-revenue pure-plays will need to raise additional capital as they spend on R&D and hardware manufacturing. Expect dilutive equity offerings. The $3.3 billion in IONQ's cash position provides the most protection; RGTI and QUBT are most exposed.

🦈 Final Word: The Compute Revolution That Makes AI Look Like a Warm-Up

Sharks, we've been tracking technological revolutions long enough to recognize the pattern. The internet looked like a toy in 1993. Mobile computing looked like a niche in 2005. AI looked like an academic curiosity in 2020. Every one of those moments, in hindsight, was the time to build the position.

We are not saying quantum computing is at the same moment of certainty that AI was in 2022. It isn't. The technology is harder, the timelines are longer, and the failures along the way will be spectacular and public. But the inflection points are stacking up at a pace we haven't seen before: Google's Willow chip, Microsoft's Majorana 2, IBM's $1 billion federal endorsement, IonQ's 755% revenue growth, Quantinuum's $1.68 billion IPO, D-Wave's quantum supremacy claim, and $7+ billion in federal investment in a single budget cycle.

The institutional money has started moving. The government is now a co-investor. The hyperscalers are watching — and some, like Microsoft and Google, are already building. The question every Shark in our tank needs to answer is not if this trade is real. It's whether you want to be positioned before the next wave of institutional allocation — or explaining to yourself in 2031 why you missed it.

Position like a predator. Think in years, not quarters. Size for survival, not maximum exposure. And always — always — know your exit before you enter.

Good hunting, Sharks.

— The Sharkwater Trading Analysis Team

Disclaimer: This blog post is for informational and educational purposes only and should not be considered financial advice. The information presented reflects our research and analysis as of June 27, 2026, and may not remain accurate as market conditions, technology developments, and company circumstances change rapidly in the quantum computing sector. Pure-play quantum computing stocks are speculative in nature and carry substantial risk of loss, including total loss of invested capital. Past performance of any stock or sector discussed is not indicative of future results. Revenue figures, analyst price targets, market capitalizations, and technical claims cited are based on publicly available information and are subject to change. Quantum computing timelines cited are estimates from various sources and should not be treated as predictions. Please consult with a qualified financial professional before making any investment decisions. Sharkwater Trading does not hold positions in any securities mentioned at the time of this writing, and this post does not constitute a solicitation to buy or sell any security.

🦈 Why Nuclear? Why Now? The AI Energy Math

noreply@blogger.com (Unknown) — Sat, 27 Jun 2026 17:03:04 +0000

By Sharkwater Trading Analysis Team | June 27, 2026

Welcome to the shark tank, energy bulls. The feeding frenzy is on — and this time, the current is nuclear.

For decades, nuclear power sat in the penalty box. Aging plants. Regulatory nightmares. Three Mile Island. Chernobyl. Fukushima. Wall Street wanted nothing to do with it. But in 2024, something changed. Then in 2025 it changed more. And right now in 2026, we are living through what may be the most significant energy investment supercycle of the next twenty years — and the trigger is artificial intelligence.

AI data centers are voracious. The International Energy Agency now projects that global data center electricity consumption will triple by 2030. Goldman Sachs puts the number at a 165% surge in power demand from AI alone. The U.S. alone will need an estimated 50 gigawatts of new capacity by 2028 just to keep pace. Wind and solar can't deliver always-on baseload power. Natural gas is politically complicated. But nuclear? Nuclear runs 24 hours a day, 365 days a year, regardless of cloud cover or wind speed — and it produces zero carbon emissions.

Microsoft, Amazon, Google, and Meta didn't miss this memo. They've been quietly signing some of the most consequential energy deals in corporate history — and nearly all of them point to one source: nuclear power.

Today, Sharkwater is mapping every corner of this trade for you. Pure-play SMR developers. Uranium suppliers. Nuclear fleet operators. Grid infrastructure. The whole food chain. Let's hunt.

🦈 Why Nuclear? Why Now? The AI Energy Math

Let's get the macro straight before we start picking stocks, because the macro is what makes this trade work at every level of the food chain.

U.S. data center electricity demand is expected to explode from 176 TWh in 2023 to as much as 580 TWh by 2028 — that's according to Lawrence Berkeley National Lab. To put that in perspective, 580 TWh is roughly what the entire country of France consumes in a year. We need to build that much new power generation capacity in under five years.

The hyperscalers figured this out before almost anyone else. Look at what they've committed to since 2024:

Company	Nuclear Deal	Capacity	Details
Microsoft	Three Mile Island restart (Crane Clean Energy Center)	835 MW	20-year PPA with Constellation; entire plant output; targeting 2027 restart
Amazon	X-energy Xe-100 SMR fleet	320–960 MW	$700M investment; 4 units (Phase 1), scalable to 12
Google	Kairos Power SMR fleet	500 MW	First-ever U.S. corporate SMR fleet deal; delivery 2030+
Google	NextEra Energy (Iowa)	600 MW	Reactivating Iowa's nuclear plant from 2029
Meta	Vistra Corp — 3 nuclear PPAs	2,609 MW	Largest nuclear uprates ever by a corporate customer; starts late 2026
Meta	Oklo — Aurora reactors	~1,000 MW	Long-term deal; part of Meta's 6.6 GW total nuclear commitment by 2035
Walmart	Constellation (Dresden plant)	176 MW	Dual 15-year contracts beginning 2029–2030

Over 13 nuclear deals totaling more than 9.7 gigawatts of committed capacity — and that number is still growing. This isn't a trend. This is a structural shift. And the Trump administration is pouring rocket fuel on it.

The Policy Tailwind: On May 23, 2025, President Trump signed four executive orders aimed directly at nuclear energy — reforming the NRC to mandate 18-month decision timelines on new reactor licenses, directing the DOE to rebuild the domestic nuclear supply chain, and setting a national goal of 400 gigawatts of nuclear capacity by 2050. That's four times what the U.S. operates today. The DOE has already awarded up to $800 million in federal cost-share to early SMR deployment projects. The wind is at nuclear's back like never before in a generation.

Now let's talk about who gets paid.

🦈 TIER 1: THE NUCLEAR FLEET OPERATORS — Current Power, Current Cash Flow

These are the sharks already in the water — companies operating real, producing nuclear plants today and signing billion-dollar PPAs with the biggest corporations in the world.

CEG — Constellation Energy | ~$263–$277 | Analyst Target: $360

If you want to own the nuclear renaissance without the pre-revenue risk of pure-play SMR developers, Constellation Energy is the anchor position. It operates the largest nuclear fleet in America — approximately 22 gigawatts across 21 reactors — and it's the company that is literally restarting Three Mile Island for Microsoft.

The Crane Clean Energy Center (the rebranded TMI Unit 1) is on track for a second-half 2027 restart, running ahead of schedule. The NRC cleared a major environmental hurdle in June 2026, and FERC approved the transfer of 760 MW of capacity interconnection rights just weeks ago. The entire 835 MW output is sold to Microsoft under a 20-year power purchase agreement. Walmart signed dual 15-year contracts for 176 MW at its Dresden plant beginning 2029. This company is not hunting for customers — the customers are hunting for it.

Analyst consensus sits at $360 average price target (range: $296–$441) against a current price of ~$265. That's 35%+ implied upside from a company with the most enviable nuclear asset base in the country and locked-in long-term cash flows from investment-grade counterparties like Microsoft and Walmart. CEG is the blue-chip entry point into this theme.

The Trade: Core long position. Buy on any sector-wide pullbacks. The 20-year PPA structure means near-guaranteed revenue regardless of spot electricity price volatility. This is the kind of stock you build around.

VST — Vistra Corp | ~$165 | Analyst Target: $225 (Strong Buy)

Vistra doesn't get enough credit. It's often lumped in with traditional utilities — but after its acquisition of Energy Harbor, Vistra now operates one of the largest competitive nuclear fleets in the U.S., including Comanche Peak (TX), Beaver Valley (PA), Perry (OH), and the Illinois plants at Braidwood, Byron, and Dresden.

On January 9, 2026, Vistra dropped a bombshell announcement: three 20-year PPAs with Meta covering 2,609 megawatts of nuclear power — the single largest nuclear uprate deal ever supported by a corporate buyer in American history. Deliveries begin in late 2026 with the full contract ramping to 2,609 MW by 2034. Goldman Sachs and Jefferies upgraded the stock immediately after the announcement.

19 analysts cover VST. The consensus is Strong Buy with an average target of $225. The stock is currently at $165 — a 36% discount to that average. With Meta locking in two-decades of cash flows and the broader nuclear renaissance lifting all boats, Vistra looks like a coiled spring.

The Trade: Strong Buy for total return. The Meta deal de-risks a massive chunk of Vistra's nuclear output for 20 years. Watch for additional corporate PPA announcements — each one is a potential catalyst. Position sizing note: Vistra carries meaningful debt from the Energy Harbor acquisition, so size accordingly.

🦈 TIER 2: THE SMR PURE-PLAYS — Tomorrow's Power, Today's Opportunity

This is where it gets exciting — and where the risk profile changes significantly. Small Modular Reactors are the future of nuclear. Smaller footprint, faster to build, factory-manufactured, and designed specifically for the kind of modular, on-site power that data centers need. None of these companies have commercial revenue yet at scale. But the pipelines, partnerships, and regulatory milestones are starting to stack up fast.

XE — X-energy | ~$28.67 | Analyst Target: $39.86 | Amazon-Backed

Let's clear something up first: when you see "XE" in nuclear discussions, this is X-energy, Inc. — not Constellation Energy (that's CEG). X-energy completed its IPO on April 24, 2026, raising approximately $1.1 billion on the Nasdaq. Fresh money, fresh ticker, and one of the most credible backers in the business: Amazon invested $700 million into X-energy and is a committed customer for up to 12 of its Xe-100 reactor units.

The Xe-100 is a high-temperature gas-cooled reactor (HTGR) producing 80 megawatts of electricity per unit. Stack four of them together and you have a 320 MW power plant that can power roughly 240,000 homes — or a very large data center campus. X-energy is also part of the DOE's Reactor Pilot Program, giving it federal support alongside commercial backing.

Eight analysts cover XE with an average 12-month price target of $39.86 against a current price near $28.67 — roughly 39% implied upside. As a recent IPO, price discovery is still happening, and early-stage volatility should be expected. But the Amazon anchor and the $1.1B in fresh capital give X-energy a serious runway to reach first commercial deployment.

The Trade: Speculative long — best for traders comfortable with pre-revenue, pre-deployment risk. The Amazon relationship is the moat. Watch for NRC pre-application activities and DOE Pilot Program milestones as near-term catalysts. Consider scaling in rather than a single entry given IPO volatility.

OKLO — Oklo Inc. | ~$61 | Analyst Target: $90.41 | Sam Altman's Nuclear Bet

If OKLO had a mascot it would be a Great White in a three-piece suit. Backed by OpenAI's Sam Altman (who serves as Chairman), Oklo is developing the Aurora fast fission reactor — starting at 1.5 MWe and scaling toward 50 MWe per unit. It currently boasts a staggering 14 gigawatt customer pipeline, anchored by Switch's 12 GW data center power agreement.

June 2026 was a landmark month for Oklo. The Department of Energy issued preliminary safety approval for Oklo's first Aurora Powerhouse at Idaho National Laboratory — the first time the DOE has granted this level of regulatory clearance to an advanced fission company. That same week, Oklo signed a Letter of Intent with Centrus Energy for HALEU fuel supply — enough enriched uranium for up to five Aurora reactors, with delivery beginning 2029. Meta's nuclear commitment also includes an Oklo component as part of its 6.6 GW total pledge.

Oklo sits on $2.5 billion in cash and marketable securities — an enviable war chest for a pre-revenue company. First Aurora deployment is targeted for late 2027. The stock is down 21% YTD from its highs but still carries a market cap of $9.4 billion, reflecting the market's confidence in the pipeline and the Altman halo.

The Trade: High-conviction speculative long. The DOE safety approval in June 2026 is a genuine de-risking event — not just an MOU or a handshake. The Centrus fuel deal anchors the supply chain. Watch the INL deployment timeline closely; first criticality at Idaho National Lab is the next major catalyst. The 21% YTD pullback may offer a reasonable entry versus the $90 analyst target.

SMR — NuScale Power | ~$12–$13 | Analyst Target: $15.36

NuScale holds a unique position in the SMR landscape: it's the only company with an NRC-certified SMR design. The NuScale Power Module (77 MWe) received NRC design certification in 2022 — a regulatory milestone no other advanced reactor developer has achieved. In a world where NRC approval timelines have historically stretched for years, NuScale's certified design is a genuine competitive moat.

That said, Sharks need to know the full story. NuScale's cancellation of its UAMPS Carbon Free Power Project in 2023 — a high-profile first commercial deployment — shook investor confidence and the stock has never fully recovered. Revenue remains primarily development-stage and government-contract based. The path from "NRC-certified design" to "operating plant" still requires a customer willing to commit to a first-of-a-kind deployment.

Recent positive signals: NuScale opened a new Houston Operations Center (April 2026) to be closer to petrochemical and data center customers in Texas, secured a safety milestone on its Highly Integrated Protection System, and formed a Framatome partnership for European fuel fabrication. The company holds approximately $1 billion in liquidity, providing runway.

17 analysts cover NuScale with an average target of $15.36 and a Hold consensus — more cautious than the other SMR names. The upside from $12–$13 to $15 is real but modest. NuScale is a "show me" story: the catalyst you need is a definitive, signed commercial customer contract for a U.S. deployment.

The Trade: Speculative — lower conviction than OKLO or XE. Hold the NRC-certified design as a trump card. Consider a smaller position and watch for a commercial contract announcement as the trigger to add size. This one needs patience.

NNE — Nano Nuclear Energy | ~$21.33 | Analyst Target: $45 | Roth Capital Buy

Nano Nuclear is the most speculative name in this group — and also potentially the most interesting for traders who like to get in early on emerging themes. NNE is developing microreactors — the "ZEUS" and "ODIN" designs that are portable, deployable units aimed at remote sites, military applications, and eventually AI data centers.

The company has been making real moves behind the speculative buzz. It filed a Construction Permit Application with the NRC for its Kronos Microreactor Manufacturing and Research Reactor (MMR). It acquired Specialized Transportation Services — a nuclear logistics and transport company — giving it a full-stack capability from manufacture to fuel delivery to deployment. And it signed a significant MOU with Supermicro (SMCI) to explore powering AI data centers directly with microreactor technology.

NNE sits on $569 million in cash with a $400 million ATM facility untapped — plenty of fuel in the tank. Roth Capital is the most vocal institutional voice, initiating with a Buy and a $45 target against the current $21 price — more than 100% implied upside. The 52-week range of $18.93 to $60.87 tells you exactly what kind of volatility ride this is.

The Trade: Small, speculative position for aggressive traders. The microreactor thesis is real — military and remote site applications are genuine near-term markets. The Supermicro MOU plants a flag for the data center use case. But this is the furthest from revenue of any name on this list. Treat it like a venture bet, not a value play. Size accordingly.

🦈 TIER 3: THE NUCLEAR PICKS AND SHOVELS — Less Glamour, More Certainty

Every gold rush makes millionaires out of the people selling the picks and shovels. The nuclear renaissance is no different. These companies don't need to build a single new reactor to win — they supply the fuel, the components, and the grid infrastructure that make all of this work.

BWXT — BWX Technologies | ~$198 | Analyst Target: $238 | Buy

BWX Technologies is the nuclear supply chain in a single stock. BWXT manufactures fuel and reactor components for the entire U.S. Naval Nuclear Propulsion Program — every nuclear-powered submarine and aircraft carrier in the U.S. Navy runs on BWXT fuel and components. That alone gives it a government-backed revenue base that will grow as the Navy expands its fleet.

But BWXT is also positioned for the commercial nuclear renaissance. It manufactures reactor components for existing commercial plants, produces medical radioisotopes (a fast-growing business independent of power markets), and licensed its mPower SMR technology to Applied Atomics for next-generation deployment.

The Q1 2026 numbers were exceptional: 26% revenue growth, 22% EPS growth, and order backlog up 77% year-over-year. The $200M PCG acquisition expanded its manufacturing capability, and a new U.S. facility is in planning. 15 analysts cover BWXT with 8 Buy ratings and an average target of $238 — about 20% above the current price of $198.

The Trade: Core long position. BWXT is the lowest-risk way to play the nuclear buildout — government contracts provide floor, commercial upside provides ceiling. The 77% backlog growth in one quarter tells you everything about where orders are headed. Sleep well at night holding this one.

LEU — Centrus Energy | ~$166–$172 | Analyst Target: $274 | Buy

Centrus Energy is the only U.S. company authorized by the NRC to produce HALEU — High-Assay Low-Enriched Uranium, the fuel that most advanced SMRs require. You can build the most sophisticated reactor in the world, but without HALEU, it's a very expensive paperweight. Centrus is the chokepoint in the entire SMR supply chain.

The business has been firing on all cylinders in 2026. The DOE awarded Centrus a $900 million HALEU production contract in Q1 2026, and the company raised its full-year 2026 revenue guidance to $450–500 million as a result. Its order backlog now stretches to $3.9 billion through 2040 — extraordinary long-term visibility for a company with a market cap in the $2–3 billion range.

The June 18, 2026 announcement that Centrus signed an LOI with Oklo to supply HALEU for up to five Aurora reactors beginning in 2029 is a perfect encapsulation of the leverage here: as each SMR developer reaches deployment, they all have to come to Centrus. There is no domestic alternative for HALEU at commercial scale.

One caveat Sharks need to respect: the 52-week range of $144.65 to $464.25 is not a typo. Centrus has been brutally volatile — trading near $464 at its highs and now sitting around $170. The 11-analyst average price target of $274 represents 60%+ upside from current levels, but you need to be mentally prepared for significant price swings.

The Trade: High-conviction long for patient traders. The fundamental moat (sole domestic HALEU supplier) gets more valuable as each SMR project matures. The $900M DOE contract and $3.9B backlog provide a floor. The volatility is real — consider a staged entry over several weeks rather than a single print.

GEV — GE Vernova | ~$1,057 | Analyst Target: $1,212 | Buy (30 analysts, 0 sells)

GE Vernova is the ultimate picks-and-shovels play for the entire energy transition — not just nuclear. Spun out of General Electric in April 2024, GEV manufactures the gas turbines, grid solutions, electrification equipment, and nuclear steam components that power both the existing grid and the nuclear buildout simultaneously.

The Q1 2026 results were staggering: orders up 71% year-over-year, revenue growing at a rapid clip, and total backlog expanded by $13 billion to reach $163 billion. The company raised its 2026 revenue guidance to $44.5–$45.5 billion. GEV has near-monopoly positioning on large gas turbines — the backup generation that data centers absolutely require — and it services nuclear plants globally, including new builds like Hinkley Point in the UK.

30 analysts cover GEV. Zero have sell ratings. The average price target is $1,212 against a current price of ~$1,057 — about 15% upside. It's not the highest-return opportunity on this list, but it might be the highest-quality one. This is a Berkshire-level business hidden inside an energy-transition story.

The Trade: Long-term core position. Own GEV for the multi-year energy infrastructure supercycle — data centers need more gas backup, the nuclear fleet needs servicing, and the grid needs upgrades. The 30-0 analyst consensus says it all. If you want one stock to own for the next decade of the energy transition, GEV is in the conversation.

🦈 TIER 4: THE URANIUM FOOD CHAIN — Fuel for the Renaissance

No uranium, no nuclear renaissance. As the world commits to building hundreds of new reactors over the next two decades, the demand for uranium — both conventional enriched uranium and advanced HALEU — is going to ratchet up dramatically. The spot price is cyclical, but the long-term contract market is what matters here, and utilities are locking in supply now at higher prices than they've agreed to in years.

CCJ — Cameco | ~$109 | Analyst Target: $140–$175 | Buy

Cameco is the world's largest publicly traded uranium company, operating the Cigar Lake and McArthur River mines in Saskatchewan — two of the highest-grade uranium deposits on the planet. If the nuclear renaissance is real, Cameco prints money. It's that simple.

What makes Cameco even more interesting is its 49% stake in Westinghouse Electric — the global leader in nuclear reactor design, engineering, and services, shared with Brookfield. Westinghouse has its fingers in virtually every new reactor build globally, from the AP1000 fleet in the U.S. to international projects across Europe and Asia. Owning Cameco is owning the uranium mine and a piece of the world's dominant nuclear services firm.

Scotiabank recently raised its price target on CCJ to $175 from $150 — a vote of confidence in the long-term uranium demand thesis. Current price near $109. Strong Buy consensus from the analyst community.

The Trade: Long-term core uranium position. Buy Cameco when uranium spot prices pull back — the long-term contract repricing cycle has years to run. The Westinghouse stake gives you leverage to the global reactor buildout that doesn't depend on uranium pricing at all.

UEC — Uranium Energy Corp | ~$10.66 | Analyst Target: $18 | Strong Buy

UEC is the scrappier, higher-beta uranium play for traders who want more torque. Uranium Energy focuses on in-situ recovery (ISR) uranium mining in Texas and Wyoming — a lower-cost, lower-environmental-impact extraction method that works well in the U.S. regulatory environment. ISR doesn't require open-pit mines or underground operations; uranium is dissolved from the ore in place and pumped to the surface.

The Trump administration's "energy dominance" push specifically favors domestic uranium sourcing, and UEC is one of the few pure-play domestic producers capable of scaling production quickly. The company also holds a physical uranium inventory that provides NAV support independent of production timing.

The numbers tell a compelling story: 9 analysts covering with a Strong Buy consensus, a median price target of $18 against a current price of $10.66 — nearly 70% implied upside. The 52-week range of $5.90 to $20.34 reflects the cyclical volatility of uranium stocks, but the direction of the long-term trend is clear.

The Trade: Speculative long with strong fundamental support. Size it for the volatility — this is not a $5.90 stock you buy all at once at $10. Accumulate on weakness and hold for the domestic uranium demand cycle. The 70% implied upside to analyst targets is hard to ignore at current levels.

🦈 The Full Scorecard: Every Name, Ranked by Conviction

Tier	Ticker	Company	Price	Analyst Target	Implied Upside	Risk Level	Sharkwater Conviction
Fleet Operator	CEG	Constellation Energy	~$265	$360	+36%	Low-Medium	⭐⭐⭐⭐⭐
Fleet Operator	VST	Vistra Corp	~$165	$225	+36%	Medium	⭐⭐⭐⭐⭐
Picks & Shovels	BWXT	BWX Technologies	~$198	$238	+20%	Low	⭐⭐⭐⭐⭐
Picks & Shovels	GEV	GE Vernova	~$1,057	$1,212	+15%	Low-Medium	⭐⭐⭐⭐⭐
Uranium	CCJ	Cameco	~$109	$140–$175	+28–60%	Medium	⭐⭐⭐⭐⭐
Fuel Supply	LEU	Centrus Energy	~$170	$274	+61%	Medium-High	⭐⭐⭐⭐☆
SMR Developer	OKLO	Oklo Inc.	~$61	$90	+48%	High	⭐⭐⭐⭐☆
SMR Developer	XE	X-energy	~$29	$40	+39%	High	⭐⭐⭐⭐☆
Uranium	UEC	Uranium Energy Corp	~$10.66	$18	+69%	High	⭐⭐⭐☆☆
SMR Developer	SMR	NuScale Power	~$12–$13	$15.36	+20%	High	⭐⭐⭐☆☆
Microreactor	NNE	Nano Nuclear Energy	~$21	$45	+100%+	Very High	⭐⭐☆☆☆

🦈 The Key Milestones to Watch — Your Trading Calendar

In a theme this multi-year, milestones are your catalysts. Every NRC approval, every signed PPA, every DOE award is a potential price mover. Here's the calendar that matters:

July 8, 2026: NRC public comment deadline for Crane Clean Energy Center (TMI) Environmental Assessment — clearance here keeps the 2027 restart on track for CEG
Late 2026: Vistra begins delivering first nuclear power to Meta under its 2,609 MW agreement — first real cash flow from the landmark deal; VST catalyst
Late 2027: Crane Clean Energy Center (TMI) targeted restart — biggest single nuclear power event in the U.S. in decades; CEG and the entire sector likely re-rates
Late 2027: Oklo's first Aurora reactor at Idaho National Laboratory — if achieved, transforms Oklo from pre-revenue story to operational company; massive OKLO catalyst
2029: Centrus begins HALEU deliveries to Oklo; Google/NextEra Iowa nuclear plant reactivation; Walmart/CEG Dresden contracts begin — multiple LEU and CEG catalysts
2030+: Google/Kairos Power SMR fleet first power; NuScale first U.S. commercial modules — sector validation events that lift all SMR names
2035: Meta's total 6.6 GW nuclear commitment fully online — the largest single corporate nuclear portfolio in history
2050: U.S. target of 400 GW nuclear (vs. ~100 GW today) — the generational backdrop against which every trade on this list takes place

🦈 How to Build the Nuclear Portfolio: The Sharkwater Framework

Not every investor has the same risk appetite, and the nuclear trade is not one-size-fits-all. Here's how we think about constructing exposure across the food chain:

Conservative Sharks — You want the nuclear theme with minimal binary risk. Focus on CEG, VST, BWXT, and GEV. These companies have real revenue, real cash flows, and real assets. The nuclear renaissance makes them grow faster, but the floor doesn't disappear if one SMR project slips a year.

Balanced Sharks — Add CCJ and LEU to the core positions above. Cameco gives you the uranium commodity play with Westinghouse optionality. Centrus gives you the HALEU chokepoint — the one supply that every advanced SMR must eventually buy. Combined with the operators, this builds a full food-chain position.

Aggressive Sharks — Layer in OKLO and XE as your high-beta, pre-revenue exposure. These are the names that double or triple if the deployment milestones hit — but they're also the ones that get cut in half on a regulatory delay or a broader risk-off tape. Keep position sizes disciplined; don't let speculation become your largest holding.

Apex Sharks Only — NNE and UEC are for traders who understand they're making venture-style bets in public markets. The upside is real. So is the volatility. Size these at 1–3% of portfolio maximum and let the thesis develop over 18–24 months.

🦈 Risks Every Nuclear Shark Must Respect

We wouldn't be doing our job if we didn't call out the currents that could pull this trade underwater.

Regulatory timeline slippage: The Trump executive orders are meant to speed NRC approvals to 18 months. The NRC has a long history of exceeding timelines. Any slippage pushes deployment dates right and defers revenue for the pre-revenue names.
Construction cost overruns: Nuclear has a storied history of going massively over budget. First-of-a-kind SMR deployments carry higher construction risk than nth-of-a-kind plants. Watch for cost disclosures carefully.
Technology risk in advanced designs: Fast fission (Oklo), high-temperature gas-cooled (X-energy), and microreactor designs have never operated at commercial scale. Technical hurdles could delay deployment.
Uranium price volatility: CCJ and UEC are commodity businesses. Uranium spot prices can drop sharply on market dislocations, oversupply rumors, or reduced reactor commitments globally.
Policy reversal: This administration is strongly pro-nuclear. A future administration could change priorities, slow federal support, or delay DOE cost-share programs.
Big Tech capex pullback: If AI spending growth slows materially, hyperscaler demand for new power capacity could ease, reducing the urgency behind nuclear PPA signing.

🦈 Final Word: The Biggest Energy Trade of Our Generation

Sharks, we've been around long enough to recognize when a structural shift is happening in real time — not in hindsight. The convergence of AI electricity demand, government nuclear policy, and Big Tech balance sheet spending on 20-year power agreements is not a cyclical trade. This is a generational repositioning of the U.S. energy grid.

The U.S. generated roughly 100 gigawatts of nuclear power in 2024. The national goal is 400 gigawatts by 2050. Building 300 new gigawatts of nuclear capacity over the next 24 years means this is a multi-decade construction and fuel cycle — one that touches fleet operators, SMR developers, fuel producers, and grid infrastructure builders simultaneously.

Microsoft is restarting Three Mile Island. Meta is locking in 6.6 gigawatts of nuclear. Amazon is backing X-energy with $700 million. Google signed the first-ever corporate SMR fleet deal. These are not press release moves — these are 20-year balance sheet commitments from some of the most analytically rigorous capital allocators in the world. When Amazon, Microsoft, Google, and Meta all agree on the same energy strategy, it's worth paying attention.

The current may look calm on the surface. But underneath, there is a very large, very fast-moving nuclear trade forming. We'd rather be in the water early than watching from the shore.

Stay sharp. Stay liquid. Know your exit. And as always — happy hunting.

— The Sharkwater Trading Analysis Team

Disclaimer: This blog post is for informational and educational purposes only and should not be considered financial advice. The information presented reflects our research and analysis as of June 27, 2026, and may not remain accurate as market conditions, regulatory developments, and company circumstances change. Past performance of any stock or sector discussed is not indicative of future results. All investing involves risk, including the possible loss of principal. Nuclear energy stocks — particularly pre-revenue SMR developers — carry substantial speculative risk. Analyst price targets cited are third-party estimates and are not guarantees of future performance. Please consult with a qualified financial professional before making any investment decisions. Sharkwater Trading does not hold positions in any securities mentioned at the time of this writing, and this post does not constitute a solicitation to buy or sell any security.

🦈 What Makes mREITs a Unique Hunting Ground (ORC, MFA, AGNC, MFA)

noreply@blogger.com (Unknown) — Sat, 27 Jun 2026 16:50:44 +0000

By Sharkwater Trading Analysis Team | June 27, 2026

Calling all income-hunting Sharks! You've seen the headlines — yields of 13%, 15%, even 20% from mortgage REITs. Numbers like that make the average investor's jaw drop. But here at Sharkwater, we don't just chase the yield. We hunt the inefficiency hidden inside the yield.

Today we're diving deep on four of the most actively traded mREITs in the market: ORC (Orchid Island Capital), AGNC (AGNC Investment Corp), RITM (Rithm Capital), and MFA (MFA Financial). We're going to answer a question that most retail investors never even think to ask:

Is it more profitable to buy in before the ex-dividend date and ride the run-up — or to hold through and collect the payout?

Spoiler: the answer is different for every one of these four, and the reasons why will change the way you think about high-yield income investing forever. Let's get in the water.

🦈 What Makes mREITs a Unique Hunting Ground

Mortgage REITs are not your typical dividend stocks. They borrow money at short-term rates, invest it in mortgage-backed securities, and pay out the spread as dividends. When rates behave, the dividends are fat. When rates spike, book values erode and dividend cuts follow.

What makes them particularly interesting for traders is a structural quirk: every ex-dividend date is a mini-event. Short sellers — who are often heavily positioned in mREITs — must pay the dividend to their stock lenders every cycle. For monthly payers like ORC and AGNC, that's 12 times per year. That creates a rhythm of short-covering pressure in the days before each ex-date that savvy traders can exploit.

Add in the dividend capture community — buyers who scoop shares specifically to collect the dividend before selling — and you have a recurring, structural bid under these stocks in the 3–10 days before every ex-dividend date. Academic research (Lund University, ScienceDirect) confirms statistically significant pre-ex-date buying pressure (p = 0.008) across high-yield dividend stocks. These aren't random ripples. They're predictable tides.

Here's the snapshot on all four before we go deeper:

Ticker	Price	Annual Yield	Div / Event	Frequency	Short % Float	Div Trend
ORC	~$6.95	~17–20%	$0.10/mo	Monthly	5.82%	❌ Serial cuts
AGNC	~$10.91	~13–14%	$0.12/mo	Monthly	~8.0%	✅ Stable since 2020
RITM	~$9.28	~10–11%	$0.25/qtr	Quarterly	1.13%	✅ Stable since 2021
MFA	~$9.50	~14–15%	$0.36/qtr	Quarterly	~2–3%	📈 Growing

🦈 ORC — Orchid Island Capital: The High-Yield Yield Trap

Let's start with the flashiest number in the group. ORC's 17–20% yield has been luring retail investors for years. And every year, a fresh batch of buyers learns the hard way that headline yield is not the same as total return.

ORC is an externally managed, pure-play agency mREIT — it buys nothing but agency residential mortgage-backed securities. That narrow mandate means it has almost no defense when the rate environment turns hostile. The proof is in the dividend history:

2021: $0.065/month — stable, respectable
January 2022: Cut to $0.055 — Fed rate hike fears begin
March 2022: Cut again to $0.045 — rates keep climbing
Mid-2023: Brief spike to $0.16/month — elevated MBS spreads provided temporary relief
Early 2024: Cut back to $0.12
Late 2025/2026: Cut again to $0.10 — accompanied by a 7.8% same-day stock drop

That's at least four dividend cuts in five years, Sharks. The 20% yield advertised today was 13% six months ago. And it might be 10% by the time you read this. When you account for the consistent book value erosion and share price decay, the net total return for ORC holders over any meaningful multi-year period has been mediocre at best.

Short interest: ORC carries about 5.82% of float short (~10.66 million shares). Shorts pay $0.10/share to their lenders every month — roughly 17% of the stock's price per year in carry cost alone. That is an eye-watering cost to maintain a short position, which creates modest but recurring short-covering pressure before each monthly ex-date.

The pre-ex trade opportunity: The covering window is real but small. On a $6.95 stock, the $0.10 monthly dividend represents just 1.44% of the share price. That's within normal daily noise. Transaction costs can eat the entire edge if you're not careful.

The Trade (ORC)

Entry: D-5 to D-3 before ex-date (last business day of the month)
Exit: Day before ex-date — do NOT hold through the drop
Target gain: 0.3–0.8% per cycle
Verdict: Weakest capture candidate. Small absolute dividend makes the math tight. ORC is a trading vehicle only — not a long-term hold.

🦈 AGNC — AGNC Investment Corp: The King of the Capture Trade

If ORC is the flashy bait, AGNC is the patient apex predator. It's the largest agency mREIT by market cap, internally managed (a meaningful advantage over externally managed peers like ORC), and has maintained an unchanged $0.12/month dividend since early 2020 — over five years of consistency in a sector famous for cuts. That's remarkable.

Here's what makes AGNC the most compelling dividend capture candidate of the four:

The short interest math is staggering. AGNC carries approximately 90.76 million shares short — roughly 8% of its float. With a $0.12/month dividend, short sellers are collectively paying approximately $10.9 million per month in dividend payments to their stock lenders. Every. Single. Month. That is a structural, institutional-scale pressure to cover short positions before the end-of-month ex-date.

The timing is also uniquely predictable. AGNC consistently sets its ex-dividend date on the last business day of every month — no guessing, no surprises. Traders who want to front-run the short covering know exactly when to position. And with average daily volume exceeding 13 million shares, the stock is liquid enough to execute without moving the market against you.

The one caveat to keep in mind: AGNC currently trades at approximately 1.32× book value (stock ~$10.91 vs. book ~$8.25/share). That premium to book is a meaningful risk if the rate environment deteriorates. This is not a stock you want to fall asleep holding. The capture trade suits it perfectly precisely because you're not overstaying your welcome.

The Trade (AGNC)

Entry: D-7 to D-5 before ex-date (institutional covering typically begins building here)
Exit: Day before ex-date — collect the run-up, skip the drop
Target gain: 0.5–1.2% per cycle × 12 months = 6–14% annualized
Verdict: Best capture candidate in the group. High liquidity, predictable schedule, massive short covering pressure, tight bid-ask spreads. This is the trade you build the playbook around.

🦈 RITM — Rithm Capital: Don't Trade It. Own It.

Rithm Capital is the black sheep of this group — in the best possible way. When New Residential Investment Corp. rebranded as Rithm Capital in August 2022, it wasn't just a name change. It was a signal that this company was evolving beyond the pure-play mREIT model that makes stocks like ORC so vulnerable to rate cycles.

RITM has built meaningful businesses in mortgage servicing rights (MSRs) — which naturally appreciate in value when interest rates rise, providing a hedge against the MBS book value losses that hammer pure-play agency mREITs. It also owns Newrez LLC, one of the largest mortgage origination and servicing platforms in the country. This diversification fundamentally changes the risk profile.

The numbers tell the story:

Stock price: ~$9.28
Book value per share: ~$12.51 (Q1 2026)
Price-to-book: ~0.73× — trading at a 27% discount to book value
Analyst consensus: Strong Buy (11 analysts)
12-month price target: $13.65 — implying nearly +49% upside from current levels
Quarterly dividend: $0.25/share — stable since 2021, $1.00 annualized
Short interest: A mere 1.13% of float

That last point matters for the capture strategy conversation. With barely any short sellers in the water, there's no significant short-covering tailwind before quarterly ex-dates. The pre-ex-date trade on RITM loses its most powerful engine.

But here's the thing, Sharks — when a stock trades at 73 cents on the dollar of book value, when 11 professional analysts say Strong Buy, when the 12-month target implies nearly 50% appreciation, you don't trade around the edges. You get a full position and let it work.

The Trade (RITM)

Strategy: Buy on weakness — particularly after any mREIT sector selloffs that drag all boats down regardless of fundamentals
Hold: Through multiple dividend cycles; this is a total-return play
Target: $13.65 analyst consensus (49% upside) + 10–11% yield while you wait
Verdict: The strongest risk-adjusted opportunity of the four. The capture trade is inferior here. Buy it, hold it, collect it.

🦈 MFA Financial: The Best Capture Math in the Pond

MFA Financial is the most interesting stock in this analysis for capture traders. Here's why: with a quarterly dividend of $0.36 per share on a ~$9.50 stock, every single ex-dividend date represents a 3.8% event. Compare that to AGNC's 1.1% or ORC's 1.44% — MFA's per-event dividend is more than double the monthly payers on a per-cycle basis.

A larger dividend means a larger gravitational pull of dividend capture buyers in the days before ex-date. It also means the dollar-magnitude run-up that pre-positions can exploit is proportionally larger. The math just works better.

MFA also stands out from a fundamental perspective. It's not a pure agency shop — MFA invests in non-QM loans, transitional loans, and residential whole loans, which gives it a different risk profile and better credit spread income. And uniquely among these four, MFA has been raising its dividend — from $0.35/quarter to $0.36/quarter most recently, signaling confidence in its earnings power.

One important housekeeping note: MFA executed a 1-for-4 reverse stock split in April 2022. Any pre-split dividend figures (which were around $0.10–$0.11/quarter) are not directly comparable to the current post-split $0.35–$0.36 range. Make sure you're looking at adjusted data if you're reviewing historical charts.

Short interest is moderate (~2–3% estimated), lower than ORC or AGNC, so the short-covering dynamic is present but not dominant. The primary driver of the pre-ex run-up here is pure dividend capture buyer demand attracted by the large per-event payout.

The Trade (MFA)

Entry: D-10 to D-7 before quarterly ex-date (end of March, June, September, December)
Exit: Day before ex-date — skip the opening drop
Target gain: 1.5–3.0% per cycle × 4 quarters = 6–12% annualized
Verdict: Best per-event capture math of the four. Larger dividend creates a more visible, more crowded run-up. Only 4 cycles per year keeps transaction costs manageable.

🦈 The Big Question Answered: Run-Up or Hold for the Dividend?

So what's the verdict? Here's the Sharkwater framework, broken down cleanly:

Ticker	Best Strategy	Key Reason	Annualized Target
AGNC	Capture Trade ⚡	$11M/month in short covering pressure; end-of-month timing is clockwork; best liquidity	6–14%
MFA	Capture Trade ⚡	Largest per-event dividend (3.8%); only 4 cycles/yr keeps costs low; growing dividend adds support	6–12%
RITM	Hold + Collect 💰	27% discount to book; 49% analyst upside; MSR hedge; Strong Buy consensus. Don't trade this one.	10% yield + 20–49% appreciation potential
ORC	Trade Only / Avoid Long ⚠️	Serial dividend cutter; capital erosion consumes the yield; capture window exists but margin is thin	3–6% (tight margin)

🦈 Short Interest: The Hidden Engine Behind the Run-Up

Let's spell out the mechanics so it's crystal clear. When you short a stock, you borrow shares from someone else's brokerage account. If that stock pays a dividend while you're short, you pay the dividend — not the lender. It comes out of your account and goes to the lender to compensate them for the income they missed.

For these four mREITs, that carry cost is brutal:

ORC: $1.20/share per year in dividend carry — approximately 17.3% of share price annually
AGNC: $1.44/share per year — approximately 13.2% of share price annually, paid to lenders by ~91 million short shares
MFA: $1.44/share per year — approximately 15.2% of share price annually
RITM: $1.00/share per year — approximately 10.8% of share price annually (but very few shorts to begin with)

No rational short seller carries this cost a single day longer than necessary. That's why you see a pattern of short covering building in the week before ex-date — particularly in AGNC and ORC where the monthly cadence makes this a recurring feature of the tape. It's not guaranteed to move the stock dramatically every single cycle, but it is a structural, repeating tailwind that adds to whatever organic buying demand is already in the market.

🦈 The Tax Angle You Can't Ignore

Here's the part most retail income investors skip entirely — and it changes the math significantly.

To qualify for the lower 15–20% long-term capital gains tax rate on dividends, you must hold the stock for at least 61 days around the ex-dividend date. If you're running a dividend capture strategy — buying 5–10 days before ex-date and selling the day before — your holding period is nowhere near 61 days.

That means dividends you collect during a capture strategy are taxed as ordinary income — potentially up to 37% depending on your bracket. Meanwhile, if you're trading the price run-up and selling before the ex-date, any gain is a short-term capital gain — also ordinary income rates, but you avoided the ex-date drop entirely and your gross return may be higher before tax.

The bottom line: for taxable accounts, capturing the price appreciation before ex-date is often more tax-efficient than holding through and collecting the dividend itself. Another point in favor of the capture trade over the hold strategy — especially for ORC and AGNC where no one should be holding long-term anyway.

🦈 Optimal Entry and Exit: Timing the Tide

Based on the structural dynamics above, here are the specific windows we watch for each ticker:

AGNC (Monthly — Last Business Day of Month)
Entry: D-7 to D-5 before ex-date | Exit: Day before ex-date
Why D-7? Institutional short-covering desks typically begin reducing exposure 5–7 business days before month-end to manage their carry cost exposure. Getting in before the bulk of that covering puts you on the right side of the flow.

MFA (Quarterly — End of March, June, September, December)
Entry: D-10 to D-7 before ex-date | Exit: Day before ex-date
Why earlier? The larger dividend ($0.36 = 3.8% of price) means more traders are trying to position in advance. The queue gets longer, so you want to be near the front. Enter early, let the crowd build behind you.

ORC (Monthly — Last Business Day of Month)
Entry: D-5 to D-3 | Exit: Day before ex-date
Why shorter window? The $0.10 dividend is small enough that early entry risks whipsaw from unrelated market noise. Keep the hold period tight to minimize exposure to ORC's serial dividend cut risk.

RITM (Quarterly)
Don't time the ex-date. Just buy on weakness — ideally when the broader mREIT sector sells off — and hold for the total return story. The 49% analyst upside makes timing around a $0.25 quarterly dividend feel like rearranging deck chairs on a yacht.

🦈 Risks Every Shark Must Respect

We'd be doing you a disservice if we didn't lay out the risks clearly. This is a feeding ground, but these waters have teeth.

The run-up is structural, not guaranteed. If a major macro event hits — a surprise Fed announcement, a credit market shock, an earnings miss — it can override the pre-ex buying pressure entirely. You can enter a capture trade and have the stock go down in the days before ex-date.
Capital erosion is real. ORC and AGNC have both lost significant book value over the past five years. A 17% yield means very little if the stock price drops 12% per year. Track total return, not just yield.
AGNC's book value premium is a risk. Paying 1.32× book for an agency mREIT leaves you exposed if rates spike again and spreads widen. The capture trade keeps your holding period short specifically to manage this risk.
Transaction costs matter at scale. Running 12 capture trades per year on AGNC or ORC means 24 commissions (buy and sell). With a $0.12 dividend as the target, even small costs erode the edge. Size positions appropriately and use zero-commission platforms.
Tax drag in taxable accounts. As outlined above — all short-term gains and collected dividends in capture strategies are ordinary income. Model your after-tax return before committing to the strategy.

🦈 Final Verdict: The Sharkwater Call

After five years of data, structural analysis, and putting these four tickers through the grinder, here's where we stand:

RITM is the standout long-term opportunity. Trading at a 27% discount to book value with a 49% analyst price target and a diversified business model that includes natural rate hedges, this is the one you own, not trade. If you're an income investor and you only buy one of these four, make it RITM.

AGNC is the best capture trade machine. The combination of $10.9 million per month in short covering pressure, end-of-month predictability, and deep liquidity makes AGNC the most reliable pre-ex-date run-up candidate. Set your calendar, set your alerts, and execute the same playbook every month.

MFA is the best per-trade capture opportunity. Fewer cycles per year, but the $0.36 quarterly dividend creates the largest absolute run-up target. A growing dividend adds fundamental support. Good for traders who want quality over quantity.

ORC is a trading vehicle only. The headline yield is seductive. The reality — serial dividend cuts, chronic book value erosion, thin capture margins — makes it a poor fit for anything other than short-term tactical trades. Respect the tide, don't swim against it.

The water is warm out there, Sharks. Know which current you're swimming with — the income hold or the capture trade — and you'll navigate these mREITs better than 90% of the yield-chasing crowd.

Good luck out there. Stay sharp, stay liquid, and always know your exit before you enter.

— The Sharkwater Trading Analysis Team

Disclaimer: This blog post is for informational and educational purposes only and should not be considered financial advice. The information presented reflects our analysis as of the publication date and may not remain accurate as market conditions change. Past performance of any stock or strategy discussed is not indicative of future results. All investing involves risk, including the possible loss of principal. Dividend rates, book values, short interest data, and analyst targets cited are based on publicly available information and are subject to change. Please consult with a qualified financial professional before making any investment decisions. Sharkwater Trading does not guarantee the accuracy or completeness of any information contained in this post.

War, Nukes, Rockets, REITS and Rates.

noreply@blogger.com (Unknown) — Fri, 29 May 2026 15:35:13 +0000

SHARKWATERTRADING.COM

Macro Deep Dive • May 2026

WAR, NUKES,
ROCKETS & RATES

The full macro picture — Iran, nuclear energy, space stocks, REITs, and the tactical trades threading them all together.

May 20, 2026·SharkWater Trading·10 min read

This isn't a normal market. You have a Middle East war rattling global oil supply, a Federal Reserve without a permanent chair, nuclear energy being re-rated in real time, and the SpaceX IPO loading on the launchpad. Every one of these stories is moving markets independently — but they're also deeply connected underneath. Understanding the linkage is how you avoid getting jerked around by the headlines and start trading the map instead of the noise.

Let's go layer by layer.

THE IRAN WAR

The volatility engine driving everything else

Brent crude peak

~$120

From $72 pre-conflict

Brent now

~$94

Fragile ceasefire price

EU nat. gas spike

+38%

Single day, March 2026

Gold peak

$5,400

Haven demand surge

US CPI (March)

3.3%

Highest since May 2024

The U.S.-Israeli attack on Iran and the closure of the Strait of Hormuz created what the International Energy Agency called the "largest supply disruption in the history of the global oil market" — echoing the 1970s energy crisis. Oil swung from $72 to nearly $120 before settling around $94 as ceasefire talks began. Europe's natural gas posted its largest single-day gain since 2022. Gold briefly reclaimed $5,400. The volatility wasn't noise — it was the market genuinely repricing geopolitical risk.

Here's the key insight from Morgan Stanley: historically, the S&P 500 rises 8.4% on average in the 12 months following major external shocks — wars, pandemics, energy crises. That's reassuring long term. But the near-term risk is duration: if oil stays elevated, inflation stays hot, and the Fed stays frozen. The current ceasefire is fragile — a genuine breakthrough sends oil back to $80; a breakdown sends it above $110. You're trading a binary outcome structure, not a trend.

The second-order effects matter most for portfolio positioning. Energy sector outperformance, defense spending acceleration, food inflation risk, and — critically — pressure on the Fed not to cut even as the new chair wants to. All of those feed into the rest of this post.

"The market rallied on the ceasefire announcement — but Schwab's analysts noted it was driven by hedge unwinds, not fundamental resolution. The Strait isn't open. Infrastructure is damaged. Energy prices can stay elevated even after the guns go quiet."

NUCLEAR ENERGY

The Iran war just made the long-term case louder

Here's the paradox that should have your full attention: the same war that's spiking oil and gas prices is simultaneously making the case for nuclear energy stronger than ever. Energy security is no longer a theoretical argument — it's a daily front-page story. When a single strait closure can put Europe's heating costs up 38% in a day, governments and corporations are suddenly very motivated to find power sources that don't flow through chokepoints.

Layered on top of the geopolitical argument is the AI power demand story. Data centers are consuming electricity at an unprecedented rate. Every major hyperscaler — Microsoft, Google, Meta, Amazon — is signing nuclear power deals because it's the only carbon-free, always-on energy source that can deliver the load AI requires. Nuclear isn't just a hedge against war. It's the infrastructure backbone of the AI economy.

"Nuclear is no longer the 'alternative' energy play. It's the convergence of energy security, AI infrastructure, and geopolitical reality — all in one sector."

CEGPrice: $303
PT: $375

Constellation Energy

The blue chip. Largest nuclear operator in the U.S., pays a dividend, has existing long-term power agreements with Microsoft and others. The safest way into nuclear.

✓ Revenue now✓ DividendLow risk

GEVPrice: $1,040
PT: $1,240

GE Vernova

The picks-and-shovels nuclear play. Makes the turbines and grid infrastructure that every new nuclear plant needs — regardless of which reactor design wins.

✓ Infrastructure playLower volatility

OKLOPrice: $72
PT: $92

Oklo Inc.

Sam Altman-backed. Broke ground at Idaho National Lab. Partnered with Nvidia on AI-enabled reactor R&D. Acquiring Atomic Alchemy for medical isotopes — potential revenue before reactors go live. $1.6B cash runway. No commercial reactor yet.

✓ $1.6B cash✓ Nvidia partnershipPre-revenueHigh vol

SMRPrice: $12.55
PT: $16–19

NuScale Power

First NRC-approved SMR design in the U.S. 6 GW deal pipeline with TVA via ENTRA1. No commercial revenue yet — still in development. Cheapest entry into the SMR thesis. Paired bet with OKLO makes sense for speculative allocation.

✓ NRC approvedPre-revenueHigh vol

CCJPrice: $116
PT: $129

Cameco Corp

World's largest publicly traded uranium producer. The fuel-side play — as more reactors come online, uranium demand rises. More stable than SMR developers but moves with uranium spot prices.

✓ Revenue nowCommodity-linked

URAETF basket

Global X Uranium ETF

Holds Cameco, Oklo, Sprott Physical Uranium Trust, and international uranium exposure. The diversified basket approach for nuclear without picking individual winners.

✓ DiversifiedETF structure

SPACE STOCKS

The secular growth story hiding inside the geopolitical one

The Iran war has an underappreciated connection to space: the Golden Dome missile defense initiative is now a national security priority, not a budget line item. Defense spending is accelerating across satellite infrastructure, launch capacity, and space-based surveillance. That's a structural tailwind for the space sector that has nothing to do with the SpaceX IPO — and everything to do with it at the same time.

We've covered Rocket Lab's 20X run from $3–4 in 2024 and the full pre-IPO SpaceX playbook (XOVR, RONB, DXYZ, ARKVX, XOVL) in recent posts. The macro add here: if the Iran conflict extends, defense-adjacent space infrastructure spending accelerates. Space isn't just the next frontier — it's current operational theater. Companies providing launch, communications, and surveillance capabilities are defense contractors now.

Rocket Lab specifically is positioned at that intersection: smallsat launches for defense payloads, Neutron for larger missions, and a growing space systems business that hasn't been fully priced in yet. The SpaceX IPO, whenever it arrives, will re-rate the entire sector — not just the SpaceX proxy funds.

"Space isn't the next frontier anymore. It's current operational theater — and investors who treat it like a sci-fi bet are leaving defense-grade tailwinds on the table."

THE FED TRANSITION & REITs

New leadership, dovish tilt, and what it means for income

Current rate

3.5–3.75%

Held 3 meetings

New Fed chair

Warsh

Kevin Warsh nominated

Expected cuts

1–3

Post-chair, H2 2026

Target range

3–3.25%

iShares / ING forecast

Jerome Powell's term expired May 15. Kevin Warsh has been nominated as the next Fed chair — and while his confirmation has been delayed by Senate Republicans, the direction of travel is clear. Trump wants lower rates. His preferred candidates are dovish. Markets are pricing in 1–3 cuts in the back half of 2026, with the target rate moving toward 3%–3.25%.

Here's the complication: the Iran war has pushed CPI to 3.3% — the highest since May 2024 — and the Fed has held rates unchanged at three straight meetings precisely because cutting into an oil shock would be reckless. The new chair walks into a trap: political pressure to cut, inflation pressure not to. That tug-of-war creates uncertainty in the short term, but directional clarity over the medium term. Rates are going lower in 2026 — the question is when, not if.

For REIT investors, that setup is genuinely constructive. REITs are essentially rate-sensitive yield instruments — when the 10-year Treasury yield declines, REIT valuations improve and capital costs fall. The window between the first confirmed rate cut and full market repricing of REIT NAVs is typically where the best entry points live. That window may be opening right now.

"The new Fed chair inherits an inflation problem he didn't create and a president demanding cuts he may not be able to deliver immediately. But rates are going lower. Build your REIT position before the first cut headlines hit — not after."

EQIXData center REIT

Equinix

The AI-adjacent REIT play. Data center infrastructure for hyperscalers. Rate cuts improve development economics, and AI spending drives long-term occupancy. The best of both macro tailwinds in one name.

✓ AI infrastructure✓ Rate cut upside

DLRData center REIT

Digital Realty

EQIX's closest peer. Development yields improve meaningfully with a 25bp cut. Slightly more rate-sensitive than EQIX, making it a higher-beta bet on the rate cut thesis.

✓ Rate-cut leverageAI tenant base

AMTTower REIT

American Tower

Defensive REIT with contractual escalators — income doesn't depend on reletting risk. Cell tower leases are long-duration and inflation-linked. Holds up in volatility and benefits from rate cuts.

✓ Defensive✓ Contractual escalators

PSAStorage REIT

Public Storage

Self-storage is one of the most resilient REIT subsectors — people rent units in good times and bad. Low capex, strong free cash flow, and a haven-like quality during macro uncertainty.

✓ Recession resilientStable cash flow

One important flag: avoid office REITs and structurally challenged retail REITs regardless of rate cuts. Lower borrowing costs can't fix vacant floors or dying malls. Stick to data center, tower, and storage names where the underlying business fundamentals are intact.

TACTICAL PLAYBOOK

How to trade the volatility without abandoning the thesis

The mistake most retail investors make in a macro environment like this is binary thinking — either going full-risk or going to cash. The better approach is a tiered framework: core long-term positions that benefit from structural trends, tactical satellite positions that trade the volatility, and a hedge layer that protects the portfolio when the next headline hits.

Category	Tactical Trade	Rationale	Time Frame
Energy	Long XOM / CVX on ceasefire pullbacks in oil	Integrated majors with dividend coverage and downstream hedging. Outperform in elevated-price environments even if headline oil dips.	Core position
Energy	Trade UCO (2X crude ETF) around Hormuz headlines	Binary event structure in Hormuz news makes leveraged crude a short-term momentum trade. Buy escalation, trim on ceasefire rally. Hard exits required.	Short-term only
Nuclear	Core: CEG + GEV. Speculative: OKLO + SMR paired	Layer risk across the stack — established cash-flow names anchor, high-vol SMR developers for upside. URA ETF as diversified middle ground.	Multi-year core
Space	RKLB core hold; XOVR for SpaceX pre-IPO	RKLB still has Neutron optionality. XOVR for clean SpaceX ETF exposure. XOVL for IPO filing pop only — short-term leveraged play.	Mixed — see post
REITs	Accumulate EQIX, DLR, AMT ahead of first rate cut	Rate cut timing uncertain but directional. Entering before the confirmation headline means buying before the retail wave reprices the sector.	Position now, hold 12–18mo
Defense	LMT, NOC, RTX on Golden Dome spending	Iran war + Golden Dome = multi-year defense budget expansion. Missile defense, satellite comms, and launch infrastructure are the beneficiaries.	Core position
Hedge	Gold position (GLD or physical) sized at 5–10%	Gold at $5,400 still has room if Iran escalates or inflation re-accelerates. Pairs against the rate-cut thesis — if cuts are delayed, gold wins.	Ongoing hedge
Income	Ladder short-duration bonds into the belly of the curve	iShares notes opportunity in 2–5 year Treasuries as rate cuts approach. Capturing yield today while maintaining flexibility if cuts accelerate.	6–18 month ladder

RISK MATRIX

Know which levers blow up which positions

⚠ HIGH RISK

Hormuz re-escalation. Oil back above $110 → inflation spikes → rate cuts pushed to 2027 → REITs and growth stocks re-rate lower. Gold wins, energy wins, everything else suffers.

⚠ HIGH RISK

New Fed chair surprises hawkish. If Warsh prioritizes inflation over Trump's rate-cut demands, the dovish playbook unwinds. REIT thesis delays, growth premium compresses.

⚡ MEDIUM RISK

SMR commercialization delays. OKLO and SMR are pre-revenue. Any setback in permitting, construction, or funding resets the story. Size accordingly — these are satellite positions, not anchors.

⚡ MEDIUM RISK

SpaceX IPO delays. Every SpaceX proxy (DXYZ, XOVR, RONB) gives back premium quickly if the IPO timeline slips. The thesis is intact long-term but the near-term catalyst evaporates.

✓ MANAGEABLE RISK

Ceasefire holds, oil dips to $80. Energy positions give back some gains. Rotate profits into REITs and nuclear on the dip. This is the ideal soft-landing scenario for the broader portfolio.

✓ MANAGEABLE RISK

Rate cuts come slower than expected. REITs tread water for another quarter. Add on weakness — the direction is confirmed, only the speed is uncertain. Patient money wins here.

🦈 The SharkWater Framework

The anchor:CEG, GEV, LMT, XOM — established cash-flow businesses that win across multiple macro scenarios. These don't need a catalyst. They need time.

The growth layer:OKLO + SMR paired bet, RKLB, XOVR for SpaceX — higher vol, longer horizon, sized appropriately. These are 3–5 year positions, not quarterly trades.

The income build:EQIX, DLR, AMT, PSA — accumulate ahead of rate cuts. The entry window before the first confirmed cut is typically the best one you'll get.

The tactical trades:UCO on Hormuz escalation, XOVL on SpaceX IPO filing, GLD as permanent hedge. Sized small, hard exits — these are trades, not investments.

The through-line:War, AI, energy security, and rate normalization are all pointing at the same sectors — nuclear, space, defense, and real assets. The macro is messy. The thesis isn't.

"The biggest macro mistake right now is treating each of these stories as isolated. The Iran war is an energy story. The energy story is a nuclear story. The nuclear story is an AI story. The AI story is a space and defense story. And the Fed story runs underneath all of it. Connect the threads — and trade the whole picture."

#MacroOutlook#Nuclear#Iran#SpaceStocks#REITs#OKLO#SMR#Fed#RateCuts#GoldenDome#Defense#RKLB

Not financial advice. All investment vehicles carry risk including total loss of capital. Geopolitical events, rate decisions, and regulatory changes can materially impact any of the sectors discussed. Leveraged ETFs like UCO and XOVL are short-term instruments subject to daily decay and are unsuitable for long-term holding. Always do your own due diligence. SharkWater Trading content is for educational and entertainment purposes only.

SpaceX IPO

noreply@blogger.com (Unknown) — Wed, 20 May 2026 22:28:47 +0000

SHARKWATERTRADING.COM

IPO Guide • SpaceX • Pre-IPO Access

HOW TO GET IN ON
THE SPACEX IPO

The biggest public offering in history could be weeks away. Here's every retail door into the rocket before liftoff.

May 20, 2026·SharkWater Trading·7 min read

SpaceX is reportedly days away from filing its IPO prospectus — a potential $1.75 trillion debut that would be the largest public offering in history, dwarfing Saudi Aramco. Elon Musk has reportedly indicated up to 30% of shares could go to retail investors, but there's no guarantee you'll get allocated on Day 1. The smarter move? Get pre-positioned now through vehicles that already own SpaceX before the bell rings.

Here's every listed option on the table — what each one is, how much SpaceX exposure you actually get, and the real trade-offs.

"Waiting for IPO day is like showing up to a rocket launch after it's already off the pad. The best seats were sold months ago — but a few doors are still open."

XOVRERShares Private-Public
Crossover ETF

SpaceX %

~28%

Structure

ETF

Liquidity

Daily

SpaceX $

~$230M

XOVR is the cleanest ETF route — it blends 30 large-cap public tech stocks (Nvidia, Meta, Palantir, Tesla, Alphabet) with a private sleeve holding ~$230M in SpaceX via a Special Purpose Vehicle. As a true ETF, it trades at NAV with no closed-end premium risk. It was also the first ETF to hold a private company through IPO (Klarna), giving it a track record others don't have. Also holds Anduril. Watch out: the SpaceX % has crept higher than managers likely intended because redemption pressure forces selling public positions while the SPV stays locked — a quirk that inflates SpaceX concentration over time.

✓ No closed-end premium✓ Daily liquidity✓ Largest $ SpaceX position⚡ SPV valuation opacity⚡ SpaceX % drifts on redemptions

RONBBaron First Principles ETF

SpaceX %

~8.7%

Structure

ETF

Exp. Ratio

AUM

~$71M

RONB is the most straightforward and cheapest option. Launched December 2025, it holds actual SpaceX Class A and Class C shares — not an SPV wrapper — at a combined ~8.72% allocation. Biggest position is Tesla at 14%, followed by MSCI, Shopify, Charles Schwab, and Hyatt. Lowest fees of any vehicle here at 1%. The catch: SpaceX exposure is the smallest on this list. The SEC filing also explicitly calls out "Musk risk" — Tesla and SpaceX share the same CEO, so you're effectively doubling down on one individual's orbit.

✓ Cheapest fees (1%)✓ Actual SpaceX shares — no SPV✓ Daily liquidity⚡ Lowest SpaceX allocation⚠ Tesla + Musk concentration risk

DXYZDestiny Tech100 Inc.

SpaceX %

16.2%

Structure

CEF

Price

~$54

Holdings

32 cos

The most diversified pre-IPO play on this list. DXYZ doesn't just give you SpaceX — it delivers a basket of 32 private companies including OpenAI, Anthropic, xAI, Databricks, and Shield AI. That's the bull case: multiple IPO catalysts stacking up over the next 12–18 months, not just one. The bear case is the $1 billion ATM share offering through Jefferies creating persistent dilution — it's what just pushed the stock from a $71 high back down to $54. As a closed-end fund, it can also trade at a steep premium to NAV. Check our dedicated DXYZ post for the full breakdown.

✓ 32 private cos — most diversified✓ Multi-IPO pipeline (OpenAI, Anthropic)⚠ $1B ATM dilution actively happening⚡ Trades at premium to NAV (~3x)⚡ 4.98% expense ratio

ARKVXARK Venture Fund
Cathie Wood

SpaceX %

17.96%

Structure

Interval

AUM

$654M

1yr Return

+63%

ARKVX carries the highest SpaceX allocation of the bunch at nearly 18% — and Cathie Wood swings hard on conviction. Also holds Replit, Anthropic, Figure AI, Databricks, and Zipline. Up 63% over the past year. There's one dealbreaker for active traders though: this is an interval fund with no daily liquidity. You can only redeem quarterly, and even then it may be capped. Think of it like a hotel with a checkout policy you can't change. If the SpaceX IPO pops and you want to lock in gains the next morning, you're stuck. Sized for patient, long-term capital only.

✓ Highest SpaceX % allocation✓ Deep AI bench (Anthropic, Replit, Figure)⚠ NO daily liquidity — quarterly exit only⚡ 2.9–3.49% expense ratio

XOVLDefiance 2X Long XOVR ETF
Launched May 5, 2026

Leverage

Tracks

XOVR

Structure

Lev. ETF

For

Traders

Just launched May 5 — Defiance's XOVL is the first leveraged ETF with SpaceX exposure. It targets 2X the daily return of XOVR: XOVR up 5% means XOVL aims for 10%. This is not a hold-forever instrument — leveraged ETFs decay over time due to daily rebalancing and volatility drag, making them strictly a short-term momentum play. But if you believe SpaceX's IPO filing triggers a sharp multi-day XOVR run, XOVL is how you maximize that pop. Treat it like a leveraged options position: size it, set your exit, and don't overstay the welcome.

✓ Maximum SpaceX IPO leverage✓ Daily liquidity⚠ Decay kills long-term holders⚠ 2X losses on red days

Ticker	SpaceX %	Structure	Fees	Liquidity
XOVR	~28%	ETF (SPV)	~0.75%	Daily ✓
RONB	~8.7%	ETF (direct)	1%	Daily ✓
DXYZ	16.2%	Closed-end fund	4.98%	Daily ✓
ARKVX	17.96%	Interval fund	2.9–3.49%	Quarterly ✗
XOVL	~56% eff.	2X Leveraged ETF	TBD	Daily ✓

🦈 SharkWater Verdict

Long-term investor:DXYZ for the multi-IPO basket, or ARKVX if you're comfortable locking capital quarterly and want the highest pure SpaceX %. Just price the illiquidity honestly.

Active trader:XOVR for a clean ETF with real SpaceX dollar exposure, no dilution overhang, and no closed-end premium risk.

Cost-conscious:RONB wins on fees and holds actual shares — not an SPV wrapper. Just know Tesla and Musk come with it.

IPO pop trader:XOVL for maximum leverage on the filing catalyst — but treat it like an options trade with a hard exit plan, not a position.

The SpaceX IPO filing could drop any day — possibly timed alongside the next Starship test flight for maximum cultural impact. When that headline hits, every one of these vehicles will spike. The question is whether you're already positioned before it or scrambling after.

We already broke down DXYZ in detail in our last post, including the ATM offering headwind sitting on the stock right now at $54. That pullback may actually be one of the better pre-IPO entry points across this entire list.

"Five doors into the most anticipated IPO in history. Pick the one that fits how you trade — not just which one sounds the most exciting."

#SpaceX#IPO#XOVR#RONB#DXYZ#ARKVX#XOVL#PreIPO

Not financial advice. All investment vehicles carry risk including total loss of capital. Pre-IPO, interval, and leveraged products carry significant additional risk. Leveraged ETFs experience daily decay and are unsuitable for long-term holding. Always do your own due diligence. SharkWater Trading content is for educational and entertainment purposes only.

THE VELVET ROPE IS NOW A TICKER (DXYZ)

noreply@blogger.com (Unknown) — Tue, 12 May 2026 15:07:00 +0000

Deep Dive • Pre-IPO • $DXYZ

THE VELVET ROPE
IS NOW A TICKER

DXYZ gives retail investors a seat at the private tech table — SpaceX, Anthropic, OpenAI — before the IPO bell rings.

May 12, 2026·SharkWater Trading·6 min read

Current price

$54

Pulled back on share news

52-wk range

$19 – $71

Up 130%+ in 2026

ATM offering

$1B

Active dilution headwind

Portfolio cos.

Of 100 target slots

For decades, the most valuable companies in the world — the ones minting billionaires in Silicon Valley conference rooms — were completely off-limits to you. Venture capital was a club with no public entrance. DXYZ is the door someone finally left open.

Destiny Tech100 is a closed-end fund listed on the NYSE since March 2024. Think of it like a mutual fund built in a VC firm's back office — it acquires equity stakes in late-stage, venture-backed private companies and packages them into a single ticker you can buy on any brokerage account. No accredited investor status required. No $250K minimum. Just a market order.

"DXYZ is venture capital you can buy like a stock. And right now, it's sitting on some of the most anticipated IPO candidates in history."

Top holdings as of the most recent reporting period:

SpaceX16.2%

Shield AI4.1%

Databricks4.0%

xAI3.5%

OpenAIposition

Anthropicposition

That's SpaceX, the company reportedly filing its IPO prospectus imminently with advisers eyeing a valuation near $1.75 trillion — potentially the largest IPO in history. It's OpenAI, running nearly $20 billion in annual revenue and reportedly eyeing a late-2026 listing. It's Databricks, valued at over $130 billion in its last funding round. And it's Anthropic — the AI lab that needs no introduction. These are the company's institutional investors fight to get allocation in. DXYZ lets you get there first.

The thesis plays out in stages. When one of these companies files for an IPO, DXYZ's stated value of that position re-prices — often dramatically upward. Investors holding DXYZ are essentially pre-positioned ahead of Day 1 retail pricing, without scrambling for shares in an oversubscribed offering. As the IPO pipeline heats up across the portfolio, every listing is a potential catalyst for the fund's NAV and stock price.

"You're not buying DXYZ for what it's worth today. You're buying it for what it unlocks when SpaceX rings the bell."

The stock has responded accordingly — and so has the dilution. DXYZ ran hard recently, jumping 21% on May 8 and another 30% on May 11 on SpaceX IPO momentum, touching a 52-week high near $71. Then today hit $54 as the market digested news of an increased share offering. That's the DXYZ pattern in a nutshell: explosive upside, then the ATM offering steps in and bleeds the rally.

⚠ The share offering is the story today

The $1 billion ATM offering — now in focus. Destiny Tech100 disclosed an up-to-$1 billion at-the-market share offering through Jefferies in a February 2026 SEC filing. An ATM offering lets the company sell new shares directly into the open market whenever it chooses — and today's price drop to $54 is the market pricing in exactly that. New shares hit the float, supply increases, and buyers who just rode the rally find themselves underwater. It's not a company in trouble; it's a structural feature of how this fund raises capital to deploy into new positions. But it's painful if you're long and not expecting it.

The NAV premium. The fund's net asset value was reported at ~$19.97 per share as of December 2025. At $54 today — after the pullback — you're still paying nearly 3x stated NAV. That premium exists because the market believes the private valuations are stale and that SpaceX alone will reprice everything upward at IPO. If the IPO delays, that premium compresses.

The fee drag. A 4.98% annual expense ratio is steep. Over a multi-year hold, it compounds against you. Factor it in.

None of that makes DXYZ uninvestable. It makes it a trader's instrument more than a buy-and-hold. The $54 level after an offering-driven flush is actually the setup worth watching — historically, DXYZ bounces hard once the dilution overhang gets absorbed and the next IPO headline drops.

Watch the offering activity closely. When DXYZ runs, check whether Jefferies is hitting the ask with new share sales — that's your signal on whether the rally has legs or is about to get bled again. The thesis is intact. The timing is the trade.

"The velvet rope is now a ticker symbol. Just know the bouncer still charges a fee at the door — and today he handed out extra tickets."

#DXYZ#PreIPO#SpaceX#Anthropic#OpenAI#PrivateTech#ATMOffering

Not financial advice. Past performance is not indicative of future results. SharkWater Trading content is for educational and entertainment purposes only. Always do your own due diligence. Premium-to-NAV investing carries significant risk of rapid capital loss.

RKLB Best Day Ever and 20X

noreply@blogger.com (Unknown) — Fri, 08 May 2026 21:05:00 +0000

ROCKETLAB
BLASTS OFF

The best single day in RKLB history — and we called it at $3.

May 8, 2026·SharkWater Trading·5 min read

Today's move

+34%

Best single day ever

Current price

~$84

vs. $3–4 in 2024

Return (from $4)

20X+

If you listened

Backlog

$2.2B

Doubled year-over-year

RKLB just had its single best trading day in company history — up 34% in one session — after reporting Q1 2026 earnings that beat on every line that matters. If you were following SharkWater Trading back in 2024 when we were pounding the table at $3 and $4, today is your day. Pop the champagne.

"We didn't say 10X. We said it was a generational setup. At $84 today from $3–4 in 2024, you're looking at a 20X. That's not a typo."

Here's what lit the fuse: Rocket Lab reported Q1 revenue of $136.7M in space systems (estimate: $132.1M) and $63.7M in launch services (estimate: $59M) — beats across the board. EPS came in at -$0.07 vs. a -$0.08 estimate. Narrowing losses, accelerating revenue. That's the playbook we've been watching them run.

But the headline number is the backlog: $2.2 billion, more than double what it was a year ago. That's not a fluke — that's a company winning. On top of that, management guided Q2 revenue between $225M and $240M, handily blowing past Wall Street's $207.5M consensus. And they dropped the largest single launch contract in the company's history on the same day. That's a mic drop earnings call.

They also announced an acquisition of Motiv Space Systems, a space robotics company — a smart move that deepens their vertical integration and builds out capabilities that will matter as on-orbit servicing becomes a bigger part of the market.

The macro setup has been working in their favor too. Trump's Golden Dome defense initiative has flooded enthusiasm into defense-adjacent space stocks. And with the long-awaited SpaceX IPO looming later this year, the entire sector is getting a halo effect. Rocket Lab is the best pure-play public space stock in the market, and Wall Street is finally pricing it that way.

The 52-week range tells the full story: $20.23 low, $99.58 high. And the Wall Street average price target? $87.56 — with some analysts modeling $311 by 2030 if the trajectory holds.

"Rocket Lab isn't catching up to the space race — it's leading the commercialization of it."

We know some of you are sitting on 10x, 15x, even 20x gains right now asking whether to ring the register. That's a personal decision. What we can say is: the business has fundamentally re-rated. This isn't the same company that was trading at $3. The backlog doubled. Revenue is scaling. And Neutron — their medium-lift rocket still in development — hasn't even contributed a dollar of revenue yet. If Neutron delivers, the next leg could be just as powerful as the first.

We don't know where the stock trades tomorrow. But we know what we saw in 2024, and we said it loud. The sharks who were patient are eating well today.

#RKLB#Earnings#SpaceStocks#GoldenDome#SpaceXIPO#RocketLab

🦈 Harvesting Alpha: Selling Puts in Memory, SMR, and Gene Editing

noreply@blogger.com (Unknown) — Fri, 01 May 2026 12:56:00 +0000

Welcome back to the shark tank. Most retail traders are obsessed with guessing direction—chasing green candles and panic-selling the red ones. But the real alpha isn't always in picking the perfect top or bottom; it's in being the house. When implied volatility (IV) spikes, options premiums inflate. Instead of buying the underlying assets and hoping they go up, we are going to sell the right for others to panic.

Selling bullish puts—specifically cash-secured puts or put credit spreads—is the ultimate "get paid to wait" strategy. If the stock stays flat or goes up, you keep 100% of the premium. If it drops, you get assigned shares of a stock you already wanted to own, but at a massive discount.

Here is how we are structuring our premium-harvesting operations across three of the most explosive, high-IV sectors in 2026: Memory, Small Modular Reactors (SMRs), and Gene Editing.

1. The Memory Space: Monetizing the AI Bottleneck

As we covered recently, the AI supercycle has created a brutal supply shock in High-Bandwidth Memory (HBM) and data center storage. The fundamentals are bulletproof, but tech sector volatility remains predictably high.

The Targets: Micron Technology (NASDAQ: MU), Western Digital (NASDAQ: WDC), and Applied Materials (NASDAQ: AMAT).
The Play: These are high-quality, profitable companies with immense institutional backing. You want to own these long-term. By selling 30-to-45 day out-of-the-money (OTM) puts at established technical support levels, you are harvesting theta (time decay) from anxious traders.
The Edge: Because the AI narrative drives sharp, violent pullbacks in semiconductor stocks, IV frequently overstates the actual downside risk. If MU takes a 5% haircut on broader market weakness, put premiums will swell. Sell the put, collect the inflated credit, and let the underlying strength of the 2026 memory shortage bail you out.

2. Small Modular Reactors (SMRs): Powering the Grid, Harvesting the Volatility

Data centers cannot survive without base-load power, and nuclear energy has officially roared back. However, the companies building Small Modular Reactors are largely early-stage, pre-revenue, or highly speculative.

The Targets: NuScale Power (NYSE: SMR) and Oklo (NYSE: OKLO).
The Play: SMR stocks are infamous for their wild price swings, trading more on regulatory news and futuristic $10 trillion total addressable market (TAM) projections than current earnings. Buying shares outright is a rollercoaster. Selling puts is the antidote.
The Edge: The implied volatility on stocks like OKLO and SMR is astronomical. The market is pricing in massive uncertainty. By selling deeply OTM puts, you can generate double-digit annualized yields on your cash. If the stock drops and you are assigned, your cost basis is significantly lower than the retail traders who bought the hype. If it bounces, you keep the fat premium.

3. Gene Editing: Fading the Biotech Binary Binary Events

Biotech is the casino of the stock market. In 2026, the patent cliff is driving massive M&A activity, and gene editing has transitioned from science fiction to FDA-approved reality.

The Targets: CRISPR Therapeutics (NASDAQ: CRSP), Intellia Therapeutics (NASDAQ: NTLA), and Beam Therapeutics (NASDAQ: BEAM).
The Play: Gene editing stocks trade violently around clinical trial readouts, FDA approvals, and earnings calls. While CRSP actually has a commercial product on the market (CASGEVY), companies like NTLA (pioneering in vivo editing) and BEAM (base editing) are heavily dependent on future catalysts.
The Edge: Avoid the "binary event" trap of holding long shares through a Phase 3 trial readout where the stock could gap up or down 30%. Instead, let the IV crush work for you. Sell put credit spreads (to strictly define your downside risk) just outside the expected move of these events. When the news drops, IV collapses, the options rapidly lose value, and you buy them back for pennies on the dollar.

The Shark's Takeaway

Directional trading is a tough way to make an easy living. Premium harvesting shifts the math in your favor. In the memory space, we use puts to acquire fundamentally dominant companies at a discount. In the SMR and Gene Editing spaces, we use puts to extract cash from the market's overreaction to volatility.

Manage your position sizing, never sell naked puts on margin you can't cover, and respect the strike price. Collect the premium, wait out the clock, and strike when the market bleeds.

The AI Memory Supercycle: Profiting from the 2026 Chip Shortage

noreply@blogger.com (Unknown) — Fri, 01 May 2026 12:21:14 +0000

Welcome to the shark tank. If you've been trading the semiconductor sector, you already know the headline: AI is eating the world. But while the retail crowd is blindly chasing GPU makers, the real alpha is hiding in the bottleneck. The world is running out of memory.

In 2026, we have entered a massive pricing "supercycle." Data centers are projected to devour a staggering 70% of the world's memory chips this year. Because manufacturers have completely pivoted their production lines to feed the voracious AI demand for High-Bandwidth Memory (HBM), we are facing a severe supply shortfall across the board. Conventional DRAM and NAND flash prices have surged, with some chips up over 200% compared to 2025 figures.

For the sharks hunting for explosive gains, this supply shock isn't a crisis—it's a catalyst. Here is the detailed breakdown of the best memory stocks to buy to capitalize on the 2026 shortage.

1. Micron Technology (NASDAQ: MU)

Micron is the undisputed pure-play champion in the US market, and right now, it is printing money. It is the only US-based manufacturer with direct DRAM exposure, which is critical given that DRAM prices are rising faster than NAND.

The HBM Catalyst: Early indications from management show that Micron's entire 2026 HBM capacity is 100% sold out.
The Financials: Micron's revenue growth is explosive, posting massive YoY gains with recent quarterly revenues topping $23.9 billion. The cloud memory segment alone is expanding at an unhinged rate.
The Trade: The stock recently broke the $500 barrier, and Wall Street is finally waking up. With median price targets chasing $527 and aggressive institutional targets stretching from $700 to $1,000, Micron remains the cleanest vehicle to ride the immediate HBM supply shock.

2. SK Hynix (KRX: 000660 / OTC: HXSCF)

If you are willing to trade over-the-counter or have access to international markets, SK Hynix is a mandatory portfolio addition. They are the dominant secondary player in the HBM market, working directly alongside NVIDIA to feed the AI server buildout.

First-Mover Advantage: SK Hynix locked down the early lead in HBM3E and HBM4E production.
Capacity Squeeze: Like Micron, their advanced memory lines are completely booked out through 2026 and well into 2027.
The Trade: While US investors often default to Micron, SK Hynix holds a massive structural market share in the specific high-end chips that power AI accelerators. It is a foundational play for the current shortage.

3. Western Digital (NASDAQ: WDC) & SanDisk (NASDAQ: SNDK)

Following their recent separation, both Western Digital and SanDisk have emerged as hyper-focused, lethal players in the data storage buildout. The AI demand for massive pools of fast storage for model training and inference workloads has completely wiped out the NAND flash glut of the early 2020s.

Western Digital: Now an HDD pure-play, WDC has soared from the $50 range in 2025 to over $280 in 2026. High-capacity cloud HDDs are in unprecedented demand as hyperscalers build out their 2026 infrastructure.
SanDisk: The newly independent flash memory giant is seeing a step-change in revenue and margins as NAND supply tightens and pricing power returns squarely to the suppliers.
The Trade: Both stocks offer high operating-leverage. When storage prices swing upward, it creates sudden, massive earnings power that the market is rapidly repricing.

4. Applied Materials (NASDAQ: AMAT)

If you don't want to bet on which memory maker wins the arms race, buy the company selling the arms. Applied Materials provides the wafer fabrication equipment (WFE) that allows Samsung, SK Hynix, and Micron to actually build these increasingly complex chips.

The Capex Boom: To solve the shortage, memory manufacturers are spending billions on facility expansions. AMAT is the direct beneficiary of this capital expenditure.
Premium Pricing: Complex manufacturing processes for leading-edge DRAM and HBM allow AMAT to charge a premium, insulating them from the cyclical weakness of consumer electronics.
The Trade: AMAT is effectively de-risking its business by focusing on high-margin, AI-related processes. It is a structurally safe, high-upside play on the desperate global scramble to bring more memory capacity online.

The Shark's Takeaway

The memory market is historically cyclical, but AI has fundamentally altered the baseline. Hyperscalers like Meta, Alphabet, Microsoft, and Amazon are forecasting combined 2026 capital expenditures easily exceeding $500 billion, with the vast majority earmarked for computing infrastructure.

The shortage is here, capacity takes years to build, and prices will continue to climb. Position yourself in the suppliers that own the bottleneck.

SMR Nuclear Stocks in 2026: Navigating the Factory-Built Reactor Revolution

noreply@blogger.com (Unknown) — Mon, 27 Apr 2026 00:39:00 +0000

Bottom Line Up Front: Small modular reactors represent the most compelling structural shift in energy since fracking, driven by AI data center demand and a nuclear-friendly White House. But the stock landscape splits sharply between speculative pre-revenue plays and profitable "picks and shovels" companies that win regardless of which reactor design prevails. Here's our breakdown of where the opportunities — and the traps — are right now.

Why SMRs, Why Now

If you've been following SharkWater Trading's nuclear coverage since our Trump's Nuclear Renaissance piece last May, you know we've been tracking this sector closely. The thesis has only strengthened since then, but the stock-level picture has changed dramatically.

Traditional nuclear plants are like building custom cathedrals — each one unique, decade-long, and prone to massive cost overruns. SMRs flip that model: factory-built, standardized, scalable, and deployable at data centers, military bases, and industrial sites where the grid can't deliver constant power.

Three forces are converging to make 2026 a pivotal year:

AI's Insatiable Power Appetite: Data centers need 24/7 baseload power that solar and wind simply cannot provide. Tech giants are signing nuclear power agreements at an unprecedented pace.
Regulatory Tailwinds: Trump's executive orders streamlined NRC licensing to 18 months, designated nuclear-powered AI infrastructure as critical defense facilities, and pushed domestic uranium production.
GE Vernova's Ontario Milestone: The first SMR construction in the Western hemisphere broke ground in mid-2025 — proving these aren't just PowerPoint reactors anymore.

The Pure-Play SMR Developers: High Risk, High Reward

NuScale Power (NYSE: SMR)

The Situation: NuScale is the only company in the U.S. with an NRC-certified SMR design. That first-mover advantage is real — but so are the execution challenges.

Key Metrics:

Stock Performance: Down over 75% from its highs in the last six months
Revenue: Pre-revenue. This is a development-stage company.
NRC Status: Only U.S. company with Standard Design Approval for an SMR (77 MWe module)

Bull Case:

The ticker is literally "SMR" — retail recognition matters
Signed a landmark MOU with ENTRA1 Energy and TVA for up to 6 GW of SMR deployment, the largest such program in U.S. history
Romania's RoPower project represents its closest path to a first commercial customer
Nuclear-friendly administration actively boosting SMR deployment

Bear Case:

Pulled the plug on its Utah CFPP reactor project in November 2023 — its highest-profile U.S. deal
No new domestic projects with definitive completion dates announced since
Burns cash every quarter with no revenue timeline locked in
If the Romania deal falls through, the stock could crater

SharkWater Take: NuScale at current levels is a speculative bet on the entire SMR concept succeeding. The 75% pullback makes the risk/reward more interesting than it was at the peak, but this remains a company that needs to prove it can actually build something. Position sizing should reflect that reality.

Oklo (NYSE: OKLO)

The Situation: Sam Altman's nuclear play. Oklo has emerged as the AI-nuclear convergence stock, designing compact fast reactors (the Aurora powerhouse) specifically targeting data center deployments.

Key Metrics:

Recent Catalyst: Jumped 15.6% in a single week after the Nvidia-Los Alamos nuclear AI news broke
Analyst Coverage: HSBC initiated with a Buy rating and $96 price target
Pipeline: Approximately 14 GW in non-binding agreements with data centers and industrial operators

Bull Case:

Secured U.S. government contract to build uranium supply lines — strategic national security positioning
Deal to build an SMR for the Air Force
750+ MW in data center MOUs signed in late 2024
Partnership with Lightbridge (LTBR) for advanced fuel co-location
The AI demand story gives Oklo a clearer customer than most nuclear startups

Bear Case:

Zero revenue. Operating losses accelerating (up 142% YoY as of early 2025)
First power production not targeted until late 2027 or early 2028 at the earliest
NRC application history has been bumpy — initial application was denied, required resubmission
MOUs are non-binding. They are expressions of interest, not purchase orders.

SharkWater Take: Oklo has the strongest narrative in the SMR space right now. The Altman connection, the AI angle, and the government contracts create a compelling story. But stories don't generate revenue. We're watching this one for entry points on pullbacks rather than chasing momentum.

Deep Fission — The One to Watch

Deep Fission, which builds SMRs installed one mile underground, just filed a confidential S-1 with the SEC on April 22, 2026 for a proposed IPO. Not yet tradeable, but the underground deployment concept is genuinely differentiated. We'll cover this one in detail when pricing details emerge.

The Picks-and-Shovels Plays: Lower Risk, Proven Revenue

This is where SharkWater sees the most compelling risk-adjusted opportunity. These companies profit from the SMR buildout regardless of which reactor design wins.

BWX Technologies (NYSE: BWXT)

The Situation: BWXT manufactures the actual nuclear components — fuel assemblies, reactors, pressure vessels — and provides engineering services. They also build nuclear propulsion systems for the U.S. Navy, which provides a stable revenue floor that pure-play SMR companies simply don't have.

Why It Matters:

Positioned as a key industrial partner for commercial SMR deployment
Their manufacturing experience translates directly to factory-based, commercial-scale reactor production
Extensive nuclear supply chain relationships that new entrants can't replicate
Defense contracts provide cash flow stability while the commercial SMR market develops

SharkWater Take: BWXT is the "sell shovels during a gold rush" play. They win whether NuScale, Oklo, GE, or someone else becomes the dominant SMR platform. For investors who believe in the nuclear renaissance but don't want to bet on a single horse, this is the most defensible position in the sector.

GE Vernova (NYSE: GEV)

The Situation: The energy spinoff from GE is the infrastructure king of the nuclear space. Their BWRX-300 SMR design is now under construction in Ontario — the first of its kind in the Western hemisphere.

Key Metrics:

Stock Price: ~$985 (as of late April 2026)
Backlog: $163 billion (up from $116B at spin-off)
Q1 2026 Earnings: Beat expectations
Analyst Consensus: Strong Buy — 19 Buy ratings, 2 Hold, 0 Sell. JPMorgan raised its price target to $1,150.

Bull Case:

Not just an SMR company — they provide the turbines, grid equipment, and infrastructure that all nuclear plants require
Ontario construction milestone proves execution capability
Massive and growing backlog driven by grid modernization and energy transition
Profitable, cash-flowing business — not a speculative startup

Bear Case:

At ~$985/share, much of the nuclear upside may already be priced in
Broad energy exposure means nuclear is only one growth driver — you're also buying wind, gas, and grid equipment
Premium valuation leaves little margin for error on earnings

SharkWater Take: GE Vernova is the "blue chip" of the nuclear renaissance. The Ontario SMR construction, the monster backlog, and the analyst consensus all point to continued strength. The question is whether the current price already reflects the nuclear thesis. For long-term positioning, it remains our top pick in the established nuclear infrastructure space. For traders, waiting for a pullback to the $850-900 range would improve the risk/reward.

Adjacent Plays Worth Monitoring

The SMR ecosystem extends beyond reactor builders:

Centrus Energy (NYSE: LEU): The uranium enrichment play. Produces HALEU fuel that many advanced SMR designs require. Near-monopoly positioning in the Western world for enriched uranium supply. Strategic national security asset.
Nano Nuclear Energy (NASDAQ: NNE): Micro-reactor developer. Even earlier stage than NuScale — this is essentially venture capital in public markets. Surged 30% on Trump's nuclear executive orders.
Lightbridge (NASDAQ: LTBR): Advanced nuclear fuel technology. Signed an MOU with Oklo for fuel co-location. A leveraged bet on next-gen reactor fuel demand.

How SharkWater Is Thinking About This Sector

The nuclear SMR space breaks cleanly into two investment approaches:

Approach 1: The Portfolio Anchor Allocate the majority of your nuclear exposure to profitable companies with existing revenue streams — BWXT and GE Vernova. These companies benefit from the nuclear buildout without requiring any single SMR design to succeed. They're the picks-and-shovels play, and history shows that picks-and-shovels companies often outperform the miners themselves.

Approach 2: The Speculative Allocation Reserve a smaller, risk-tolerant allocation for pure-play SMR developers like NuScale and Oklo. These are binary outcome bets — they either become the backbone of next-generation energy infrastructure or they burn through their cash and disappoint. Position sizing is everything here.

What We're Watching:

NuScale's Romania timeline: If RoPower advances through licensing, this stock re-rates. If it stalls, expect pain.
Oklo's NRC progress: The resubmitted application is the gating factor. Approval would be transformative.
GE Vernova Ontario construction: On-time, on-budget progress here validates the entire SMR thesis.
Deep Fission IPO: A fresh entrant with a differentiated underground deployment concept could reshape the competitive landscape.
DEA final telehealth rules: Wait, wrong sector. But you get the idea — regulatory catalysts matter.

The Verdict: Real Tailwinds, Real Risks

The SMR nuclear story is the rare convergence of structural demand (AI power), political support (bipartisan), and technological readiness (NRC-approved designs). That combination doesn't come along often.

But as we noted in our May 2025 nuclear analysis, success ultimately depends on execution — building actual reactors, generating real revenue, and proving these technologies can scale economically. The companies that solve the manufacturing and deployment puzzle will create enormous value. The ones that don't will join the long list of nuclear promises that never materialized.

For SharkWater traders, the playbook is clear: anchor in the infrastructure plays, speculate carefully in the pure-plays, and keep your position sizing honest about what's proven versus what's promised.

Fair winds and following seas.

Disclaimer: This blog post is for informational purposes only and does not constitute investment advice. All trading carries risk. Past performance does not guarantee future results. SharkWater Trading provides technical and fundamental analysis for active traders. Contact us for personalized trading strategies tailored to your investment goals.

Trading Energy Transfer (ET)

noreply@blogger.com (Unknown) — Mon, 12 Jan 2026 18:14:00 +0000

The tape is telling a clear story right now. ET is hovering right at the $17.00 psychological pivot. With the next monthly expiration coming up on February 20, 2026, and a dividend distribution estimated for early February, here is the technical and derivative breakdown to refine your entry.

Current Market Snapshot (Jan 12, 2026)

Spot Price: $17.05 - $17.08
Imv (Implied Volatility): ~15% – 18% (Relatively low, favoring option buyers or "Wheel" sellers)
Most Active Strike: The $17.00 Strike is the clear "battleground," with over 39,000 contracts in Open Interest for the January monthly and significant building interest for February.

The $17.00 Strike: "At-The-Money" Greeks

If you are looking at the February 20, 2026 expiration, here is how the Greeks are currently stacking up for the $17.00 strike:

Greek	Call ($17.00)	Put ($17.00)	What it means for you
Delta	0.52	-0.48	The market sees a 50/50 toss-up on whether we close above $17 by Feb expiration.
Theta	-0.01	-0.01	Time decay is minimal right now, losing about $1 per contract per day.
Vega	0.02	0.02	Low sensitivity to volatility spikes. ET is a "slow and steady" mover.
Gamma	0.35	0.38	High "bumpiness" at this price; small moves in the stock will cause large swings in option value.

Refined Trading Plans

1. The "Aggressive Entry" (Selling the $17 Put)

If you want to own ET but think it might retest the $16.80 support before the next leg up:

Trade: Sell the Feb 20 $17.00 Put for a credit of roughly $0.35 - $0.40.
The "Shark" Logic: You are essentially bidding for the stock at a net price of $16.60. If the stock stays above $17, you pocket the premium (a ~2.3% return on capital in 40 days). If it drops, you get assigned at a price that yields nearly 8.2% on the dividend.

2. The "Dividend Capture" (Buy-Write)

With the $0.3325 dividend expected around Feb 6th, the Feb options are priced for it.

Trade: Buy shares at $17.05 and sell the Feb 20 $18.00 Call.
The "Shark" Logic: You capture the $0.33 dividend plus the option premium of ~$0.15. If ET hits $18, you get called away for a total return of ~7.5% in under 6 weeks.

3. The "Lottery Ticket" (High OI Alert)

Notice the massive Open Interest (58,000+) at the $20.00 Call strike. This is "Smart Money" or "Hedge" positioning.

Trade: If we break $17.50 on high volume, look at the March $18 Calls. They are currently "cheap" because ET is viewed as a slow mover, but a breakout above the 52-week high ($21.45) would send these deep into the money quickly.

Shark Caution: The "Ex-Dividend" Risk

Since the dividend is roughly $0.33, expect the stock price to "drop" by that amount on the ex-dividend date (likely early February). If you are selling Puts, this drop is your friend (easier assignment); if you are long Calls, this drop hurts your Delta.

Trading Energy

noreply@blogger.com (Unknown) — Mon, 12 Jan 2026 18:09:00 +0000

The Oil Surge & The ET Power Play: Why Energy Transfer is the 2026 Anchor for Your Portfolio

The energy markets are flashing a signal that many retail traders are missing. While the "talking heads" are obsessed with potential 2026 supply surpluses, smart money is looking at the volume and the geopolitical floor. We aren’t just trading the price of a barrel; we’re trading the infrastructure that moves it.

As we kick off January 2026, the "Emerging Strength" in oil isn’t coming from a lack of suppl, it’s coming from a massive re-acceleration in American production and a natural gas boom driven by the AI data center revolution.

If you want to play this trend with a massive "margin of safety" and a fat 8% yield, it’s time to look at Energy Transfer (ET).

The Macro Backdrop: Why Oil & Gas are Showing Teeth

Despite predictions of a "supply wave," the floor for oil remains remarkably firm. Several factors are driving this:

Geopolitical Risk Premiums: Tensions in the Middle East and ongoing sanctions on Russian and Iranian exports are keeping a "fear floor" under prices.
The Permian Powerhouse: U.S. shale production is hitting record levels. More oil flowing means more fees for the companies that own the pipes.
The "AI Gas" Trade: Natural gas demand is skyrocketing to power the massive data centers required for the AI boom. ET is uniquely positioned to capitalize on this via its massive Texas infrastructure.

The Case for Energy Transfer (ET)

Energy Transfer isn't just another pipeline company; it’s a 140,000-mile toll booth. After a sluggish 2025, the company has "stomped on the gas" for 2026.

1. Massive Guidance Hike

ET recently issued its 2026 outlook, projecting Adjusted EBITDA of $17.3B – $17.7B. This represents a significant growth acceleration (nearly 10%) compared to last year.

2. The Growth Pipeline

The company is moving into "Growth Mode" with a capex budget of $5.0B – $5.5B for 2026. Key projects coming online include:

Mustang Draw I & II: Major processing plants in the Permian.
Nederland Flexport: Expanding NGL (Natural Gas Liquids) export capabilities.
Data Center Connections: New direct-to-utility gas lines serving the tech sector.

3. The "Double-Digit" Income Engine

With a current price around $16.95, ET is yielding roughly 8%. Management is targeting a 3% to 5% annual distribution growth, meaning you’re getting paid handsomely to wait for the capital appreciation.

Price Targets & Technical Outlook

Wall Street is turning increasingly bullish as the 2026 growth story unfolds.

Consensus Target: $21.75
Bull Case Target: $25.00
Current Floor: $16.50 - $17.00

At current levels, you are looking at nearly 28% upside to the consensus target, not including the 8% dividend. That is a massive "total return" setup for a "boring" midstream play.

The Shark Playbook: How to Trade ET

Strategy A: The "Buy and Hold" (Passive Income)

Buy the common units at current levels ($16.90 - $17.10). Reinvest the distributions to compound your share count. This is for the "set it and forget it" portion of your portfolio.

Strategy B: The "Wheel" Strategy (Income + Entry)

If you want to get paid to enter the position:

Sell Cash-Secured Puts: Sell the $16.50 or $17.00 Strike Puts (30-45 days out). You collect the premium upfront.
- If ET stays above the strike: You keep the cash and repeat.
- If ET dips: You are "forced" to buy a great company at a discount.
Sell Covered Calls: Once you own the shares, sell $19.00 or $20.00 Strike Calls. This adds another 2-3% in "synthetic yield" on top of the 8% dividend.

Strategy C: The LEAPS Play (Leveraged Growth)

For those expecting ET to hit that $21+ target by mid-year, look at the January 2027 $15 or $17 Calls. These "LEAPS" allow you to control 100 shares for a fraction of the price, capturing the upside move with limited capital at risk.

Bottom Line

The energy sector is rotating back into favor. Energy Transfer is the rare "triple threat": high yield, accelerating earnings, and a valuation that is still cheap relative to its peers like Enterprise Products (EPD).

The Plan: Accumulate ET in the $16-17 range. Use options to juice the yield. Hold for the $21+ target as the market wakes up to the 2026 growth story.

NTLA and FLY: A Tale of Two Transformations

noreply@blogger.com (Unknown) — Fri, 14 Nov 2025 02:15:00 +0000

Market Update: November 13, 2025

NTLA (Intellia Therapeutics): Clinical Hold Challenges Gene Editing Pioneer

Intellia Therapeutics faced a significant setback in their revolutionary gene editing journey, with the FDA placing a clinical hold on their flagship MAGNITUDE and MAGNITUDE-2 Phase 3 trials of nexiguran ziclumeran (nex-z) following rare Grade 4 liver transaminase elevations. This development has fundamentally altered the company's trajectory and investor sentiment.

Q3 2025 Financial Highlights:

Cash Position: $669.9M (down from $707.1M in Q1 2025)
Net Loss: $101.3M for Q3
Runway: Extended into mid-2027
Stock Impact: Significant volatility following clinical hold announcement

Key Developments:

The clinical hold represents a critical inflection point for NTLA. With over 650 patients enrolled in MAGNITUDE and 47 in MAGNITUDE-2, the safety signal has raised serious concerns about the near-term commercial viability of nex-z. The company has suspended milestone guidance pending regulatory alignment, creating substantial uncertainty for investors.

However, there's a silver lining with lonvo-z (NTLA-2002), their hereditary angioedema (HAE) treatment. The Phase 3 HAELO trial completed enrollment ahead of schedule, with topline data expected by mid-2026 and potential U.S. launch in H1 2027. This positions lonvo-z as the company's lead commercial opportunity.

Trading Analysis:

NTLA exhibits classic biotech volatility patterns. The clinical hold creates a binary setup:

Bear Case: Extended regulatory delays, potential program termination, cash burn concerns
Bull Case: Successful lonvo-z launch, resolution of nex-z safety issues, platform validation

The stock has historically shown sharp moves on clinical data releases. With $669.9M cash runway to mid-2027, dilution risk remains manageable near-term, but watch for potential equity raises if clinical timelines extend.

FLY (Firefly Aerospace): From Aircraft Leasing to Space Technology

In a dramatic sector shift, the FLY ticker now represents Firefly Aerospace Inc., following the 2021 acquisition of Fly Leasing by Carlyle Aviation Partners. Firefly went public in August 2025, raising $933.1M in net proceeds from their IPO.

Q3 2025 Financial Performance:

Revenue: $30.8M (up 38% YoY, nearly doubled QoQ)
Net Loss: $140.4M ($1.50 per share)
Stock Reaction: +15% post-earnings
2025 Guidance: $133-145M revenue
Total Backlog: $1.3B

Strategic Positioning:

Firefly's transformation from aircraft leasing to space technology represents a complete business model pivot. The company is capitalizing on increasing government and commercial space contracts, with notable wins including:

NASA Blue Ghost Mission 4: $176.7M
Recent SciTec acquisition: $855M (expanding national security capabilities)
Strong technical progress: 95 hot fire tests of Miranda engine

Trading Perspective:

FLY now trades as a high-growth space technology play rather than a stable yield vehicle. Key catalysts include:

Eclipse medium-lift vehicle development
Blue Ghost lunar missions
Expanding national security contracts
Integration of SciTec capabilities

The 38% revenue growth and backlog expansion suggest strong operational momentum, though profitability remains distant. The stock's 15% post-earnings surge indicates market appetite for space sector exposure.

Trading Strategy Considerations

NTLA:

Entry Points: Watch for capitulation on regulatory uncertainty
Risk Management: Size positions for binary outcomes
Timeframe: 12-18 months to lonvo-z data/approval
Key Levels: Monitor cash burn rate and clinical trial updates

FLY:

Momentum Play: Rising revenues and expanding backlog support growth narrative
Sector Rotation: Benefits from space/defense spending trends
Valuation: Trading on revenue multiples given lack of profitability
Catalysts: Contract wins, successful launches, M&A integration

The Bigger Picture

Both stocks represent transformation stories – NTLA navigating clinical setbacks while maintaining pipeline potential, and FLY completely reinventing itself from aircraft leasing to space technology. For active traders, these situations offer volatility and catalyst-driven opportunities, but require careful risk management given the binary nature of outcomes.

The contrast is striking: NTLA faces near-term uncertainty with long-term revolutionary potential, while FLY rides current momentum in the hot space sector. Both require strong stomachs and clear exit strategies.

Disclaimer: This analysis is for educational purposes only. Always conduct your own research and consult with financial advisors before making investment decisions.

#Biotech #SpaceTech #GeneEditing #Earnings #StockAnalysis #NTLA #FLY

Is the NTLA Bloodbath a Put Seller's Dream or a Biotech Nightmare? 📉🧬

noreply@blogger.com (Unknown) — Mon, 27 Oct 2025 17:35:00 +0000

Intellia Therapeutics (NTLA) stock is reeling, dropping significantly today after announcing a temporary pause in patient dosing and screening for its Phase 3 MAGNITUDE trials (nex-z for ATTR amyloidosis). The cause? A serious liver safety signal—specifically, Grade 4 liver transaminases and increased total bilirubin—in a patient.

The market has reacted with understandable fear, creating extreme volatility and, consequently, high options premiums. This brings up a classic options trading question for those bullish on the long-term story: Is this the time to sell cash-secured puts on NTLA?

🎲 Risk vs. Reward for Selling Puts on NTLA

Selling a cash-secured put is a bullish or neutral strategy where you collect premium (your maximum profit) in exchange for agreeing to buy the stock at a specific lower price (the strike price) if the option is assigned.

The Reward (Premium Income):

Extreme Volatility = High Premium: The sudden drop and uncertainty have sent the implied volatility (IV) on NTLA options skyrocketing. This means the premiums you collect for selling puts are significantly inflated right now.
Buying at a Discount: If the stock recovers or stabilizes above your chosen strike price, you keep the entire premium as pure profit.
Lowered Cost Basis: If the stock continues to fall and you are assigned shares, the premium you collected effectively lowers your net purchase price. For example, if you sell the $\$10$ put for $\$2.00$ and get assigned, your cost basis is $\$8.00$ per share.

The Risk (The Biotech Nightmare):

Binary Event Risk: This is the core danger in biotech. A safety signal in a Phase 3 trial—especially one involving the liver—is a major setback for the nex-z program. If the issue is systemic and irreparable, the drug could be scrapped, and the stock could fall far lower.
"Catching a Falling Knife": NTLA has already cratered, but there is no floor. If you sell a put at a strike you thought was "safe," you could still be forced to buy shares at a price much higher than the subsequent market price, leading to a significant unrealized loss on the stock.
Tie-up of Capital: You must set aside the cash to buy the shares at the strike price (e.g., $\$1,000$ for a $\$10$ strike put on 100 shares). This capital is tied up until the option expires or is closed.

⚖️ The Calculated Trade-off

This is a high-conviction trade for a long-term NTLA bull.

Select a Strike Price Wisely: Only sell a put at a strike price where you would be genuinely happy to own 100 shares of NTLA. This safety event has shaken the stock to a price that may be closer to its cash value and the value of its remaining pipeline (like the Hereditary Angioedema program, which is still in a Phase 3 trial). Consider strikes that price in a massive, continued hit to the valuation.
Factor in the Premium: The fat premium acts as a buffer. The stock has to drop below (Strike Price - Premium Received) for the trade to be a loss (not including transaction costs).
Short-Term vs. Long-Term: The risk is very high in the immediate short term as the market digests the news. Selling a put with a longer expiration date (e.g., 60-90 days out) can give the company time to communicate a risk-mitigation strategy to the FDA, which could stabilize the stock.

Bottom Line: Selling puts on NTLA now is a bet that the current sell-off over-discounts the company's entire CRISPR platform and remaining pipeline, and that the liver safety issue is either manageable, specific to a sub-population, or only impacts the nex-z program and not the fundamental technology. If you don't believe in the underlying science and the potential for a rebound, stay away.

What strike price are you watching, or are you sitting on the sidelines? Let us know in the comments! 👇

Disclaimer: This is for informational and educational purposes only and is not financial advice. Options trading involves high risk.